{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import os\n",
    "from src.data import files_to_df\n",
    "\n",
    "SOURCE_PATH_ORIG = \"data/1_original/txt\"\n",
    "SOURCE_PATH_GEN = \"data/2_generated/2step_transformation_dt4h_GPT4omini/en\"\n",
    "ORIG_ENTS = \"output/data/ents_orig_scispacy.csv\"\n",
    "GEN_ENTS = \"output/data/2step_transformation_dt4h_GPT4omini/en/ents_gen_scispacy.csv\"\n",
    "\n",
    "df_gen = files_to_df(SOURCE_PATH_GEN)\n",
    "df_gen[\"filenameid\"] = df_gen[\"filenameid\"].str.replace(\"_transformed_step1\", \"\")\n",
    "\n",
    "df_orig = files_to_df(SOURCE_PATH_ORIG)\n",
    "df_pairs = df_orig.merge(df_gen, on=\"filenameid\", suffixes=(\"_orig\", \"_gen\"))\n",
    "# assert len(df_pairs) == N_EXPECTED_SAMPLES, f\"Expected {N_EXPECTED_SAMPLES} samples, got {len(df_pairs)}\"\n",
    "\n",
    "df_pairs.rename(columns={\"text_orig\": \"clinical_case\", \"text_gen\": \"discharge_summary\"}, inplace=True)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>filenameid</th>\n",
       "      <th>span</th>\n",
       "      <th>mention_class</th>\n",
       "      <th>code</th>\n",
       "      <th>term</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>33175723_1</td>\n",
       "      <td>Amyloid light-chain amyloidosis</td>\n",
       "      <td>DISEASE</td>\n",
       "      <td>C0268381</td>\n",
       "      <td>Primary amyloidosis</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>33175723_1</td>\n",
       "      <td>cardiac amyloidosis</td>\n",
       "      <td>DISEASE</td>\n",
       "      <td>C0268407</td>\n",
       "      <td>Senile cardiac amyloidosis</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>33175723_1</td>\n",
       "      <td>cardiomyopathy</td>\n",
       "      <td>DISEASE</td>\n",
       "      <td>C0878544</td>\n",
       "      <td>Cardiomyopathies</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>33175723_1</td>\n",
       "      <td>heart failure</td>\n",
       "      <td>DISEASE</td>\n",
       "      <td>C0018801</td>\n",
       "      <td>Heart failure</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>33175723_1</td>\n",
       "      <td>AL amyloidosis</td>\n",
       "      <td>DISEASE</td>\n",
       "      <td>C0268381</td>\n",
       "      <td>Primary amyloidosis</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33130</th>\n",
       "      <td>37861254</td>\n",
       "      <td>bevacizumab</td>\n",
       "      <td>CHEMICAL</td>\n",
       "      <td>C0796392</td>\n",
       "      <td>bevacizumab</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33131</th>\n",
       "      <td>37861254</td>\n",
       "      <td>bevacizumab</td>\n",
       "      <td>CHEMICAL</td>\n",
       "      <td>C0796392</td>\n",
       "      <td>bevacizumab</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33132</th>\n",
       "      <td>37861254</td>\n",
       "      <td>palpitation</td>\n",
       "      <td>DISEASE</td>\n",
       "      <td>C0030252</td>\n",
       "      <td>Palpitations</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33133</th>\n",
       "      <td>37861254</td>\n",
       "      <td>bevacizumab</td>\n",
       "      <td>CHEMICAL</td>\n",
       "      <td>C0796392</td>\n",
       "      <td>bevacizumab</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33134</th>\n",
       "      <td>37861254</td>\n",
       "      <td>fibrosis</td>\n",
       "      <td>DISEASE</td>\n",
       "      <td>C0016059</td>\n",
       "      <td>Fibrosis</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>33135 rows × 5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       filenameid                             span mention_class      code  \\\n",
       "0      33175723_1  Amyloid light-chain amyloidosis       DISEASE  C0268381   \n",
       "1      33175723_1              cardiac amyloidosis       DISEASE  C0268407   \n",
       "2      33175723_1                   cardiomyopathy       DISEASE  C0878544   \n",
       "3      33175723_1                    heart failure       DISEASE  C0018801   \n",
       "4      33175723_1                   AL amyloidosis       DISEASE  C0268381   \n",
       "...           ...                              ...           ...       ...   \n",
       "33130    37861254                      bevacizumab      CHEMICAL  C0796392   \n",
       "33131    37861254                      bevacizumab      CHEMICAL  C0796392   \n",
       "33132    37861254                      palpitation       DISEASE  C0030252   \n",
       "33133    37861254                      bevacizumab      CHEMICAL  C0796392   \n",
       "33134    37861254                         fibrosis       DISEASE  C0016059   \n",
       "\n",
       "                             term  \n",
       "0             Primary amyloidosis  \n",
       "1      Senile cardiac amyloidosis  \n",
       "2                Cardiomyopathies  \n",
       "3                   Heart failure  \n",
       "4             Primary amyloidosis  \n",
       "...                           ...  \n",
       "33130                 bevacizumab  \n",
       "33131                 bevacizumab  \n",
       "33132                Palpitations  \n",
       "33133                 bevacizumab  \n",
       "33134                    Fibrosis  \n",
       "\n",
       "[33135 rows x 5 columns]"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_auto = pd.read_csv(ORIG_ENTS)\n",
    "\n",
    "df_auto"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>filenameid</th>\n",
       "      <th>mention_class</th>\n",
       "      <th>term</th>\n",
       "      <th>span_orig</th>\n",
       "      <th>span_gen</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>25350173</td>\n",
       "      <td>DISEASE</td>\n",
       "      <td>Aneurysm</td>\n",
       "      <td>aneurysm</td>\n",
       "      <td>aneurysm</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>25350173</td>\n",
       "      <td>DISEASE</td>\n",
       "      <td>Cardiac Arrhythmia</td>\n",
       "      <td>arrhythmia</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>25350173</td>\n",
       "      <td>DISEASE</td>\n",
       "      <td>Cerebrovascular accident</td>\n",
       "      <td>LV stroke</td>\n",
       "      <td>LV stroke</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>25350173</td>\n",
       "      <td>DISEASE</td>\n",
       "      <td>Dyspnea</td>\n",
       "      <td>dyspnoea</td>\n",
       "      <td>Dyspnoea</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>25350173</td>\n",
       "      <td>DISEASE</td>\n",
       "      <td>Tachycardia, Ventricular</td>\n",
       "      <td>ventricular tachycardia</td>\n",
       "      <td>ventricular tachycardia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53376</th>\n",
       "      <td>39101327</td>\n",
       "      <td>CHEMICAL</td>\n",
       "      <td>hydroxychloroquine</td>\n",
       "      <td>hydroxychloroquine</td>\n",
       "      <td>hydroxychloroquine</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53377</th>\n",
       "      <td>39101327</td>\n",
       "      <td>CHEMICAL</td>\n",
       "      <td>mercury</td>\n",
       "      <td>Hg</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53378</th>\n",
       "      <td>39101327</td>\n",
       "      <td>CHEMICAL</td>\n",
       "      <td>putrescine N-hydroxycinnamoyltransferase activity</td>\n",
       "      <td>PHT</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53379</th>\n",
       "      <td>39101327</td>\n",
       "      <td>CHEMICAL</td>\n",
       "      <td>putrescine N-hydroxycinnamoyltransferase activity</td>\n",
       "      <td>PHT</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53380</th>\n",
       "      <td>39101327</td>\n",
       "      <td>CHEMICAL</td>\n",
       "      <td>sodium</td>\n",
       "      <td>sodium</td>\n",
       "      <td>sodium</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>53381 rows × 5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      filenameid mention_class  \\\n",
       "0       25350173       DISEASE   \n",
       "1       25350173       DISEASE   \n",
       "2       25350173       DISEASE   \n",
       "3       25350173       DISEASE   \n",
       "4       25350173       DISEASE   \n",
       "...          ...           ...   \n",
       "53376   39101327      CHEMICAL   \n",
       "53377   39101327      CHEMICAL   \n",
       "53378   39101327      CHEMICAL   \n",
       "53379   39101327      CHEMICAL   \n",
       "53380   39101327      CHEMICAL   \n",
       "\n",
       "                                                    term  \\\n",
       "0                                               Aneurysm   \n",
       "1                                     Cardiac Arrhythmia   \n",
       "2                               Cerebrovascular accident   \n",
       "3                                                Dyspnea   \n",
       "4                               Tachycardia, Ventricular   \n",
       "...                                                  ...   \n",
       "53376                                 hydroxychloroquine   \n",
       "53377                                            mercury   \n",
       "53378  putrescine N-hydroxycinnamoyltransferase activity   \n",
       "53379  putrescine N-hydroxycinnamoyltransferase activity   \n",
       "53380                                             sodium   \n",
       "\n",
       "                     span_orig                 span_gen  \n",
       "0                     aneurysm                 aneurysm  \n",
       "1                   arrhythmia                      NaN  \n",
       "2                    LV stroke                LV stroke  \n",
       "3                     dyspnoea                 Dyspnoea  \n",
       "4      ventricular tachycardia  ventricular tachycardia  \n",
       "...                        ...                      ...  \n",
       "53376       hydroxychloroquine       hydroxychloroquine  \n",
       "53377                       Hg                      NaN  \n",
       "53378                      PHT                      NaN  \n",
       "53379                      PHT                      NaN  \n",
       "53380                   sodium                   sodium  \n",
       "\n",
       "[53381 rows x 5 columns]"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_auto_gen = pd.read_csv(GEN_ENTS)\n",
    "df_auto_gen[\"filenameid\"] = df_auto_gen[\"filenameid\"].str.replace(\"_transformed_step1\", \"\")\n",
    "df_auto_merge = df_auto.merge(df_auto_gen, on=[\"filenameid\", \"term\", \"mention_class\"], how=\"outer\", suffixes=[\"_orig\", \"_gen\"])\n",
    "df_auto_merge = df_auto_merge.drop(columns=[\"code_orig\", \"code_gen\"])\n",
    "df_auto_merge = df_auto_merge[[\"filenameid\", \"mention_class\", \"term\", \"span_orig\", \"span_gen\"]]\n",
    "df_auto_merge"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "**Discharge Summary**\n",
      "\n",
      "**Patient Information:**\n",
      "- Name: [Patient Name]\n",
      "- Gender: Male\n",
      "- Age: 63 years\n",
      "\n",
      "**Final Diagnosis:**\n",
      "1. Amyloid light-chain amyloidosis\n",
      "2. Cardiac amyloidosis\n",
      "3. Cardiomyopathy\n",
      "4. Heart failure\n",
      "5. Primary AL amyloidosis\n",
      "\n",
      "**Symptoms on Admission:**\n",
      "- Aphasia\n",
      "- Dyspnea\n",
      "- Heart failure\n",
      "- Thrombosis\n",
      "- Tongue mass\n",
      "\n",
      "**Clinical Procedures Performed:**\n",
      "- Biopsy\n",
      "- Chemotherapy\n",
      "- Echocardiography\n",
      "\n",
      "**Clinical Summary:**\n",
      "The patient was admitted with newly diagnosed heart failure, characterized by elevated levels of natriuretic peptides and chronically high troponin values. During the course of treatment, the patient experienced transient aphasia, which resolved completely without any structural cerebral damage. An electrocardiogram (ECG) revealed low voltage in the limb leads and a pseudoinfarction pattern in the precordial leads. \n",
      "\n",
      "Clinical findings, including periorbital hematoma, a thickened tongue, proteinuria below the nephrotic range, and decreased glomerular filtration rate, raised suspicion for amyloidosis. Echocardiographic evaluation revealed spontaneous echo contrast in the cardiac cavities, which may have contributed to a recent cardioembolic cerebral event, despite the patient maintaining sinus rhythm.\n",
      "\n",
      "Further hematological investigations, including serum and urine protein immunofixation and serum kappa/lambda free light chain (FLC) ratio, identified monoclonal protein–immunoglobulin G (IgG) and lambda light chains. A bone marrow biopsy confirmed the diagnosis of multiple myeloma, showing 20% CD138+ atypical plasma cells with Congo red-positive amyloid infiltrates.\n",
      "\n",
      "Chemotherapy was initiated; however, the patient succumbed to refractory heart failure two months post-admission.\n",
      "\n",
      "**Disposition:**\n",
      "The patient was discharged to hospice care for palliative management of heart failure and related complications. \n",
      "\n",
      "**Follow-Up:**\n",
      "Family was advised on the importance of follow-up care and symptom management.\n",
      "\n",
      "\n",
      "\n",
      "['Discharge', 'Summary', 'Patient', 'Information', 'Name', 'Patient', 'Name', 'Gender', 'Male', 'Age', '63', 'years', 'Final', 'Diagnosis', '1', 'Amyloid', 'light', 'chain', 'amyloidosis', '2', 'Cardiac', 'amyloidosis', '3', 'Cardiomyopathy', '4', 'Heart', 'failure', '5', 'Primary', 'AL', 'amyloidosis', 'Symptoms', 'on', 'Admission', 'Aphasia', 'Dyspnea', 'Heart', 'failure', 'Thrombosis', 'Tongue', 'mass', 'Clinical', 'Procedures', 'Performed', 'Biopsy', 'Chemotherapy', 'Echocardiography', 'Clinical', 'Summary', 'The', 'patient', 'was', 'admitted', 'with', 'newly', 'diagnosed', 'heart', 'failure', 'characterized', 'by', 'elevated', 'levels', 'of', 'natriuretic', 'peptides', 'and', 'chronically', 'high', 'troponin', 'values', 'During', 'the', 'course', 'of', 'treatment', 'the', 'patient', 'experienced', 'transient', 'aphasia', 'which', 'resolved', 'completely', 'without', 'any', 'structural', 'cerebral', 'damage', 'An', 'electrocardiogram', 'ECG', 'revealed', 'low', 'voltage', 'in', 'the', 'limb', 'leads', 'and', 'a', 'pseudoinfarction', 'pattern', 'in', 'the', 'precordial', 'leads', 'Clinical', 'findings', 'including', 'periorbital', 'hematoma', 'a', 'thickened', 'tongue', 'proteinuria', 'below', 'the', 'nephrotic', 'range', 'and', 'decreased', 'glomerular', 'filtration', 'rate', 'raised', 'suspicion', 'for', 'amyloidosis', 'Echocardiographic', 'evaluation', 'revealed', 'spontaneous', 'echo', 'contrast', 'in', 'the', 'cardiac', 'cavities', 'which', 'may', 'have', 'contributed', 'to', 'a', 'recent', 'cardioembolic', 'cerebral', 'event', 'despite', 'the', 'patient', 'maintaining', 'sinus', 'rhythm', 'Further', 'hematological', 'investigations', 'including', 'serum', 'and', 'urine', 'protein', 'immunofixation', 'and', 'serum', 'kappa', 'lambda', 'free', 'light', 'chain', 'FLC', 'ratio', 'identified', 'monoclonal', 'protein', 'immunoglobulin', 'G', 'IgG', 'and', 'lambda', 'light', 'chains', 'A', 'bone', 'marrow', 'biopsy', 'confirmed', 'the', 'diagnosis', 'of', 'multiple', 'myeloma', 'showing', '20', 'CD138', 'atypical', 'plasma', 'cells', 'with', 'Congo', 'red', 'positive', 'amyloid', 'infiltrates', 'Chemotherapy', 'was', 'initiated', 'however', 'the', 'patient', 'succumbed', 'to', 'refractory', 'heart', 'failure', 'two', 'months', 'post', 'admission', 'Disposition', 'The', 'patient', 'was', 'discharged', 'to', 'hospice', 'care', 'for', 'palliative', 'management', 'of', 'heart', 'failure', 'and', 'related', 'complications', 'Follow', 'Up', 'Family', 'was', 'advised', 'on', 'the', 'importance', 'of', 'follow', 'up', 'care', 'and', 'symptom', 'management']\n"
     ]
    }
   ],
   "source": [
    "import re\n",
    "from typing import List\n",
    "\n",
    "    \n",
    "def extract_text_without_sections(text):\n",
    "    \n",
    "    \n",
    "    # text = re.sub(r'\\[.*?\\]', '', text)  # Remove placeholders\n",
    "\n",
    "    # Remove section headers (lines with ** at the start and end)\n",
    "    # text = re.sub(r'\\*\\*.*?\\*\\*', '', text)\n",
    "    \n",
    "    # # Remove list markers (e.g., \"- \" or numbered lists)\n",
    "    # text = re.sub(r'[-\\d]+\\.\\s*', '', text)\n",
    "    \n",
    "    # # Remove inline dashes used as separators\n",
    "    # text = re.sub(r'\\s*-\\s*', ' ', text)\n",
    "    \n",
    "    \n",
    "    # # Remove extra whitespace and newlines\n",
    "    # text = re.sub(r'\\n+', ' ', text).strip()\n",
    "    \n",
    "    return text\n",
    "    \n",
    "\n",
    "def split_and_clean(text: str, extract_headers=True) -> List[str]:\n",
    "    \"\"\"\n",
    "    Splits a given text into words and removes punctuation signs.\n",
    "    \n",
    "    Args:\n",
    "        text (str): The input text.\n",
    "    \n",
    "    Returns:\n",
    "        List[str]: A list of words without punctuation.\n",
    "    \"\"\"\n",
    "    if extract_headers:\n",
    "        text = extract_text_without_sections(text)\n",
    "    return re.findall(r'\\b\\w+\\b', text)\n",
    "\n",
    "\n",
    "\n",
    "example = df_pairs[\"discharge_summary\"].iloc[0]\n",
    "print(example)\n",
    "print(\"\\n\\n\")\n",
    "print(split_and_clean(example))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Patient: Male, 63-year-old\n",
      "\n",
      "\n",
      "Final Diagnosis:\n",
      "• Amyloid light-chain amyloidosis\n",
      "• cardiac amyloidosis\n",
      "• cardiomyopathy\n",
      "• heart failure\n",
      "• primary AL amyloidosis\n",
      "\n",
      "\n",
      "Symptoms:\n",
      "• Aphasia\n",
      "• dyspnea\n",
      "• heart failure\n",
      "• thrombosis\n",
      "• tongue mass\n",
      "\n",
      "Clinical Procedure:\n",
      "• Biopsy\n",
      "• chemotherapy\n",
      "• echocardiography\n",
      "\n",
      "Patient was admitted for newly diagnosed heart failure with high levels of natriuretic peptides and chronically elevated troponin values. During standard treatment, he had experienced transitory aphasia without structural cerebral damage and recovered completely. ECG showed low voltage in the limb leads with a pseudoinfarction pattern in the precordial leads. That finding along with the patient’s clinical presentation (periorbital hematoma, thickened tongue, proteinuria below the nephrotic range, and a decreased glomerular filtration rate) and echo findings were highly suspicious for amyloidosis.\n",
      "\n",
      "Spontaneous echo contrast was detected in the man’s heart cavities, possibly explaining his recent cardioembolic cerebral event despite sinus rhythm. Monoclonal protein–immunoglobulin G (IgG) and lambda light chains were detected on further hematological workup (serum and urine protein immunofixation, serum kappa/lambda free light chain [FLC] ratio). Bone marrow biopsy confirmed the diagnosis of multiple myeloma: 20% CD138+ atypical plasma cells with Congo red-positive amyloid infiltrates. Chemotherapy was started, but unfortunately, the patient died 2 months later from refractory heart failure.\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "['Patient', 'Male', '63', 'year', 'old', 'Final', 'Diagnosis', 'Amyloid', 'light', 'chain', 'amyloidosis', 'cardiac', 'amyloidosis', 'cardiomyopathy', 'heart', 'failure', 'primary', 'AL', 'amyloidosis', 'Symptoms', 'Aphasia', 'dyspnea', 'heart', 'failure', 'thrombosis', 'tongue', 'mass', 'Clinical', 'Procedure', 'Biopsy', 'chemotherapy', 'echocardiography', 'Patient', 'was', 'admitted', 'for', 'newly', 'diagnosed', 'heart', 'failure', 'with', 'high', 'levels', 'of', 'natriuretic', 'peptides', 'and', 'chronically', 'elevated', 'troponin', 'values', 'During', 'standard', 'treatment', 'he', 'had', 'experienced', 'transitory', 'aphasia', 'without', 'structural', 'cerebral', 'damage', 'and', 'recovered', 'completely', 'ECG', 'showed', 'low', 'voltage', 'in', 'the', 'limb', 'leads', 'with', 'a', 'pseudoinfarction', 'pattern', 'in', 'the', 'precordial', 'leads', 'That', 'finding', 'along', 'with', 'the', 'patient', 's', 'clinical', 'presentation', 'periorbital', 'hematoma', 'thickened', 'tongue', 'proteinuria', 'below', 'the', 'nephrotic', 'range', 'and', 'a', 'decreased', 'glomerular', 'filtration', 'rate', 'and', 'echo', 'findings', 'were', 'highly', 'suspicious', 'for', 'amyloidosis', 'Spontaneous', 'echo', 'contrast', 'was', 'detected', 'in', 'the', 'man', 's', 'heart', 'cavities', 'possibly', 'explaining', 'his', 'recent', 'cardioembolic', 'cerebral', 'event', 'despite', 'sinus', 'rhythm', 'Monoclonal', 'protein', 'immunoglobulin', 'G', 'IgG', 'and', 'lambda', 'light', 'chains', 'were', 'detected', 'on', 'further', 'hematological', 'workup', 'serum', 'and', 'urine', 'protein', 'immunofixation', 'serum', 'kappa', 'lambda', 'free', 'light', 'chain', 'FLC', 'ratio', 'Bone', 'marrow', 'biopsy', 'confirmed', 'the', 'diagnosis', 'of', 'multiple', 'myeloma', '20', 'CD138', 'atypical', 'plasma', 'cells', 'with', 'Congo', 'red', 'positive', 'amyloid', 'infiltrates', 'Chemotherapy', 'was', 'started', 'but', 'unfortunately', 'the', 'patient', 'died', '2', 'months', 'later', 'from', 'refractory', 'heart', 'failure']\n"
     ]
    }
   ],
   "source": [
    "example = df_pairs[\"clinical_case\"].iloc[0]\n",
    "print(example)\n",
    "print(\"\\n\\n\")\n",
    "print(split_and_clean(example, extract_headers=False))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 1000/1000 [00:00<00:00, 7774.96it/s]\n",
      "100%|██████████| 1000/1000 [00:00<00:00, 10689.01it/s]\n"
     ]
    }
   ],
   "source": [
    "from tqdm import tqdm\n",
    "tqdm.pandas()\n",
    "\n",
    "df_analysis = df_pairs.copy()\n",
    "df_analysis[\"n_words_cc\"] = df_analysis[\"clinical_case\"].progress_apply(lambda x: len(split_and_clean(x, extract_headers=False)))\n",
    "df_analysis[\"n_words_ds\"] = df_analysis[\"discharge_summary\"].progress_apply(lambda x: len(split_and_clean(x, extract_headers=True)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<Axes: xlabel='n_words_cc', ylabel='n_words_ds'>"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import seaborn as sns\n",
    "\n",
    "sns.regplot(x=\"n_words_cc\", y=\"n_words_ds\", data=df_analysis)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Text(0.5, 0.98, 'Distribution of generated/original number of words')"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1500x500 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "fig, ax = plt.subplots(1, 2, figsize=(15, 5))\n",
    "\n",
    "df_analysis[\"gen_orig_ratio\"] = df_analysis[\"n_words_ds\"] / df_analysis[\"n_words_cc\"]\n",
    "df_analysis[\"gen_orig_ratio\"].hist(bins=50, ax=ax[0])\n",
    "\n",
    "avg_ratio = df_analysis[\"gen_orig_ratio\"].mean()\n",
    "std_ratio = df_analysis[\"gen_orig_ratio\"].std()\n",
    "median_ratio = df_analysis[\"gen_orig_ratio\"].median()\n",
    "\n",
    "ax[0].vlines(x=[avg_ratio, median_ratio, avg_ratio - 1.5 * std_ratio, avg_ratio + 1.5 * std_ratio], ymax=65, ymin=0, colors=[\"r\", \"g\", \"k\", \"k\"])\n",
    "ax[0].text(x=avg_ratio + 0.05, y=65, fontdict={\"color\": \"r\"}, s=f\"Avg: {avg_ratio:.2f}\")\n",
    "ax[0].text(x=median_ratio - 0.4, y=65, fontdict={\"color\": \"g\"}, s=f\"Median: {median_ratio:.2f}\")\n",
    "\n",
    "ax[0].set_xlabel(\"Ratio\")\n",
    "ax[0].set_ylabel(\"Count\")\n",
    "\n",
    "sns.boxplot(data=df_analysis, x=\"gen_orig_ratio\", ax=ax[1])\n",
    "plt.suptitle(\"Distribution of generated/original number of words\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>n_words_cc</th>\n",
       "      <th>n_words_ds</th>\n",
       "      <th>gen_orig_ratio</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>n_words_cc</th>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.543223</td>\n",
       "      <td>-0.855091</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>n_words_ds</th>\n",
       "      <td>0.543223</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>-0.474170</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gen_orig_ratio</th>\n",
       "      <td>-0.855091</td>\n",
       "      <td>-0.474170</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                n_words_cc  n_words_ds  gen_orig_ratio\n",
       "n_words_cc        1.000000    0.543223       -0.855091\n",
       "n_words_ds        0.543223    1.000000       -0.474170\n",
       "gen_orig_ratio   -0.855091   -0.474170        1.000000"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import numpy as np\n",
    "df_analysis.select_dtypes(np.number).corr()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 750x750 with 12 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.pairplot(df_analysis)\n",
    "plt.suptitle(\"Length of Original Clinical Cases vs Generated Discharge Summaries\")\n",
    "plt.tight_layout()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "count    1000.000000\n",
       "mean        0.828498\n",
       "std         0.339017\n",
       "min         0.195122\n",
       "25%         0.581132\n",
       "50%         0.778715\n",
       "75%         1.049462\n",
       "max         2.129032\n",
       "Name: gen_orig_ratio, dtype: float64"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "desc = df_analysis[\"gen_orig_ratio\"].describe()\n",
    "desc"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1.751956268516218\n",
      "0.25630540493714665\n"
     ]
    }
   ],
   "source": [
    "q3 = desc[\"75%\"]\n",
    "q1 = desc[\"25%\"]\n",
    "iqr = q3 - q1\n",
    "up_thres = q3 +  1.5 * iqr\n",
    "# low_thres = max(q1 - 1.5 * iqr, desc[\"min\"])\n",
    "# low_thres = q1\n",
    "low_thres = df_analysis[\"gen_orig_ratio\"].quantile(0.01)\n",
    "print(up_thres)\n",
    "print(low_thres)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>filenameid</th>\n",
       "      <th>clinical_case</th>\n",
       "      <th>discharge_summary</th>\n",
       "      <th>n_words_cc</th>\n",
       "      <th>n_words_ds</th>\n",
       "      <th>gen_orig_ratio</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>773</th>\n",
       "      <td>33858880</td>\n",
       "      <td>A 21-year-old man initially presented with sho...</td>\n",
       "      <td>**Discharge Summary**\\n\\n**Patient Information...</td>\n",
       "      <td>1845</td>\n",
       "      <td>360</td>\n",
       "      <td>0.195122</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>833</th>\n",
       "      <td>30785587</td>\n",
       "      <td>A 51-year-old male, hypertensive patient, a fo...</td>\n",
       "      <td>**Discharge Summary**\\n\\n**Patient Information...</td>\n",
       "      <td>2206</td>\n",
       "      <td>448</td>\n",
       "      <td>0.203083</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>635</th>\n",
       "      <td>38050248</td>\n",
       "      <td>Patient information\\nThe case involves a 42-ye...</td>\n",
       "      <td>**Discharge Summary**\\n\\n**Patient Information...</td>\n",
       "      <td>1754</td>\n",
       "      <td>365</td>\n",
       "      <td>0.208096</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>193</th>\n",
       "      <td>30226919</td>\n",
       "      <td>The patient is a 60-year-old female with Chaga...</td>\n",
       "      <td>**Discharge Summary**\\n\\n**Patient Information...</td>\n",
       "      <td>1766</td>\n",
       "      <td>388</td>\n",
       "      <td>0.219706</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>278</th>\n",
       "      <td>33544806</td>\n",
       "      <td>Clinical history\\n\\nFour years before the admi...</td>\n",
       "      <td>**Discharge Summary**\\n\\n**Patient Information...</td>\n",
       "      <td>1918</td>\n",
       "      <td>437</td>\n",
       "      <td>0.227842</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>487</th>\n",
       "      <td>33263366</td>\n",
       "      <td>We present a 55-year-old woman with a history ...</td>\n",
       "      <td>**Discharge Summary**\\n\\n**Patient Information...</td>\n",
       "      <td>1400</td>\n",
       "      <td>338</td>\n",
       "      <td>0.241429</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>563</th>\n",
       "      <td>31378248</td>\n",
       "      <td>A 50-year-old man presented to his primary car...</td>\n",
       "      <td>**Discharge Summary**\\n\\n**Patient Information...</td>\n",
       "      <td>1901</td>\n",
       "      <td>472</td>\n",
       "      <td>0.248290</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>817</th>\n",
       "      <td>37885296</td>\n",
       "      <td>A 40-year-old female patient with a history of...</td>\n",
       "      <td>**Discharge Summary**\\n\\n**Patient Information...</td>\n",
       "      <td>1339</td>\n",
       "      <td>338</td>\n",
       "      <td>0.252427</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>769</th>\n",
       "      <td>38545376</td>\n",
       "      <td>Patient information\\nThe patient was a 16-year...</td>\n",
       "      <td>**Discharge Summary**\\n\\n**Patient Information...</td>\n",
       "      <td>1560</td>\n",
       "      <td>399</td>\n",
       "      <td>0.255769</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>764</th>\n",
       "      <td>32111713</td>\n",
       "      <td>A 32 year-old woman was admitted to our instit...</td>\n",
       "      <td>**Discharge Summary**\\n\\n**Patient Information...</td>\n",
       "      <td>1513</td>\n",
       "      <td>387</td>\n",
       "      <td>0.255783</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    filenameid                                      clinical_case  \\\n",
       "773   33858880  A 21-year-old man initially presented with sho...   \n",
       "833   30785587  A 51-year-old male, hypertensive patient, a fo...   \n",
       "635   38050248  Patient information\\nThe case involves a 42-ye...   \n",
       "193   30226919  The patient is a 60-year-old female with Chaga...   \n",
       "278   33544806  Clinical history\\n\\nFour years before the admi...   \n",
       "487   33263366  We present a 55-year-old woman with a history ...   \n",
       "563   31378248  A 50-year-old man presented to his primary car...   \n",
       "817   37885296  A 40-year-old female patient with a history of...   \n",
       "769   38545376  Patient information\\nThe patient was a 16-year...   \n",
       "764   32111713  A 32 year-old woman was admitted to our instit...   \n",
       "\n",
       "                                     discharge_summary  n_words_cc  \\\n",
       "773  **Discharge Summary**\\n\\n**Patient Information...        1845   \n",
       "833  **Discharge Summary**\\n\\n**Patient Information...        2206   \n",
       "635  **Discharge Summary**\\n\\n**Patient Information...        1754   \n",
       "193  **Discharge Summary**\\n\\n**Patient Information...        1766   \n",
       "278  **Discharge Summary**\\n\\n**Patient Information...        1918   \n",
       "487  **Discharge Summary**\\n\\n**Patient Information...        1400   \n",
       "563  **Discharge Summary**\\n\\n**Patient Information...        1901   \n",
       "817  **Discharge Summary**\\n\\n**Patient Information...        1339   \n",
       "769  **Discharge Summary**\\n\\n**Patient Information...        1560   \n",
       "764  **Discharge Summary**\\n\\n**Patient Information...        1513   \n",
       "\n",
       "     n_words_ds  gen_orig_ratio  \n",
       "773         360        0.195122  \n",
       "833         448        0.203083  \n",
       "635         365        0.208096  \n",
       "193         388        0.219706  \n",
       "278         437        0.227842  \n",
       "487         338        0.241429  \n",
       "563         472        0.248290  \n",
       "817         338        0.252427  \n",
       "769         399        0.255769  \n",
       "764         387        0.255783  "
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "outliers_low = df_analysis[df_analysis[\"gen_orig_ratio\"] < low_thres].sort_values(by=\"gen_orig_ratio\", ascending=True)\n",
    "outliers_low"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "A 21-year-old man initially presented with shortness of breath and abdominal swelling. He was found to be in renal failure with urinary retention and subsequent imaging confirmed severe bilateral hydronephrosis requiring bilateral nephrostomies. He described a 4-month history of progressive shortness of breath on exertion, orthopnoea, weight loss and general malaise. Three months prior to this he had been treated by his general practitioner with a course of oral antibiotics for a productive cough, fevers and shortness of breath. There was no significant past medical history and family history was not suspicious for cardiomyopathy or sudden cardiac death. He was an ex-smoker, having stopped 3 years earlier. Alcohol and illicit drug use were denied, however there was a history of regular ‘Energy drink’ drink consumption, specifically consuming an average of four 500 mL cans per day for approximately 2 years. Each can contains 160 mg of caffeine in addition to taurine and various other ingredients. Retrospectively, the patient recalls occasional symptoms of dyspepsia, tremor and a racing heartbeat but without seeking medical review. In the 3 months prior to admission he was unable to continue his university studies due to his lethargy and feelings of ill health.\n",
      "\n",
      "Creatinine on presentation was 562 μmol/L, with urea of 47.4 mmol/L. Bilateral nephrostomies were inserted on day 3 of admission, with little subsequent improvement in renal function. He did not require any cardiovascular or respiratory support. On examination he was found to be in decompensated cardiac failure with pitting oedema to his knees and ascites. Clinically, he was not in pulmonary oedema. ECG demonstrated minor non-specific findings. A transthoracic echocardiogram showed a dilated left ventricle (LV) with a severely reduced ejection fraction (EF), biplane EF 11% with no left ventricular hypertrophy (LVH), a dilated right ventricle (RV) with impaired systolic function, bi-atrial dilatation, mild mitral regurgitation, mild tricuspid regurgitation and a small localised pericardial effusion 0.4 cm in size. There were bilateral ventricular thrombi caused by stasis requiring systemic anticoagulation with intravenous unfractionated heparin.\n",
      "\n",
      "The patient was then transferred to a tertiary hospital with access to advanced mechanical circulatory support in the event of deterioration. His admission was complicated by subclinical embolic and hypoperfusion-related cerebral infarcts, uraemic encephalopathy requiring emergency haemodialysis and heparin-induced thrombocytopenia. Haemodialysis was initiated on the intensive care unit on day 9, requiring a small amount of norepinephrine vasopressor support initially (0.04 μg/kg/min) but no inotropic agents were required. At the time there was concern that initiation of dialysis might result in cardiovascular collapse, which fortunately did not occur. This suggests that the low cardiac output was likely to have been chronic over a period of months for such haemodynamic compensation to occur. Given his intracardiac thrombi and renal failure, he initially received anticoagulation with intravenous unfractionated heparin. On day 9 of unfractionated heparin treatment his platelet count was noted to be 70×109/L following a gradual decline over the previous week (lowest platelet count 26×109/L on day 12). A positive heparin-induced thrombocytopenia screen resulted in a switch to argatroban. The patient stabilised on the intensive care unit but remained in cardiac and renal failure requiring regular haemodialysis without improvement in cardiac function and remaining haemodynamically stable off vasopressor support and without any inotrope requirement.\n",
      "\n",
      "He was referred and subsequently transferred for consideration of combined cardiac and renal transplantation. While urological investigations were being carried out to assess the suitability for kidney transplantation, his urine output via nephrostomies and urinary bladder improved with stable renal chemistry and fluid status, allowing a break from dialysis. Invasive assessment of his cardiac output with right heart catheterisation indicated that this was adequate, so imminent cardiac transplantation or mechanical circulatory support was not required at the time.\n",
      "\n",
      "Fifty-eight days after his initial presentation he was discharged home from hospital with ongoing cardiology, renal and urology follow-up with a creatinine of 383 μmol/L. His repeat outpatient cardiac magnetic resonance (CMR) scan after 2 months showed improvement in LVEF to 18% and repeat transthoracic echocardiogram at 9 months post discharge showed further improvement of LVEF to 51% with normal right ventricular function. His CMR indicated that there was no scar, inflammation or oedema.\n",
      "\n",
      "\n",
      "Investigations\n",
      "\n",
      "Admission ECG showed sinus tachycardia with a ventricular rate of 135 bpm, QRS duration of 110 ms and a normal PR interval. There was T-wave inversion in leads I and aVL and left axis deviation.\n",
      "Blood tests.\n",
      "Plain film chest radiograph (5/12/19, day 3 of admission) showed cardiomegaly, no pleural effusions and no pulmonary oedema\n",
      "\n",
      "Transthoracic echocardiogram (1) (5/12/19) showed a dilated LV (LV diameter 7.2 cm) with severely reduced EF (11%). No LVH. Laminated thrombus in LV mid anteroseptal wall extending to apex, dilated left atrium (30 cm2), dilated RV (6.3 cm base) with impaired systolic function. Tricuspid annular plane systolic excursion 14 mm. RV S’ 0.09 m/s, dilated right atrium (24 cm2), small pericardial effusion 0.4 cm atrial side, mild tricuspid regurgitation, RV systolic pressure 32 mmHg+right atrial pressure, mild mitral regurgitation, other valves were normal.\n",
      "CMR imaging (1) (11/12/19): CMR imaging showed a non-ischaemic cardiomyopathy with global severely impaired LV and RV systolic function, with LVEF of 9% and RVEF of 16%, severe bi-atrial dilatation with multiple LV and RV thrombi noted. No myocardial fibrosis, infiltration or infarction.\n",
      "CMR imaging (2) (14/2/20): CMR imaging showed improving but still severely impaired global LV systolic function (LVEF 18%). The mid inferior lateral wall is relatively more hypokinetic and there is improvement in RV function (RVEF 33%). No myocardial oedema and no obvious thrombi although gadolinium was not used on this occasion.\n",
      "Transthoracic echocardiogram (2) (10/6/20) showed a normal LV cavity size (LV diameter 5.7 cm) with global moderate impairment of systolic function (LVEF 38%). Normal RV size and function, normal bi-atrial sizes.\n",
      "Transthoracic echocardiogram (3) (18/8/20) showed a normal LV cavity size with mildly impaired systolic function (LVEF 51%). Normal RV size and function, normal bi-atrial sizes.\n",
      "Right heart catheterisation.\n",
      "MRI brain/spinal cord/lumbar spine (17/12/19): Combination of cardioembolic and hypoperfusion acute infarcts. The extensive bilateral subcortical acute infarcts as described favour a cardioembolic aetiology whereas the bilateral internal border zone acute infarcts suggest a hypoperfusion aetiology. No cauda equina/spinal cord compression, normal spinal cord and lumbar spine.\n",
      "Ultrasound abdomen (6/12/19): Enlarged kidneys with severe hydronephrosis and ureteric dilatation seen bilaterally. Increased echogenicity of the renal cortex and diffuse cortical thinning, appearance suggestive of chronic/longstanding obstruction. The liver is moderately enlarged with mild increased echogenicity of the parenchyma. The IVC in hepatic veins are prominent in size, likely in keeping with cardiac history.\n",
      "Urodynamic studies (1/7/20): Bladder capacity 400 mL. Reflux to upper tracts increasing volume and lowering pressure. Bladder outline highly trabeculated with closed bladder neck. No loss of compliance measured (upper tracts compensating for this).\n",
      "Bladder biopsy (20/08/20): Bladder mucosa shows stromal oedema, moderate chronic inflammation and stromal haemorrhage. No malignancy and no smooth muscle in biopsy samples.\n",
      "\n",
      "\n",
      "Differential diagnosis\n",
      "\n",
      "This was a case of severe biventricular failure with biventricular thrombi of uncertain aetiology. A number of differential diagnoses were considered.\n",
      "\n",
      "First, a stress-induced or ‘Takotsubo’ cardiomyopathy was felt to be less likely in this case given an absence of a preceding emotional or physical stressor, although these stressors may not be present in up to one-third of patients with Takotsubo syndrome.5 The insidious onset, over months prior to admission, was also not typical for Takotsubo syndrome, which classically presents more acutely and left ventricular function often recovers more quickly (usually within 21 days of onset).6 Furthermore, our patient did not fulfil the revised Mayo Clinic criteria7 or the international Takotsubo diagnostic criteria,8 and transthoracic echocardiography did not show any of the characteristic features (transient hypokinesis, akinesis or dyskinesis of the left ventricular mid-segments with or without apical involvement or any regional wall motion abnormalities extending beyond a single epicardial vascular distribution).9 Finally, Takotsubo syndrome predominantly affects postmenopausal women, although there have been case reports of younger male patients.10\n",
      "\n",
      "Heart failure secondary to myocarditis was also considered, however again the insidious clinical course was not typical for acute fulminant myocarditis and the CMR scan did not show the typical myocardial inflammation or fibrosis associated with this condition. Heart failure secondary to metabolic disturbances resulting from chronic renal failure was also considered as a potential differential diagnosis.\n",
      "\n",
      "A tachycardia-related cardiomyopathy was excluded as there was no evidence of arrhythmia throughout the admission, during which the patient remained on cardiac monitoring. Given the history of chronic energy drink consumption, lack of significant past medical or family history, cardiac imaging findings and improvement with ceasing intake, energy drink-induced cardiotoxicity was felt to be the most likely cause.\n",
      "\n",
      "\n",
      "Treatment\n",
      "\n",
      "Initial medical treatment was with intravenous furosemide and antibiotics for a suspected community acquired pneumonia. The patient was anticoagulated with unfractionated heparin, later switched to argatroban and then warfarin due to heparin-induced thrombocytopenia.\n",
      "\n",
      "Bilateral nephrostomies were inserted 3 days after admission, with little subsequent improvement in renal function. He later required temporary haemodialysis and now remains a low clearance patient under renal and urology follow-up with bilateral nephrostomies and ureteric stents.\n",
      "\n",
      "After stabilisation he was discharged on the following medications: warfarin once daily, carvedilol 3.125 mg twice daily, furosemide 20 mg once daily, isosorbide dinitrate 20 mg twice daily, hydralazine 25 mg three times a day, lansoprazole and oral nutritional supplements. Persisting severe renal impairment prevented the introduction of ACE inhibitor or mineralocorticoid receptor antagonist.\n",
      "\n",
      "\n",
      "Outcome and follow-up\n",
      "\n",
      "Post discharge, the patient had a considerable increase in exercise tolerance without any symptoms of heart failure or palpitations (NYHA class I). The patient had maintained euvolaemia and haemodynamic stability. Renal function remained severely impaired (estimated glomerular filtration rate 18 mL/min), and we were able to uptitrate carvedilol to 6.25 mg twice daily during the follow-up period in addition to his other medications. At 9 months post-discharge, a repeat echocardiogram showed that the left ventricular size had normalised with mildly impaired systolic function (LVEF 51%). There was no evidence of the previous intracardiac thrombus.\n",
      "\n",
      "As mentioned previously, poor renal function has largely inhibited the use of best medical therapy for heart failure. However, despite this, the patient has continued to improve and recover ventricular function. This is likely to be due to avoidance of energy drinks. He is no longer under follow-up from the cardiac transplantation team due to his improvement. However, it is difficult to predict the clinical course of recovery or potential for relapse. It is likely that the patient will at some point require renal transplantation. He has undergone urodynamic studies and bladder biopsies, which have not conclusively identified the cause of obstructive uropathy but do indicate that future bladder reconstruction is likely to be required to protect a future renal graft.\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "print(outliers_low.iloc[0][\"clinical_case\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>filenameid</th>\n",
       "      <th>clinical_case</th>\n",
       "      <th>discharge_summary</th>\n",
       "      <th>n_words_cc</th>\n",
       "      <th>n_words_ds</th>\n",
       "      <th>gen_orig_ratio</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>205</th>\n",
       "      <td>30503742_1</td>\n",
       "      <td>A third patient, a 29-year-old man with histor...</td>\n",
       "      <td>**Discharge Summary**\\n\\n**Patient Information...</td>\n",
       "      <td>124</td>\n",
       "      <td>264</td>\n",
       "      <td>2.129032</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>947</th>\n",
       "      <td>26512038</td>\n",
       "      <td>We present a case of a 34-year-old man with ac...</td>\n",
       "      <td>**Discharge Summary**\\n\\n**Patient Information...</td>\n",
       "      <td>80</td>\n",
       "      <td>163</td>\n",
       "      <td>2.037500</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>169</th>\n",
       "      <td>29437819</td>\n",
       "      <td>A 67-year-old man with a history of non-ischae...</td>\n",
       "      <td>**Discharge Summary**\\n\\n**Patient Information...</td>\n",
       "      <td>89</td>\n",
       "      <td>177</td>\n",
       "      <td>1.988764</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>520</th>\n",
       "      <td>36742441_2</td>\n",
       "      <td>A 70-year-old man with a history of advanced s...</td>\n",
       "      <td>**Discharge Summary**\\n\\n**Patient Information...</td>\n",
       "      <td>119</td>\n",
       "      <td>236</td>\n",
       "      <td>1.983193</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>302</th>\n",
       "      <td>30503742_2</td>\n",
       "      <td>A second patient, a 46-year-old man with nonis...</td>\n",
       "      <td>**Discharge Summary**\\n\\n**Patient Information...</td>\n",
       "      <td>131</td>\n",
       "      <td>259</td>\n",
       "      <td>1.977099</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>755</th>\n",
       "      <td>36742441_1</td>\n",
       "      <td>A 71-year-old woman had a history of advanced ...</td>\n",
       "      <td>**Discharge Summary**\\n\\n**Patient Information...</td>\n",
       "      <td>105</td>\n",
       "      <td>201</td>\n",
       "      <td>1.914286</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>793</th>\n",
       "      <td>30971480_1</td>\n",
       "      <td>A 67‐year‐old woman with a recurrent leiomyosa...</td>\n",
       "      <td>**Discharge Summary**\\n\\n**Patient Information...</td>\n",
       "      <td>147</td>\n",
       "      <td>273</td>\n",
       "      <td>1.857143</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>304</th>\n",
       "      <td>31452187</td>\n",
       "      <td>A 77-year-old woman was hospitalized for acute...</td>\n",
       "      <td>**Discharge Summary**\\n\\n**Patient Information...</td>\n",
       "      <td>131</td>\n",
       "      <td>242</td>\n",
       "      <td>1.847328</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>933</th>\n",
       "      <td>31939641</td>\n",
       "      <td>A 39-year-old man with a history of mild inter...</td>\n",
       "      <td>**Discharge Summary**\\n\\n**Patient Information...</td>\n",
       "      <td>168</td>\n",
       "      <td>309</td>\n",
       "      <td>1.839286</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>477</th>\n",
       "      <td>35038791_1</td>\n",
       "      <td>The first patient was a 53‐year old male and h...</td>\n",
       "      <td>**Discharge Summary**\\n\\n**Patient Information...</td>\n",
       "      <td>111</td>\n",
       "      <td>199</td>\n",
       "      <td>1.792793</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>756</th>\n",
       "      <td>34962097_1</td>\n",
       "      <td>A 55‐year‐old man affected by hypertrophic car...</td>\n",
       "      <td>**Discharge Summary**\\n\\n**Patient Information...</td>\n",
       "      <td>160</td>\n",
       "      <td>286</td>\n",
       "      <td>1.787500</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>461</th>\n",
       "      <td>30197408</td>\n",
       "      <td>A 72-year-old woman was referred for examinati...</td>\n",
       "      <td>**Discharge Summary**\\n\\n**Patient Information...</td>\n",
       "      <td>133</td>\n",
       "      <td>237</td>\n",
       "      <td>1.781955</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     filenameid                                      clinical_case  \\\n",
       "205  30503742_1  A third patient, a 29-year-old man with histor...   \n",
       "947    26512038  We present a case of a 34-year-old man with ac...   \n",
       "169    29437819  A 67-year-old man with a history of non-ischae...   \n",
       "520  36742441_2  A 70-year-old man with a history of advanced s...   \n",
       "302  30503742_2  A second patient, a 46-year-old man with nonis...   \n",
       "755  36742441_1  A 71-year-old woman had a history of advanced ...   \n",
       "793  30971480_1  A 67‐year‐old woman with a recurrent leiomyosa...   \n",
       "304    31452187  A 77-year-old woman was hospitalized for acute...   \n",
       "933    31939641  A 39-year-old man with a history of mild inter...   \n",
       "477  35038791_1  The first patient was a 53‐year old male and h...   \n",
       "756  34962097_1  A 55‐year‐old man affected by hypertrophic car...   \n",
       "461    30197408  A 72-year-old woman was referred for examinati...   \n",
       "\n",
       "                                     discharge_summary  n_words_cc  \\\n",
       "205  **Discharge Summary**\\n\\n**Patient Information...         124   \n",
       "947  **Discharge Summary**\\n\\n**Patient Information...          80   \n",
       "169  **Discharge Summary**\\n\\n**Patient Information...          89   \n",
       "520  **Discharge Summary**\\n\\n**Patient Information...         119   \n",
       "302  **Discharge Summary**\\n\\n**Patient Information...         131   \n",
       "755  **Discharge Summary**\\n\\n**Patient Information...         105   \n",
       "793  **Discharge Summary**\\n\\n**Patient Information...         147   \n",
       "304  **Discharge Summary**\\n\\n**Patient Information...         131   \n",
       "933  **Discharge Summary**\\n\\n**Patient Information...         168   \n",
       "477  **Discharge Summary**\\n\\n**Patient Information...         111   \n",
       "756  **Discharge Summary**\\n\\n**Patient Information...         160   \n",
       "461  **Discharge Summary**\\n\\n**Patient Information...         133   \n",
       "\n",
       "     n_words_ds  gen_orig_ratio  \n",
       "205         264        2.129032  \n",
       "947         163        2.037500  \n",
       "169         177        1.988764  \n",
       "520         236        1.983193  \n",
       "302         259        1.977099  \n",
       "755         201        1.914286  \n",
       "793         273        1.857143  \n",
       "304         242        1.847328  \n",
       "933         309        1.839286  \n",
       "477         199        1.792793  \n",
       "756         286        1.787500  \n",
       "461         237        1.781955  "
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "outliers = df_analysis[df_analysis[\"gen_orig_ratio\"] > up_thres].sort_values(by=\"gen_orig_ratio\", ascending=False)\n",
    "outliers"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 105,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'filenameid': '30785587', 'n_words_cc': 2206, 'n_words_ds': 348, 'gen_orig_ratio': 0.15775158658204896}\n",
      "==================================================\n",
      "|      | mention_class   | term                                      | span_orig                          | span_gen                    |\n",
      "|-----:|:----------------|:------------------------------------------|:-----------------------------------|:----------------------------|\n",
      "| 8636 | CHEMICAL        | Adrenergic beta-Antagonists               | beta-blocker                       | beta-blocker                |\n",
      "| 8637 | DISEASE         | Anemia                                    | None                               | anemia                      |\n",
      "| 8638 | DISEASE         | Anemia                                    | None                               | anemia                      |\n",
      "| 8639 | DISEASE         | Aneurysm                                  | aneurysm                           | None                        |\n",
      "| 8640 | DISEASE         | Aneurysm                                  | aneurysms                          | None                        |\n",
      "| 8641 | DISEASE         | Aneurysm                                  | aneurysms                          | None                        |\n",
      "| 8642 | DISEASE         | Aneurysm                                  | aneurysm                           | None                        |\n",
      "| 8643 | DISEASE         | Aneurysm                                  | aneurysm                           | None                        |\n",
      "| 8644 | DISEASE         | Aneurysm                                  | Aneurysm                           | None                        |\n",
      "| 8645 | DISEASE         | Aortic Aneurysm                           | aortic aneurysm                    | aortic aneurysm             |\n",
      "| 8646 | DISEASE         | Aortic Aneurysm                           | aortic aneurysm                    | aortic aneurysms            |\n",
      "| 8647 | DISEASE         | Aortic Aneurysm                           | aortic aneurysm                    | aortic aneurysm             |\n",
      "| 8648 | DISEASE         | Aortic Aneurysm                           | aortic aneurysm                    | aortic aneurysms            |\n",
      "| 8649 | DISEASE         | Aortic Aneurysm                           | aortic aneurysm                    | aortic aneurysm             |\n",
      "| 8650 | DISEASE         | Aortic Aneurysm                           | aortic aneurysm                    | aortic aneurysms            |\n",
      "| 8651 | DISEASE         | Aortic Aneurysm                           | aortic aneurysms                   | aortic aneurysm             |\n",
      "| 8652 | DISEASE         | Aortic Aneurysm                           | aortic aneurysms                   | aortic aneurysms            |\n",
      "| 8653 | DISEASE         | Aortic Aneurysm                           | aortic aneurysms                   | aortic aneurysm             |\n",
      "| 8654 | DISEASE         | Aortic Aneurysm                           | aortic aneurysms                   | aortic aneurysms            |\n",
      "| 8655 | DISEASE         | Aortic Aneurysm                           | aortic aneurysm                    | aortic aneurysm             |\n",
      "| 8656 | DISEASE         | Aortic Aneurysm                           | aortic aneurysm                    | aortic aneurysms            |\n",
      "| 8657 | DISEASE         | Aortic Aneurysm, Thoracic                 | thoracic aneurysm                  | None                        |\n",
      "| 8658 | DISEASE         | Aortic Valve Insufficiency                | aortic regurgitation               | aortic valve regurgitation  |\n",
      "| 8659 | DISEASE         | Aortic Valve Insufficiency                | aortic regurgitation               | aortic valve regurgitation  |\n",
      "| 8660 | DISEASE         | Aortic Valve Insufficiency                | aortic valve regurgitation         | aortic valve regurgitation  |\n",
      "| 8661 | DISEASE         | Aortic Valve Insufficiency                | aortic regurgitation               | aortic valve regurgitation  |\n",
      "| 8662 | DISEASE         | Aortic Valve Insufficiency                | chronic aortic valve regurgitation | aortic valve regurgitation  |\n",
      "| 8663 | DISEASE         | Aortic dilation                           | aortic dilation                    | None                        |\n",
      "| 8664 | DISEASE         | Aortic valve structure                    | None                               | aortic valve                |\n",
      "| 8665 | DISEASE         | Arteriosclerosis                          | atherosclerosis                    | None                        |\n",
      "| 8666 | DISEASE         | Arteriosclerosis                          | atherosclerosis                    | None                        |\n",
      "| 8667 | DISEASE         | Arthralgia                                | arthralgias                        | None                        |\n",
      "| 8668 | DISEASE         | Ascites                                   | ascites                            | None                        |\n",
      "| 8669 | CHEMICAL        | Bicarbonates                              | bicarbonate                        | None                        |\n",
      "| 8670 | DISEASE         | Cardiomegaly                              | cardiomegaly                       | None                        |\n",
      "| 8671 | DISEASE         | Cardiovascular system alteration          | cardiovascular alterations         | None                        |\n",
      "| 8672 | DISEASE         | Cessation of life                         | death                              | death                       |\n",
      "| 8673 | DISEASE         | Chest Pain                                | chest pain                         | chest pain                  |\n",
      "| 8674 | DISEASE         | Chest Pain                                | chest pain                         | chest pain                  |\n",
      "| 8675 | DISEASE         | Cleft Palate                              | cleft palate                       | None                        |\n",
      "| 8676 | DISEASE         | Common Cold                               | coryza                             | None                        |\n",
      "| 8677 | DISEASE         | Communicable Diseases                     | None                               | infection                   |\n",
      "| 8678 | DISEASE         | Congestive heart failure                  | Congestive heart failure           | Congestive heart failure    |\n",
      "| 8679 | DISEASE         | Connective Tissue Diseases                | None                               | connective tissue disorders |\n",
      "| 8680 | DISEASE         | Cutis Laxa                                | cutis laxa                         | None                        |\n",
      "| 8681 | DISEASE         | Diabetes Mellitus                         | diabetes mellitus                  | None                        |\n",
      "| 8682 | DISEASE         | Diarrhea                                  | diarrhea                           | None                        |\n",
      "| 8683 | DISEASE         | Dislocations                              | dislocations                       | None                        |\n",
      "| 8684 | DISEASE         | Dissecting aneurysm of the thoracic aorta | thoracic aortic dissection         | thoracic aortic dissection  |\n",
      "| 8685 | DISEASE         | Dissecting aneurysm of the thoracic aorta | thoracic aortic dissection         | thoracic aortic             |\n",
      "| 8686 | DISEASE         | Dissecting aneurysm of the thoracic aorta | thoracic aortic dissection         | thoracic aortic dissection  |\n",
      "| 8687 | DISEASE         | Dissecting aneurysm of the thoracic aorta | thoracic aortic dissection         | thoracic aortic             |\n",
      "| 8688 | DISEASE         | Dyspnea                                   | dyspnea                            | dyspnea                     |\n",
      "| 8689 | DISEASE         | Dyspnea                                   | dyspnea                            | dyspnea                     |\n",
      "| 8690 | DISEASE         | Dyspnea                                   | dyspnea                            | Dyspnea                     |\n",
      "| 8691 | DISEASE         | Dyspnea                                   | dyspnea                            | dyspnea                     |\n",
      "| 8692 | DISEASE         | Dyspnea                                   | dyspnea                            | dyspnea                     |\n",
      "| 8693 | DISEASE         | Dyspnea                                   | dyspnea                            | Dyspnea                     |\n",
      "| 8694 | DISEASE         | Dyspnea                                   | dyspnea                            | dyspnea                     |\n",
      "| 8695 | DISEASE         | Dyspnea                                   | dyspnea                            | dyspnea                     |\n",
      "| 8696 | DISEASE         | Dyspnea                                   | dyspnea                            | Dyspnea                     |\n",
      "| 8697 | DISEASE         | Ecchymosis                                | ecchymosis                         | None                        |\n",
      "| 8698 | DISEASE         | Ectopia Lentis                            | ectopia lentis                     | None                        |\n",
      "| 8699 | DISEASE         | Edema                                     | edema                              | edema                       |\n",
      "| 8700 | DISEASE         | Edema                                     | edema                              | edema                       |\n",
      "| 8701 | DISEASE         | Ehlers-Danlos Syndrome                    | Ehler-Danlos                       | None                        |\n",
      "| 8702 | DISEASE         | Ehlers-Danlos Syndrome                    | Ehler-Danlos syndrome              | None                        |\n",
      "| 8703 | DISEASE         | Fever                                     | fever                              | None                        |\n",
      "| 8704 | DISEASE         | Fibrous                                   | fibrous                            | None                        |\n",
      "| 8705 | DISEASE         | HIV                                       | None                               | HIV                         |\n",
      "| 8706 | DISEASE         | Heart failure                             | heart failure                      | heart failure               |\n",
      "| 8707 | DISEASE         | Heart failure                             | heart failure                      | heart failure               |\n",
      "| 8708 | DISEASE         | Heart failure                             | heart failure                      | heart failure               |\n",
      "| 8709 | DISEASE         | Heart failure                             | heart failure                      | heart failure               |\n",
      "| 8710 | DISEASE         | Heart failure                             | heart failure                      | heart failure               |\n",
      "| 8711 | DISEASE         | Heart failure                             | heart failure                      | heart failure               |\n",
      "| 8712 | DISEASE         | Heart failure                             | heart failure                      | heart failure               |\n",
      "| 8713 | DISEASE         | Heart failure                             | heart failure                      | heart failure               |\n",
      "| 8714 | DISEASE         | Heart failure                             | heart failure                      | heart failure               |\n",
      "| 8715 | DISEASE         | Heart failure                             | heart failure                      | heart failure               |\n",
      "| 8716 | DISEASE         | Heart failure                             | heart failure                      | heart failure               |\n",
      "| 8717 | DISEASE         | Heart failure                             | heart failure                      | heart failure               |\n",
      "| 8718 | DISEASE         | Heart valve disease                       | valvular heart disease             | None                        |\n",
      "| 8719 | DISEASE         | Hemorrhage                                | bleeding                           | None                        |\n",
      "| 8720 | DISEASE         | Hepatic necrosis                          | hepatic centrolobular necrosis     | None                        |\n",
      "| 8721 | CHEMICAL        | Hepatitis B                               | hepatitis B                        | hepatitis B                 |\n",
      "| 8722 | DISEASE         | Hyperelasticity                           | hyperelasticity                    | None                        |\n",
      "| 8723 | DISEASE         | Hypertensive (finding)                    | hypertensive                       | None                        |\n",
      "| 8724 | DISEASE         | Hypertensive disease                      | hypertension                       | Hypertension                |\n",
      "| 8725 | DISEASE         | Hypertensive disease                      | hypertension                       | hypertension                |\n",
      "| 8726 | DISEASE         | Hypertensive disease                      | hypertension                       | Hypertension                |\n",
      "| 8727 | DISEASE         | Hypertensive disease                      | hypertension                       | hypertension                |\n",
      "| 8728 | DISEASE         | Hypertensive disease                      | hypertension                       | Hypertension                |\n",
      "| 8729 | DISEASE         | Hypertensive disease                      | hypertension                       | hypertension                |\n",
      "| 8730 | DISEASE         | Hypertensive disease                      | hypertension                       | Hypertension                |\n",
      "| 8731 | DISEASE         | Hypertensive disease                      | hypertension                       | hypertension                |\n",
      "| 8732 | DISEASE         | Hypertensive disease                      | Etiology: arterial hypertension    | Hypertension                |\n",
      "| 8733 | DISEASE         | Hypertensive disease                      | Etiology: arterial hypertension    | hypertension                |\n",
      "| 8734 | DISEASE         | Hypertrophy                               | hypertrophy                        | None                        |\n",
      "| 8735 | DISEASE         | Infarction                                | infarctions                        | None                        |\n",
      "| 8736 | DISEASE         | Inflammation                              | inflammation                       | None                        |\n",
      "| 8737 | CHEMICAL        | Lactates                                  | lactate                            | None                        |\n",
      "| 8738 | CHEMICAL        | Lactates                                  | lactate                            | None                        |\n",
      "| 8739 | DISEASE         | Left ventricular mass                     | left ventricular overload          | None                        |\n",
      "| 8740 | DISEASE         | Loeys-Dietz Syndrome                      | Loeys-Dietz syndrome               | None                        |\n",
      "| 8741 | DISEASE         | Marfan Syndrome                           | Marfan syndrome                    | None                        |\n",
      "| 8742 | DISEASE         | Marfan Syndrome                           | Marfan syndrome                    | None                        |\n",
      "| 8743 | DISEASE         | Marfan Syndrome                           | Marfan syndrome                    | None                        |\n",
      "| 8744 | DISEASE         | Marfan Syndrome                           | Marfan Syndrome                    | None                        |\n",
      "| 8745 | DISEASE         | Marfan Syndrome                           | Marfan syndrome                    | None                        |\n",
      "| 8746 | DISEASE         | Mitral Valve Insufficiency                | mitral regurgitation               | None                        |\n",
      "| 8747 | DISEASE         | Mitral Valve Insufficiency                | mitral regurgitation               | None                        |\n",
      "| 8748 | DISEASE         | Mitral Valve Insufficiency                | valve regurgitation                | None                        |\n",
      "| 8749 | DISEASE         | Mitral Valve Insufficiency                | valve regurgitation                | None                        |\n",
      "| 8750 | DISEASE         | Necrosis                                  | necrotic                           | None                        |\n",
      "| 8751 | DISEASE         | Oliguria                                  | oliguria                           | oliguria                    |\n",
      "| 8752 | DISEASE         | Orbital separation excessive              | hypertelorism                      | None                        |\n",
      "| 8753 | DISEASE         | Orthopnea                                 | orthopnea                          | orthopnea                   |\n",
      "| 8754 | CHEMICAL        | Oxygen saturation measurement             | O2 saturation                      | None                        |\n",
      "| 8755 | DISEASE         | Pallor                                    | paleness                           | None                        |\n",
      "| 8756 | DISEASE         | Palpitations                              | palpitation                        | None                        |\n",
      "| 8757 | DISEASE         | Pleural effusion disorder                 | right pleural effusion             | None                        |\n",
      "| 8758 | DISEASE         | Pleural effusion disorder                 | pleural effusion                   | None                        |\n",
      "| 8759 | DISEASE         | Pleural effusion disorder                 | pleural effusion                   | None                        |\n",
      "| 8760 | DISEASE         | Pulmonary Hypertension                    | pulmonary hypertension             | None                        |\n",
      "| 8761 | DISEASE         | Pulmonary Infarction                      | pulmonary infarctions              | pulmonary infarctions       |\n",
      "| 8762 | DISEASE         | Pulmonary Thromboembolisms                | pulmonary thromboembolism          | None                        |\n",
      "| 8763 | DISEASE         | Pulmonary congestion                      | pulmonary congestion               | pulmonary congestion        |\n",
      "| 8764 | DISEASE         | Retinal Detachment                        | retinal detachment                 | None                        |\n",
      "| 8765 | DISEASE         | Rupture                                   | rupture                            | None                        |\n",
      "| 8766 | DISEASE         | Rupture                                   | rupture                            | None                        |\n",
      "| 8767 | DISEASE         | Rupture                                   | rupture                            | None                        |\n",
      "| 8768 | DISEASE         | Scar Tissue                               | scars                              | None                        |\n",
      "| 8769 | DISEASE         | Shock                                     | shock                              | shock                       |\n",
      "| 8770 | DISEASE         | Shock                                     | shock                              | shock                       |\n",
      "| 8771 | DISEASE         | Shock                                     | shock                              | shock                       |\n",
      "| 8772 | DISEASE         | Shock                                     | shock                              | shock                       |\n",
      "| 8773 | DISEASE         | Shock                                     | shock                              | shock                       |\n",
      "| 8774 | DISEASE         | Shock                                     | shock                              | shock                       |\n",
      "| 8775 | DISEASE         | Shock                                     | shock                              | shock                       |\n",
      "| 8776 | DISEASE         | Shock                                     | shock                              | shock                       |\n",
      "| 8777 | DISEASE         | Shock                                     | shock                              | shock                       |\n",
      "| 8778 | DISEASE         | Shock                                     | shock                              | shock                       |\n",
      "| 8779 | DISEASE         | Shock                                     | shock                              | shock                       |\n",
      "| 8780 | DISEASE         | Shock                                     | shock                              | shock                       |\n",
      "| 8781 | DISEASE         | Shock, Cardiogenic                        | cardiogenic shock                  | None                        |\n",
      "| 8782 | DISEASE         | Thrombosis                                | thrombosis                         | None                        |\n",
      "| 8783 | DISEASE         | Thrombus                                  | thrombi                            | None                        |\n",
      "| 8784 | DISEASE         | Tricuspid Valve Insufficiency             | tricuspid regurgitation            | None                        |\n",
      "| 8785 | DISEASE         | Venous Thrombosis                         | vein thrombosis                    | None                        |\n",
      "| 8786 | DISEASE         | Ventricular Dysfunction                   | ventricular dysfunction            | ventricular dysfunction     |\n",
      "| 8787 | DISEASE         | Vessel perforation                        | vessel ruptures                    | None                        |\n",
      "| 8788 | DISEASE         | Vomiting                                  | vomiting                           | vomiting                    |\n",
      "| 8789 | CHEMICAL        | creatinine                                | creatinine                         | Creatinine                  |\n",
      "| 8790 | CHEMICAL        | creatinine                                | creatinine                         | creatinine                  |\n",
      "| 8791 | CHEMICAL        | creatinine                                | creatinine                         | Creatinine                  |\n",
      "| 8792 | CHEMICAL        | creatinine                                | creatinine                         | creatinine                  |\n",
      "| 8793 | CHEMICAL        | creatinine                                | creatinine                         | Creatinine                  |\n",
      "| 8794 | CHEMICAL        | creatinine                                | creatinine                         | creatinine                  |\n",
      "| 8795 | CHEMICAL        | creatinine                                | creatinine                         | Creatinine                  |\n",
      "| 8796 | CHEMICAL        | creatinine                                | creatinine                         | creatinine                  |\n",
      "| 8797 | CHEMICAL        | daptomycin                                | daptomycin                         | None                        |\n",
      "| 8798 | CHEMICAL        | dobutamine                                | dobutamine                         | None                        |\n",
      "| 8799 | CHEMICAL        | glycine                                   | glycine                            | None                        |\n",
      "| 8800 | DISEASE         | hypermotility                             | hypermotility                      | None                        |\n",
      "| 8801 | CHEMICAL        | magnesium                                 | magnesium                          | None                        |\n",
      "| 8802 | CHEMICAL        | magnesium                                 | magnesium                          | None                        |\n",
      "| 8803 | CHEMICAL        | meropenem                                 | meropenem                          | None                        |\n",
      "| 8804 | CHEMICAL        | micafungin                                | micafungin                         | None                        |\n",
      "| 8805 | CHEMICAL        | norepinephrine                            | noradrenaline                      | None                        |\n",
      "| 8806 | DISEASE         | physiopathological                        | RV dysfunction                     | None                        |\n",
      "| 8807 | CHEMICAL        | potassium                                 | potassium                          | None                        |\n",
      "| 8808 | CHEMICAL        | potassium                                 | potassium                          | None                        |\n",
      "| 8809 | CHEMICAL        | potassium                                 | potassium                          | None                        |\n",
      "| 8810 | CHEMICAL        | rifampin                                  | rifampicin                         | None                        |\n",
      "| 8811 | CHEMICAL        | sodium                                    | sodium                             | None                        |\n",
      "| 8812 | CHEMICAL        | sodium                                    | sodium                             | None                        |\n",
      "| 8813 | CHEMICAL        | sodium                                    | sodium                             | None                        |\n",
      "| 8814 | CHEMICAL        | urea                                      | urea                               | None                        |\n",
      "| 8815 | CHEMICAL        | urea                                      | urea                               | None                        |\n",
      "| 8816 | CHEMICAL        | urea                                      | urea                               | None                        |\n",
      "| 8817 | CHEMICAL        | vancomycin                                | vancomycin                         | None                        |\n",
      "| 8818 | DISEASE         | None                                      | hydrosaline                        | None                        |\n",
      "| 8819 | DISEASE         | None                                      | Marfan, Loeys-Dietz                | None                        |\n",
      "| 8820 | DISEASE         | None                                      | visceral congestion                | None                        |\n",
      "| 8821 | DISEASE         | None                                      | cavitary lesion                    | None                        |\n",
      "| 8822 | DISEASE         | None                                      | peri-aortic cavitary lesion        | None                        |\n",
      "| 8823 | DISEASE         | None                                      | Peri-aortic cavitary lesion        | None                        |\n",
      "==================================================\n",
      "A 51-year-old male, hypertensive patient, a former smoker, was transferred for treatment of thoracic aortic dissection and heart failure.\n",
      "\n",
      "After a three-week period with progressively more intense chest pain, accompanied by dyspnea, sweating and vomiting, he was admitted to the Hospital in the city where he lived.\n",
      "\n",
      "At hospital admission, he had high blood pressure and the diagnosis of thoracic aortic dissection was made. He received antihypertensive and beta-blocker medications. On the fifth day, he was transferred to Instituto do Coração for treatment. At that moment, he was asymptomatic.\n",
      "\n",
      "The physical examination (June 14, 2012) showed good general health status, paleness, ++ / 4+, increased jugular venous pressure, heart rate of 80 bpm, blood pressure 80 x 60 mmHg; clear lungs; cardiac auscultation disclosed rhythmic heart sounds and ++++ diastolic murmur on the left sternal border, no abdominal alterations, lower limbs without edema, besides palpable and symmetrical pulses.\n",
      "\n",
      "Laboratory tests (June 14, 2012) showed hemoglobin 15.9 g/dL; hematocrit, 49%; leukocytes, 10,080/mm3 (neutrophils 64%, eosinophils 7%, lymphocytes 21%, and monocytes 8%); platelets 232,000/mm3; CKMB, 1.33 ng/mL; troponin I, 0.106 ng/mL; urea, 38 mg / dL; creatinine, 0.94 mg /dL; sodium, 137 mEq/L; potassium, 4.2 mEq/L; prpthrombin time (PT) (INR), 1.1; APTT time ratio, 0.78; AST, 30 U/L; ALT, 61 U/L; gamma-GT, 116 IU/L; alkaline phosphatase, 81 U/L; and negative serology for hepatitis B, C, and HIV.\n",
      "\n",
      "The electrocardiogram (ECG) performed on June 16, 2012 showed sinus rhythm, left atrial and left ventricular overload with strain pattern.\n",
      "\n",
      "The echocardiogram performed on June 17, 2012, disclosed the following measurements: aorta, 37 mm; left atrium, 48 mm; septal thickness and posterior wall, 9 mm; left ventricle, 87/78 mm; ejection fraction, 22%. The patient showed eccentric hypertrophy with diffuse hypokinesis; moderate mitral regurgitation; marked aortic regurgitation; ascending aortic dissection was observed, with the original intimal tear 25 mm from the valve plane. The aortic measurements at the different levels were: aortic sinus, 37 mm, sinotubular junction, 46 mm, ascending aorta, 67 mm and aortic arch, 34 mm.\n",
      "\n",
      "The posteroanterior chest X-ray performed on June 18, 2012 showed normal lung fields, aorta with an image suggestive of aneurysm, and enlarged cardiac area.\n",
      "\n",
      "The coronary angiography did not show any coronary lesions. The pressures were: aorta: (syst/diast/mean) 100/50/67 mmHg and left ventricular: (Syst/initial diast/end diast) 100/10/20 mmHg. The left ventricle showed diffuse hypokinesis. There was marked aortic regurgitation and an ascending aortic aneurysm, with an image suggestive of dissection.\n",
      "\n",
      "The patient underwent surgery for repair of the ascending aortic dissection, with the interposition of a Dacron tube and aortic valve repair (June 19, 2012). The postoperative period was uneventful, and the patient was discharged on the ninth postoperative day.\n",
      "\n",
      "Almost a month after hospital discharge (July 11, 2012), he sought emergency medical attention for worsening of dyspnea, attributed to non-adherence to the prescribed medication.\n",
      "\n",
      "The physical examination (July 11, 2012) disclosed a heart rate of 60 bpm, blood pressure 80 x 60 mmHg; clear lungs; normal cardiac auscultation, no abdominal alterations; lower limbs without edema and no signs of deep vein thrombosis, with normal pulses.\n",
      "\n",
      "The laboratory tests (July 18, 2012) showed hemoglobin 10.7 g/dL; hematocrit, 32%; leukocytes, 9,750/mm3 (band cells 1%, segmented 69%, eosinophils 8%, basophils 3%, lymphocytes 14%, monocytes 5%), platelets, 443,000/mm3, C-reactive protein, 65.05 mg/L; urea 29 mg/dL; creatinine, 0.90 mg/dL, sodium, 130 mEq/L; potassium, 4.8 mEq/L; magnesium, 1.70 mEq/L, BNP, 1280 pp / mL, venous lactate 21 mg/dL; venous gasometry: pH 7.38, pCO2, 48 mmHg; pO2, 34.9 mmHg, O2 saturation, 53.8%; bicarbonate, 26.5 mEq/L, base excess, 2 mEq/L. Blood, urine and catheter tip cultures were negative.\n",
      "\n",
      "One month after this episode he was again brought to emergency care (August 11, 2012) with dyspnea on minimal exertion, orthopnea and oliguria for two days. He denied coughing, fever, coryza or diarrhea; chest pain or palpitation. He reported correct use of medications and hydrosaline restriction.\n",
      "\n",
      "The physical examination on admission showed blood pressure of 80x60 mmHg, heart rate of 102 bpm, fine pulses and decreased peripheral perfusion; jugular venous pulse was present; rhythmic heart sounds, presence of third heart sound, mitral systolic murmur +++ / 6+, tricuspid systolic murmur +++ / 6+ and aortic systolic murmur ++ / 6+; abdominal assessment - liver palpable at 5 cm from the right costal border; palpable and symmetrical lower-limb pulses.\n",
      "\n",
      "He was started on intravenous dobutamine, vasodilator and diuretic drugs, in addition to the antibiotics vancomycin and meropenem.\n",
      "\n",
      "Laboratory tests (August 11, 2012) showed hemoglobin: 9.2 g/dL, hematocrit: 31%, leukocytes: 12,980/mm3 (neutrophils 74%, eosinophils 1%, basophils 1%, lymphocytes 19%, monocytes 5%), platelets: 395,000/mm³, C-reactive protein: 79.58 mg/dL, urea: 55 mg/dL, creatinine: 1.26 mg/dL, sodium: 135 mEq/L, potassium: 5.1 mEq/L, prothrombin time: (INR) = 1.2, APTT:(rel) = 0.97, venous lactate: 55 mg/dL\n",
      "\n",
      "The chest x-ray showed pulmonary congestion and cardiomegaly.\n",
      "\n",
      "The echocardiogram (August 13, 2012) showed the following measurements: aorta, 41 mm; left atrium, 50 mm; right ventricle, 35 mm; septum, 9 mm; posterior wall, 10 mm; left ventricle, 86 mm; ejection fraction, 20%; hypertrophic left ventricle with diffuse hypokinesis; right ventricle with moderate hypokinesis; severe mitral regurgitation; normal aortic valve; pulmonary valve with indirect signs of pulmonary hypertension; estimated pressure of 43 mmHg and presence of Dacron tube in the aorta.\n",
      "\n",
      "The transesophageal echocardiogram (August 16, 2012) also showed the presence of marked tricuspid regurgitation and no images suggestive of thrombi or vegetations were observed.\n",
      "\n",
      "The laboratory tests performed on August 12 showed hemoglobin decrease to 7.7 g/dL and no evidence of bleeding and, therefore, an upper digestive endoscopy was requested, which did not show any alterations.\n",
      "\n",
      "A Doppler ultrasonography of the lower limbs carried out due to suspicion of pulmonary thromboembolism (recent RV dysfunction) showed no signs of thrombosis. The patient then underwent a chest tomography, which identified a small consolidation on the right side, with right pleural effusion.\n",
      "\n",
      "He developed refractory shock, despite the use of antibiotics. The right pleural effusion was punctured, and the presence of transudate was identified.\n",
      "\n",
      "All blood cultures and urine cultures were negative. He required orotracheal intubation for ventilatory support on August 29, 2012, developing an increasing need for noradrenaline, and the antibiotics were replaced by daptomycin, micafungin, and rifampicin.\n",
      "\n",
      "Laboratory reassessment (September 4, 2012) showed: hemoglobin: 10 g/dL; hematocrit: 33%; leukocytes: 5,450/mm³ (neutrophils 85%, lymphocytes 10% and monocytes 5%); platelets: 313,000/mm³; C-reactive protein: 221.38 mg/L; urea: 44 mg/dL; creatinine: 2.21 mg/dL; phosphorus: 2.2 mg/dL; magnesium: 1.6 mEq/L.\n",
      "\n",
      "The patient remained in shock and died (September 4, 2012).\n",
      "\n",
      "\n",
      "Clinical aspects\n",
      "\n",
      "This was a male patient, who presented with ascending aortic dissection, and who, even after surgery for dissection repair, developed a picture of severe heart failure and died.\n",
      "\n",
      "The International Registry of Acute Aortic Dissection (IRAD) showed that patients with aortic dissection were older than our patient, 61 years; and a majority of males (63%). Regarding the diseases related to the dissection, they were: Marfan syndrome (6.7%), hypertension (69.3%), atherosclerosis (24.4%), previously known aortic aneurysm (12.4%), previous aortic dissection 3.9%) and diabetes mellitus (4.3%). Also, 15.9% had a history of previous cardiac surgery and iatrogenic cause in 4.8% (1.7% coronary angiography and 3.1% after cardiac surgery). The 2015 update of the same registry, with a ten-fold higher number of patients, showed an increase in hypertension (75.5%) and a decrease in the presence of Marfan syndrome (4.5%), (75.5%), atherosclerosis (19.6%) and previous cardiac surgery (10.6%).\n",
      "\n",
      "Genetic tests can be performed in the presence of aortic aneurysm in younger patients. The syndromes related to the presence of aortic aneurysms are Marfan, Loeys-Dietz, Ehler-Danlos syndromes, the cutis laxa or elastolysis and that related to a defect in the transforming growth factor beta (TGFβ).\n",
      "\n",
      "Classically, the genetic alterations found in Marfan syndrome are related to the fibrillin-1 gene. Changes in the physical examination involve ocular (myopia, ectopia lentis, and risk of retinal detachment), skeletal (exaggerated growth and joint laxity, exaggerated growth of the extremities) and cardiovascular alterations (dilation of the aorta at the level of the sinuses of Valsalva, predisposing to dissection). In the present case, we do not have a description of these phenotypic changes that might suggest such diagnosis.\n",
      "\n",
      "Loeys-Dietz syndrome includes several manifestations similar to those of Marfan Syndrome, but they also include hypertelorism, broad or bifid uvula, cleft palate and generalized arterial tortuosity, aneurysms, and arterial dissection. Generally no increase of extremities and ocular alterations are observed.\n",
      "\n",
      "As well as for Marfan syndrome, we do not have evidence in the present case to suggest such a diagnosis.\n",
      "\n",
      "The Ehler-Danlos syndrome is characterized by fragility of the connective tissue and the manifestations occur in the skin (hyperelasticity, atrophic scars and easy ecchymosis), joints (hypermotility, frequent dislocations and arthralgias) and vessels (aneurysms and spontaneous vessel ruptures). The vascular form, in which dissection occurs most frequently, occurs through a mutation in the alpha-1 gene of type III collagen, with a silent substitution that leads to the replacement of glycine in the collagen chain.\n",
      "\n",
      "We also have no clinical evidence of such changes in the present case. A more recent study showed gene panel alterations in 25% of patients with aortic aneurysms.\n",
      "\n",
      "What should be taken into account is that even today the criterion for the indication of surgical treatment for rupture prevention remains the diameter of the aneurysm, 50 mm.\n",
      "\n",
      "In the present case, the patient had arterial hypertension and it must have had an important role in the development of the thoracic aneurysm and its rupture. Biomechanical studies show that for hypertension to lead an aneurysm development, there must be concomitant failure in the composition and maintenance of the extracellular matrix and membrane receptors. Consequently, there is damage to the mechanical stress transduction in the cell-signaling response.\n",
      "\n",
      "Regarding the patient’s unfavorable evolution after the surgery, it is probably due to the long evolution of the aortic aneurysm with aortic valve regurgitation, leading to left ventricular dilation and severe dysfunction, which in the very late states do not undergo regression or relief despite valve replacement surgery and progress to progressive heart failure. The ECG disclosed left ventricular overload with strain and the echocardiogram showed large left ventricular dilation and marked dysfunction.\n",
      "\n",
      "The European Guidelines of Cardiology and Thoracic Surgery recommends valve replacement surgery in patients with aortic dilation or aortic regurgitation accentuated with symptoms. In asymptomatic patients, this recommendation appears if there is reduction in ejection fraction (<50%) or ventricular dilation (diastolic diameter >70 mm or diastolic >50 mm).\n",
      "\n",
      "The patient had degrees of dilation (diastolic diameter, 87 mm and systolic diameter, 78 mm) and ventricular dysfunction (ejection fraction of 22%) well beyond those recommended for the indication of valve replacement surgery.\n",
      "\n",
      "This is the most plausible explanation for the poor evolution. (Dr. Desiderio Favarato)\n",
      "\n",
      "Diagnostic hypotheses: Aneurysm in the thoracic aorta, chronic aortic valve regurgitation, aortic dissection. Etiology: arterial hypertension and extracellular matrix disease of the aorta. Final clinical picture: cardiogenic shock due to valvular heart disease. (Dr. Desiderio Favarato)\n",
      "\n",
      "\n",
      "Necropsy\n",
      "\n",
      "The heart weighed 890g, with marked increase in volume and dilation of all chambers, predominantly the ventricles. The atrioventricular valves showed no abnormalities. The aortic valve showed thickening of the free margins of the semilunar leaflets, with a central non-coaptation aspect, compatible with valve regurgitation. A corrugated tube replaced the ascending aorta and was sutured just above the aortic sinotubular junction. Around the junction area between the ascending aorta and the ventricular mass, we noticed cavitation with irregular margins, partially filled by liquefied material, of a yellowish-brown color. There was also a concave circular lesion of the aortic intima, with 1.5 cm in diameter, just below the emergence of the renal arteries. The lungs showed areas of wine-colored parenchyma condensation, triangular in shape when sectioned. There were signs of generalized visceral congestion, as well as ascites (700 mL) and bilateral pleural effusion (200mL in each hemithorax).\n",
      "\n",
      "\n",
      "Histological examination showed accumulation of mucoid material in the tunica media throughout the aorta, as well as focal rupture of elastic fibers in the cavitary lesion described in the abdominal aorta. The anatomopathological study of the peri-aortic cavitary lesion showed mixed inflammation, with necrotic cellular and polymorphonuclear neutrophil debris, among sutures and other synthetic materials. Bacterial and fungal tests were negative at this site. The aortic valve showed fibrous thickening of the margins. There was chronic passive visceral congestion, with hepatic centrolobular necrosis; the wine-colored lesions in the lungs corresponded to recent infarctions. (Dr. Vera Demarchi Aiello)\n",
      "\n",
      "\n",
      "Anatomopathological diagnoses\n",
      "\n",
      "- Post-surgical correction of acute dissection of the ascending aorta\n",
      "- Peri-aortic cavitary lesion, with mixed inflammatory reaction, without the identification of infectious agents\n",
      "- Intramural dissection located in the abdominal aorta\n",
      "- Aortic valve regurgitation\n",
      "- Recent pulmonary infarctions\n",
      "Cause of death: Congestive heart failure with terminal shock (Dr. Vera Demarchi Aiello)\n",
      "\n",
      "\n",
      "==================================================\n",
      "**Discharge Summary**\n",
      "\n",
      "**Patient Information:**\n",
      "- **Name:** [Patient Name]\n",
      "- **Age:** 51 years\n",
      "- **Gender:** Male\n",
      "- **Medical History:** Hypertension, former smoker\n",
      "\n",
      "**Admission Details:**\n",
      "- **Date of Admission:** [Initial Admission Date]\n",
      "- **Transfer to Instituto do Coração:** June 14, 2012\n",
      "- **Reason for Transfer:** Treatment of thoracic aortic dissection and heart failure.\n",
      "\n",
      "**Clinical Presentation:**\n",
      "The patient presented with a three-week history of progressively worsening chest pain, dyspnea, sweating, and vomiting. Upon admission, he exhibited high blood pressure and was diagnosed with thoracic aortic dissection. He received antihypertensive and beta-blocker therapy.\n",
      "\n",
      "**Physical Examination on Admission (June 14, 2012):**\n",
      "- General health: Good\n",
      "- Vital signs: Heart rate 80 bpm, Blood pressure 80/60 mmHg\n",
      "- Jugular venous pressure: Increased\n",
      "- Cardiac auscultation: Rhythmic heart sounds, ++++ diastolic murmur at left sternal border\n",
      "- Lungs: Clear\n",
      "- Abdomen: No alterations\n",
      "- Lower limbs: No edema, symmetrical pulses\n",
      "\n",
      "**Laboratory Findings (June 14, 2012):**\n",
      "- Hemoglobin: 15.9 g/dL\n",
      "- Hematocrit: 49%\n",
      "- Leukocytes: 10,080/mm³\n",
      "- Platelets: 232,000/mm³\n",
      "- CKMB: 1.33 ng/mL\n",
      "- Troponin I: 0.106 ng/mL\n",
      "- Creatinine: 0.94 mg/dL\n",
      "- Negative serology for hepatitis B, C, and HIV\n",
      "\n",
      "**Imaging Studies:**\n",
      "- **ECG (June 16, 2012):** Sinus rhythm, left atrial and left ventricular overload.\n",
      "- **Echocardiogram (June 17, 2012):** Ejection fraction 22%, ascending aortic dissection observed.\n",
      "- **Chest X-ray (June 18, 2012):** Normal lung fields, suggestive of aortic aneurysm.\n",
      "\n",
      "**Surgical Intervention:**\n",
      "- **Date:** June 19, 2012\n",
      "- **Procedure:** Repair of ascending aortic dissection with Dacron tube interposition and aortic valve repair.\n",
      "- **Postoperative Course:** Uncomplicated; discharged on the ninth postoperative day.\n",
      "\n",
      "**Subsequent Admissions:**\n",
      "1. **Date:** July 11, 2012\n",
      "   - **Reason:** Worsening dyspnea due to non-adherence to medication.\n",
      "   - **Findings:** Blood pressure 80/60 mmHg, heart rate 60 bpm, laboratory tests indicated anemia and elevated BNP.\n",
      "\n",
      "2. **Date:** August 11, 2012\n",
      "   - **Reason:** Dyspnea on exertion, orthopnea, oliguria.\n",
      "   - **Findings:** Blood pressure 80/60 mmHg, heart rate 102 bpm, pulmonary congestion on chest X-ray, severe heart failure noted.\n",
      "\n",
      "**Final Admission:**\n",
      "- **Date:** August 29, 2012\n",
      "- **Condition:** Developed refractory shock, required intubation and increased vasopressor support.\n",
      "- **Laboratory Findings:** Persistent anemia, elevated creatinine, and signs of infection.\n",
      "\n",
      "**Outcome:**\n",
      "- The patient remained in shock and passed away on September 4, 2012.\n",
      "\n",
      "**Clinical Summary:**\n",
      "The patient presented with ascending aortic dissection and underwent surgical repair. Despite initial recovery, he developed severe heart failure and ultimately succumbed to cardiogenic shock. Contributing factors included chronic hypertension and significant left ventricular dysfunction.\n",
      "\n",
      "**Anatomopathological Findings:**\n",
      "- Post-surgical changes consistent with aortic dissection repair.\n",
      "- Evidence of aortic valve regurgitation and pulmonary infarctions.\n",
      "- Cause of death: Congestive heart failure with terminal shock.\n",
      "\n",
      "**Recommendations for Future Care:**\n",
      "- Close monitoring for patients with a history of aortic dissection and heart failure.\n",
      "- Consideration of genetic counseling for potential connective tissue disorders in younger patients with aortic aneurysms.\n",
      "\n",
      "**Prepared by:**\n",
      "[Your Name]\n",
      "[Your Title]\n",
      "[Date]\n",
      "==================================================\n",
      "==================================================\n",
      "\n",
      "\n",
      "\n",
      "{'filenameid': '38050248', 'n_words_cc': 1754, 'n_words_ds': 285, 'gen_orig_ratio': 0.16248574686431014}\n",
      "==================================================\n",
      "|       | mention_class   | term                             | span_orig                                  | span_gen                           |\n",
      "|------:|:----------------|:---------------------------------|:-------------------------------------------|:-----------------------------------|\n",
      "| 49966 | CHEMICAL        | Adrenergic beta-Antagonists      | beta-blocker                               | beta-blocker                       |\n",
      "| 49967 | CHEMICAL        | Adrenergic beta-Antagonists      | beta-blockers                              | beta-blocker                       |\n",
      "| 49968 | CHEMICAL        | Adrenergic beta-Antagonists      | beta-blocker                               | beta-blocker                       |\n",
      "| 49969 | CHEMICAL        | Adrenergic beta-Antagonists      | beta-blocker                               | beta-blocker                       |\n",
      "| 49970 | DISEASE         | Anxiety                          | anxiety                                    | anxiety                            |\n",
      "| 49971 | DISEASE         | Anxiety                          | anxiety                                    | anxiety                            |\n",
      "| 49972 | DISEASE         | Anxiety                          | anxiety                                    | anxiety                            |\n",
      "| 49973 | DISEASE         | Anxiety                          | Anxiety                                    | anxiety                            |\n",
      "| 49974 | DISEASE         | Anxiety                          | Anxiety                                    | anxiety                            |\n",
      "| 49975 | DISEASE         | Anxiety                          | Anxiety                                    | anxiety                            |\n",
      "| 49976 | DISEASE         | Anxiety                          | anxiety                                    | anxiety                            |\n",
      "| 49977 | DISEASE         | Anxiety                          | anxiety                                    | anxiety                            |\n",
      "| 49978 | DISEASE         | Anxiety                          | anxiety                                    | anxiety                            |\n",
      "| 49979 | DISEASE         | Anxiety                          | anxiety                                    | anxiety                            |\n",
      "| 49980 | DISEASE         | Anxiety                          | anxiety                                    | anxiety                            |\n",
      "| 49981 | DISEASE         | Anxiety                          | anxiety                                    | anxiety                            |\n",
      "| 49982 | DISEASE         | Anxiety                          | anxiety                                    | anxiety                            |\n",
      "| 49983 | DISEASE         | Anxiety                          | anxiety                                    | anxiety                            |\n",
      "| 49984 | DISEASE         | Anxiety                          | anxiety                                    | anxiety                            |\n",
      "| 49985 | DISEASE         | Anxiety                          | anxiety                                    | anxiety                            |\n",
      "| 49986 | DISEASE         | Anxiety                          | anxiety                                    | anxiety                            |\n",
      "| 49987 | DISEASE         | Anxiety                          | anxiety                                    | anxiety                            |\n",
      "| 49988 | DISEASE         | Anxiety                          | anxiety                                    | anxiety                            |\n",
      "| 49989 | DISEASE         | Anxiety                          | anxiety                                    | anxiety                            |\n",
      "| 49990 | DISEASE         | Anxiety                          | anxiety                                    | anxiety                            |\n",
      "| 49991 | DISEASE         | Atrial Fibrillation              | atrial fibrillation                        | None                               |\n",
      "| 49992 | DISEASE         | Atrial Flutter                   | atrial flutter                             | None                               |\n",
      "| 49993 | DISEASE         | Autoimmune Diseases              | autoimmune disorders                       | autoimmune disorders               |\n",
      "| 49994 | DISEASE         | Autoimmune Diseases              | autoimmune disorders                       | autoimmune disorders               |\n",
      "| 49995 | DISEASE         | Autoimmune Diseases              | autoimmune disorders                       | autoimmune disorders               |\n",
      "| 49996 | DISEASE         | Autoimmune Diseases              | autoimmune disorders                       | autoimmune disorders               |\n",
      "| 49997 | DISEASE         | Autoimmune Diseases              | autoimmune disorders                       | autoimmune disorders               |\n",
      "| 49998 | DISEASE         | Autoimmune Diseases              | autoimmune disorders                       | autoimmune disorders               |\n",
      "| 49999 | DISEASE         | Body fluid retention             | fluid retention                            | None                               |\n",
      "| 50000 | DISEASE         | Cardiac Arrhythmia               | arrhythmias                                | arrhythmias                        |\n",
      "| 50001 | DISEASE         | Cardiac Arrhythmia               | arrhythmias                                | arrhythmias                        |\n",
      "| 50002 | DISEASE         | Cardiac Arrhythmia               | arrhythmias                                | arrhythmias                        |\n",
      "| 50003 | DISEASE         | Cardiac Arrhythmia               | arrhythmias                                | arrhythmias                        |\n",
      "| 50004 | DISEASE         | Cardiac Arrhythmia               | arrhythmias                                | arrhythmias                        |\n",
      "| 50005 | DISEASE         | Cardiac Arrhythmia               | arrhythmias                                | arrhythmias                        |\n",
      "| 50006 | DISEASE         | Cardiac Arrhythmia               | arrhythmias                                | arrhythmias                        |\n",
      "| 50007 | DISEASE         | Cardiac Arrhythmia               | arrhythmias                                | arrhythmias                        |\n",
      "| 50008 | DISEASE         | Cardiac function                 | impaired cardiac function                  | None                               |\n",
      "| 50009 | DISEASE         | Cardiac function                 | impaired cardiac function                  | None                               |\n",
      "| 50010 | DISEASE         | Cardiac function                 | Turner cardiac function                    | None                               |\n",
      "| 50011 | DISEASE         | Cardiomyopathies                 | cardiomyopathy                             | None                               |\n",
      "| 50012 | DISEASE         | Cardiovascular Abnormalities     | cardiovascular and endocrine abnormalities | None                               |\n",
      "| 50013 | DISEASE         | Cardiovascular system            | cardiovascular sequelae                    | None                               |\n",
      "| 50014 | DISEASE         | Cardiovascular system alteration | cardiovascular alterations                 | None                               |\n",
      "| 50015 | DISEASE         | Chief complaint (finding)        | Turner chief complaints                    | None                               |\n",
      "| 50016 | DISEASE         | Disease                          | this disorder                              | None                               |\n",
      "| 50017 | DISEASE         | Dyspnea                          | shortness of breath                        | shortness of breath                |\n",
      "| 50018 | DISEASE         | Fatigue                          | fatigue                                    | fatigue                            |\n",
      "| 50019 | DISEASE         | Fatigue                          | fatigue                                    | fatigue                            |\n",
      "| 50020 | DISEASE         | Fatigue                          | fatigue                                    | fatigue                            |\n",
      "| 50021 | DISEASE         | Fatigue                          | fatigue                                    | fatigue                            |\n",
      "| 50022 | DISEASE         | Gastrointestinal symptom         | gastrointestinal symptoms                  | gastrointestinal symptoms          |\n",
      "| 50023 | DISEASE         | Goiter                           | Thyroid enlargement                        | thyroid enlargement                |\n",
      "| 50024 | DISEASE         | Goiter                           | goiter                                     | thyroid enlargement                |\n",
      "| 50025 | DISEASE         | Goiter                           | thyroid enlargement                        | thyroid enlargement                |\n",
      "| 50026 | DISEASE         | Hashimoto Disease                | Hashimoto thyroiditis                      | Hashimoto thyroiditis              |\n",
      "| 50027 | DISEASE         | Heart failure                    | heart failure                              | heart failure                      |\n",
      "| 50028 | DISEASE         | Heart failure                    | heart failure                              | heart failure                      |\n",
      "| 50029 | DISEASE         | Heart failure                    | heart failure                              | heart failure                      |\n",
      "| 50030 | DISEASE         | Heart failure                    | heart failure                              | heart failure                      |\n",
      "| 50031 | DISEASE         | Heart failure                    | heart failure                              | heart failure                      |\n",
      "| 50032 | DISEASE         | Heart failure                    | heart failure                              | heart failure                      |\n",
      "| 50033 | DISEASE         | Heart failure                    | heart failure                              | heart failure                      |\n",
      "| 50034 | DISEASE         | Heart failure                    | heart failure                              | heart failure                      |\n",
      "| 50035 | DISEASE         | Heart failure                    | heart failure                              | heart failure                      |\n",
      "| 50036 | DISEASE         | Heart failure                    | heart failure                              | heart failure                      |\n",
      "| 50037 | DISEASE         | Heart failure                    | heart failure                              | heart failure                      |\n",
      "| 50038 | DISEASE         | Heart failure                    | heart failure                              | heart failure                      |\n",
      "| 50039 | DISEASE         | Heart murmur                     | murmurs                                    | None                               |\n",
      "| 50040 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50041 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50042 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50043 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50044 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50045 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50046 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50047 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50048 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50049 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50050 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50051 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50052 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50053 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50054 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50055 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50056 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50057 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50058 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50059 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50060 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50061 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50062 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50063 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50064 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50065 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50066 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50067 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50068 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50069 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50070 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50071 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50072 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50073 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50074 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50075 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50076 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50077 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50078 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50079 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50080 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50081 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50082 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50083 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50084 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50085 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50086 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50087 | DISEASE         | Hyperthyroidism                  | hyperthyroidism                            | hyperthyroidism                    |\n",
      "| 50088 | DISEASE         | Hypothyroidism                   | hypothyroidism                             | None                               |\n",
      "| 50089 | DISEASE         | Hypothyroidism                   | hypothyroidism                             | None                               |\n",
      "| 50090 | DISEASE         | Nausea                           | nausea                                     | nausea                             |\n",
      "| 50091 | DISEASE         | Palpitations                     | palpitations                               | palpitations                       |\n",
      "| 50092 | DISEASE         | Palpitations                     | palpitations                               | palpitations                       |\n",
      "| 50093 | DISEASE         | Palpitations                     | palpitations                               | palpitations                       |\n",
      "| 50094 | DISEASE         | Palpitations                     | palpitations                               | palpitations                       |\n",
      "| 50095 | DISEASE         | Peripheral edema                 | Peripheral edema                           | peripheral edema                   |\n",
      "| 50096 | DISEASE         | Peripheral edema                 | peripheral edema                           | peripheral edema                   |\n",
      "| 50097 | DISEASE         | Peripheral edema                 | peripheral edema                           | peripheral edema                   |\n",
      "| 50098 | DISEASE         | Peripheral edema                 | peripheral edema                           | peripheral edema                   |\n",
      "| 50099 | DISEASE         | Peripheral edema                 | peripheral edema                           | peripheral edema                   |\n",
      "| 50100 | DISEASE         | Rheumatoid Arthritis             | rheumatoid arthritis                       | rheumatoid arthritis               |\n",
      "| 50101 | DISEASE         | Tachycardia                      | tachycardia                                | None                               |\n",
      "| 50102 | DISEASE         | Thyroid Hormones                 | Turner thyroid hormone                     | None                               |\n",
      "| 50103 | DISEASE         | Thyroid dysfunction              | thyroid dysfunction                        | thyroid dysfunction                |\n",
      "| 50104 | DISEASE         | Thyroid dysfunction              | thyroid dysfunction                        | thyroid dysfunction                |\n",
      "| 50105 | DISEASE         | Thyroid dysfunction              | thyroid dysfunction                        | thyroid dysfunction                |\n",
      "| 50106 | DISEASE         | Thyroid dysfunction              | thyroid dysfunction                        | thyroid dysfunction                |\n",
      "| 50107 | DISEASE         | Thyrotoxic cardiomyopathy        | thyrotoxic cardiomyopathy                  | Thyrotoxic cardiomyopathy          |\n",
      "| 50108 | DISEASE         | Thyrotoxic cardiomyopathy        | thyrotoxic cardiomyopathy                  | Thyrotoxic cardiomyopathy          |\n",
      "| 50109 | DISEASE         | Thyrotoxic cardiomyopathy        | thyrotoxic cardiomyopathy                  | Thyrotoxic cardiomyopathy          |\n",
      "| 50110 | DISEASE         | Thyrotoxic cardiomyopathy        | thyrotoxic cardiomyopathy                  | Thyrotoxic cardiomyopathy          |\n",
      "| 50111 | DISEASE         | Thyrotoxic cardiomyopathy        | thyrotoxic cardiomyopathy                  | Thyrotoxic cardiomyopathy          |\n",
      "| 50112 | DISEASE         | Thyrotoxic cardiomyopathy        | thyrotoxic cardiomyopathy                  | Thyrotoxic cardiomyopathy          |\n",
      "| 50113 | DISEASE         | Thyrotoxic cardiomyopathy        | thyrotoxic cardiomyopathy                  | Thyrotoxic cardiomyopathy          |\n",
      "| 50114 | DISEASE         | Thyrotoxic cardiomyopathy        | thyrotoxic cardiomyopathy                  | Thyrotoxic cardiomyopathy          |\n",
      "| 50115 | DISEASE         | Thyrotoxicosis                   | thyrotoxicosis                             | None                               |\n",
      "| 50116 | DISEASE         | Tremor                           | tremor                                     | tremor                             |\n",
      "| 50117 | DISEASE         | Tremor                           | tremor                                     | tremor                             |\n",
      "| 50118 | DISEASE         | Turnera (plant)                  | None                                       | Turner                             |\n",
      "| 50119 | DISEASE         | Ventricular Dysfunction, Left    | impaired left ventricular function         | impaired left ventricular function |\n",
      "| 50120 | DISEASE         | Ventricular Dysfunction, Left    | impaired left ventricular function         | impaired left ventricular function |\n",
      "| 50121 | DISEASE         | Ventricular Dysfunction, Left    | impaired left ventricular function         | impaired left ventricular function |\n",
      "| 50122 | DISEASE         | Weight Loss                      | weight loss                                | weight loss                        |\n",
      "| 50123 | DISEASE         | Weight Loss                      | weight loss                                | weight loss                        |\n",
      "| 50124 | DISEASE         | Weight Loss                      | weight loss                                | weight loss                        |\n",
      "| 50125 | DISEASE         | Weight Loss                      | weight loss                                | weight loss                        |\n",
      "| 50126 | CHEMICAL        | levothyroxine                    | thyroxine                                  | thyroxine                          |\n",
      "| 50127 | CHEMICAL        | levothyroxine                    | thyroxine                                  | thyroxine                          |\n",
      "| 50128 | CHEMICAL        | methimazole                      | methimazole                                | Methimazole                        |\n",
      "| 50129 | CHEMICAL        | methimazole                      | methimazole                                | Methimazole                        |\n",
      "| 50130 | CHEMICAL        | methimazole                      | Methimazole                                | Methimazole                        |\n",
      "| 50131 | CHEMICAL        | methimazole                      | methimazole                                | Methimazole                        |\n",
      "| 50132 | CHEMICAL        | methimazole                      | methimazole                                | Methimazole                        |\n",
      "| 50133 | CHEMICAL        | propranolol                      | propranolol                                | Propranolol                        |\n",
      "| 50134 | CHEMICAL        | propranolol                      | propranolol                                | Propranolol                        |\n",
      "| 50135 | CHEMICAL        | propranolol                      | propranolol                                | Propranolol                        |\n",
      "| 50136 | DISEASE         | None                             | Turner thyrotoxic cardiomyopathy           | None                               |\n",
      "| 50137 | DISEASE         | None                             | Turner thyrotoxic cardiomyopathy           | None                               |\n",
      "| 50138 | DISEASE         | None                             | Turner thyrotoxic cardiomyopathy           | None                               |\n",
      "| 50139 | DISEASE         | None                             | Turner thyrotoxic cardiomyopathy           | None                               |\n",
      "| 50140 | DISEASE         | None                             | Turner thyrotoxic cardiomyopathy           | None                               |\n",
      "| 50141 | DISEASE         | None                             | Turner reported reduced palpitations       | None                               |\n",
      "==================================================\n",
      "Patient information\n",
      "The case involves a 42-year-old female patient, Ms. Emily Turner, of Caucasian ethnicity. Ms. Turner works as an elementary school teacher, leading an active lifestyle. The patient’s age, gender, and occupation are crucial demographic factors contributing to a comprehensive understanding of her medical history.\n",
      "\n",
      "Main symptoms\n",
      "Upon presentation, Ms. Turner chief complaints included palpitations, unexplained weight loss, and increased anxiety. These symptoms were accompanied by heightened sensitivity to heat and intermittent episodes of fatigue. The constellation of these symptoms prompted her to seek medical attention, leading to a detailed clinical evaluation.\n",
      "\n",
      "Medical, family, and psychosocial history\n",
      "Ms. Turner medical history revealed no significant chronic illnesses; however, there was a family history of autoimmune disorders, notably Hashimoto thyroiditis and rheumatoid arthritis. This genetic predisposition provided valuable context for her current presentation. Psychosocially, Ms. Turner described increased stress due to her profession’s demands and family responsibilities.\n",
      "\n",
      "Relevant past interventions and outcomes\n",
      "In the past, Ms. Turner had sought medical consultation for weight loss management, which yielded limited success. She had been prescribed dietary modifications and exercise routines, which helped stabilize her weight temporarily. However, the persistence of her symptoms prompted further investigation.\n",
      "\n",
      "Genetic information\n",
      "Genetic testing was performed to assess for predisposition to autoimmune disorders, given the family history. Results indicated specific genetic markers associated with susceptibility to thyroid dysfunction and autoimmune conditions, reinforcing the potential relevance of hereditary factors.\n",
      "\n",
      "These pseudonymously outlined patient-specific details form the foundation for understanding the unique context in which Ms. Turner thyrotoxic cardiomyopathy developed. They underscore the significance of considering demographic, medical, familial, and psychosocial factors when analyzing the complexities of her case.\n",
      "\n",
      "\n",
      "Clinical findings\n",
      "During the physical examination of Ms. Emily Turner, several pertinent findings emerged, shedding light on the cardiovascular sequelae of her hyperthyroidism and thyrotoxic cardiomyopathy.\n",
      "\n",
      "Cardiovascular examination\n",
      "\n",
      "Elevated heart rate. A palpable and sustained tachycardia was noted, with a resting heart rate exceeding 100 beats per minute. This high heart rate was consistent with the hyperthyroid state, reflecting the direct impact of excess thyroid hormones on cardiac contractility and heart rate regulation.\n",
      "\n",
      "Irregular rhythms. Auscultation revealed intermittent irregular heartbeats, suggesting arrhythmias such as atrial fibrillation or atrial flutter. The presence of these arrhythmias further emphasized the cardiac repercussions of thyrotoxicosis.\n",
      "\n",
      "Murmurs and gallops. A systolic murmur was audible over the mitral area, possibly indicative of increased flow across the mitral valve due to hyperdynamic circulation. A third heart sound (S3 gallop) was auscultated, suggesting impaired left ventricular function.\n",
      "\n",
      "Peripheral edema. Mild peripheral edema was detected, hinting at potential fluid retention secondary to impaired cardiac function. This finding supported the possibility of heart failure due to thyrotoxic cardiomyopathy.\n",
      "\n",
      "Endocrine and general examination\n",
      "\n",
      "Thyroid enlargement. Physical examination of the thyroid gland revealed diffuse enlargement, consistent with a goiter, corroborating the diagnosis of hyperthyroidism.\n",
      "\n",
      "Fine tremor. A fine tremor was observed in the patient’s outstretched hands, a classic neurological manifestation of hyperthyroidism that underscores the systemic impact of thyroid hormone excess.\n",
      "\n",
      "Psychosocial evaluation\n",
      "\n",
      "Anxiety and restlessness. The patient exhibited signs of restlessness and anxiety, which could be attributed to the direct influence of excess thyroid hormones on the central nervous system.\n",
      "These clinical findings collectively portrayed a complex interplay between thyroid dysfunction and cardiovascular alterations. The physical examination underscored the remarkable influence of hyperthyroidism on cardiac function, evident through the elevated heart rate, arrhythmias, murmurs, and signs of heart failure. These findings informed the subsequent diagnostic and therapeutic interventions to manage Ms. Turner thyrotoxic cardiomyopathy.\n",
      "\n",
      "Timeline depicting the crucial milestones related to the diagnosis and interventions for Ms. Emily Turner thyrotoxic cardiomyopathy\n",
      "\n",
      "Month 1:\n",
      "Ms. Turner presents with palpitations, weight loss, and anxiety. Physical examination reveals elevated heart rate, irregular rhythms, and mild peripheral edema.\n",
      "Initial thyroid function tests show significantly elevated levels of free thyroxine (T4) and suppressed thyroid-stimulating hormone (TSH), confirming hyperthyroidism.\n",
      "Cardiovascular imaging (echocardiogram) reveals impaired left ventricular function and signs of heart failure.\n",
      "\n",
      "Month 2:\n",
      "Ms. Turner genetic testing results indicate specific genetic markers associated with thyroid dysfunction and autoimmune disorders.\n",
      "Consultation with an endocrinologist confirms the diagnosis of thyrotoxic cardiomyopathy, a rare manifestation of hyperthyroidism affecting cardiac function.\n",
      "\n",
      "Month 3:\n",
      "Initiation of antithyroid medications (methimazole) to manage excess thyroid hormone production.\n",
      "Commencement of beta-blocker therapy to control heart rate and manage arrhythmias.\n",
      "\n",
      "Month 4:\n",
      "Follow-up thyroid function tests show a gradual decline in free T4 levels and normalization of TSH, indicating a positive response to antithyroid medications.\n",
      "Ms. Turner heart rate stabilizes within a normal range, and the irregular heartbeats become less frequent.\n",
      "\n",
      "Month 6:\n",
      "A repeat echocardiogram reveals improved left ventricular function and reduced signs of heart failure.\n",
      "Ms. Turner weight stabilizes, and her anxiety symptoms diminish.\n",
      "\n",
      "Month 9:\n",
      "Thyroid hormone levels continue to trend towards normal range, and antithyroid medication dosage is adjusted accordingly.\n",
      "The echocardiogram shows further improvement in left ventricular function, and arrhythmias are infrequent.\n",
      "\n",
      "Month 12:\n",
      "Ms. Turner thyroid function tests return to within the normal range, indicating successful management of hyperthyroidism.\n",
      "An echocardiogram confirms significant improvement in cardiac function, and peripheral edema resolves completely.\n",
      "\n",
      "\n",
      "\n",
      "Diagnostic assessments\n",
      "\n",
      "Diagnostic methods\n",
      "The diagnostic assessment for Ms. Emily Turner thyrotoxic cardiomyopathy involved a multidimensional approach encompassing various methods:\n",
      "\n",
      "\n",
      "Physical examination\n",
      "The physical examination revealed elevated heart rate, irregular heart rhythms, peripheral edema, and thyroid enlargement. These findings provided crucial clues to the underlying cardiovascular and endocrine abnormalities.\n",
      "\n",
      "\n",
      "Laboratory testing\n",
      "Thyroid function tests played a pivotal role in confirming the diagnosis of hyperthyroidism. Elevated free thyroxine (T4) levels and suppressed thyroid-stimulating hormone (TSH) levels were consistent with this disorder. Genetic testing was also performed to assess hereditary predisposition to thyroid dysfunction and autoimmune conditions.\n",
      "\n",
      "\n",
      "Cardiovascular imaging\n",
      "Echocardiography was employed to visualize the heart structure and function. The echocardiogram revealed impaired left ventricular function and signs of heart failure, thereby indicating the presence of thyrotoxic cardiomyopathy.\n",
      "\n",
      "\n",
      "Diagnostic challenges\n",
      "Several challenges were encountered during the diagnostic process:\n",
      "\n",
      "\n",
      "Financial constraints\n",
      "Financial limitations have impeded access to specific diagnostic tests and medications, potentially affecting the timeliness and comprehensiveness of the assessment.\n",
      "\n",
      "\n",
      "Language and cultural factors\n",
      "Effective communication and understanding of Ms. Turner symptoms and medical history could have been influenced by language barriers and cultural nuances.\n",
      "\n",
      "\n",
      "Diagnostic reasoning\n",
      "In Ms. Turner case, the primary diagnosis of thyrotoxic cardiomyopathy was reached through careful diagnostic reasoning:\n",
      "\n",
      "\n",
      "Clinical presentation\n",
      "The combination of palpitations, weight loss, anxiety, and elevated heart rate initially indicated hyperthyroidism.\n",
      "\n",
      "\n",
      "Thyroid function tests\n",
      "Elevated free T4 and suppressed TSH levels were consistent with hyperthyroidism. However, the cardiac manifestations indicated the presence of thyrotoxic cardiomyopathy as the underlying complication.\n",
      "\n",
      "\n",
      "Echocardiography\n",
      "The echocardiogram confirmed impaired cardiac function, linking the hyperthyroidism to cardiomyopathy.\n",
      "\n",
      "\n",
      "Prognostic characteristics\n",
      "In thyrotoxic cardiomyopathy, prognostic assessment revolves around cardiac function and the response to treatment. As Ms. Turner cardiac function improved throughout treatment, evidenced by echocardiographic findings, her prognosis became more favorable. Typically used in oncology, staging does not directly apply to thyrotoxic cardiomyopathy; cardiac function parameters serve as prognostic indicators, guiding treatment response evaluation and long-term outcome predictions.\n",
      "\n",
      "\n",
      "Therapeutic Interventions\n",
      "The management of Ms. Emily Turner thyrotoxic cardiomyopathy involved a comprehensive and multifaceted approach:\n",
      "\n",
      "\n",
      "Pharmacologic interventions:\n",
      "Antithyroid Medications: Mys. Turner was prescribed methimazole, an antithyroid medication, to inhibit excessive thyroid hormone production—this pharmacologic intervention aimed to normalize thyroid hormone levels and mitigate their impact on cardiovascular function.\n",
      "Beta-Blockers: To control her elevated heart rate and manage arrhythmias, Ms. Turner was administered beta-blockers. These medications reduce heart rate, decrease cardiac workload, and enhance cardiac stability.\n",
      "\n",
      "Self-care strategies\n",
      "Lifestyle Modifications: Ms. Turner was advised to adopt stress-reduction techniques, prioritize adequate sleep, and maintain a balanced diet to support her overall health and recovery.\n",
      "\n",
      "Administration of intervention\n",
      "Antithyroid Medications (Methimazole): Initiated at 10 mg daily, Ms. Turner dosage was adjusted based on regular thyroid function tests. Dosage titration aimed to achieve normal thyroid hormone levels while minimizing the risk of hypothyroidism.\n",
      "Beta-Blockers: Ms. Turner was prescribed propranolol at 40 mg twice daily. The dosage was tailored to her heart rate and individual response to achieve heart rate control and symptom relief.\n",
      "\n",
      "Changes in intervention\n",
      "\n",
      "Dosage adjustment of antithyroid medications. As Ms. Turner thyroid hormone levels normalized, her methimazole dosage was gradually reduced. This adjustment aimed to prevent overtreatment while maintaining thyroid function within the normal range.\n",
      "\n",
      "Modification of beta-blocker dosage. As Ms. Turner heart rate stabilized within a healthy range and arrhythmias diminished, the propranolol dosage was tapered down. This reflected her improved cardiac function and reduced need for heart rate control.\n",
      "\n",
      "Rationale for changes\n",
      "\n",
      "Dosage adjustment of antithyroid medications. Reducing the methimazole dosage prevented the risk of inducing hypothyroidism, a common side effect of excessive treatment. This step ensured that Ms. Turner thyroid function was restored to a balanced state.\n",
      "\n",
      "Modification of beta-blocker dosage. As her cardiac function improved and her heart rate stabilized, lowering the propranolol dosage reflected the positive response to treatment. The gradual reduction of medication aimed to maintain her heart rate within a physiological range without unnecessary drug exposure.\n",
      "\n",
      "Follow-up and outcomes. Ms. Emily Turner follow-up encompassed regular assessments to monitor her progress:\n",
      "\n",
      "Clinician-assessed outcomes\n",
      "Cardiac Function Improvement: Subsequent echocardiograms revealed progressive improvement in left ventricular function and resolution of heart failure signs.\n",
      "Heart Rate Control: Ms. Turner heart rate stabilized within the normal range, with arrhythmias becoming infrequent.\n",
      "Normalization of Thyroid Function: Thyroid function tests consistently showed free T4 and TSH levels within the normal range, indicating successful management of hyperthyroidism.\n",
      "\n",
      "Patient-assessed outcomes\n",
      "Symptom Relief: Ms. Turner reported reduced palpitations, anxiety, and fatigue, contributing to an enhanced quality of life.\n",
      "\n",
      "Significant follow-up test result\n",
      "\n",
      "Thyroid function tests. Regular thyroid function tests confirmed the sustained normalization of thyroid hormone levels, confirming the effectiveness of antithyroid medications.\n",
      "\n",
      "Echocardiograms. Serial echocardiograms demonstrated the progressive improvement of left ventricular function, validating the efficacy of the treatment approach.\n",
      "\n",
      "Intervention adherence and tolerability. Intervention adherence and tolerability were assessed through:\n",
      "Patient Self-Reports: Ms. Turner provided feedback on her adherence to medication regimens and any observed side effects.\n",
      "Clinical Consultations: Regular clinical check-ins allowed clinicians to inquire about any difficulties or concerns related to medication adherence and tolerability.\n",
      "\n",
      "Adverse and unanticipated events\n",
      "\n",
      "Adverse events. Ms. Turner reported mild gastrointestinal symptoms, such as nausea and upset stomach, attributed to the antithyroid medication. These symptoms were managed through dose adjustments and supportive measures.\n",
      "\n",
      "Unanticipated event. Ms. Turner experienced brief palpitations and shortness of breath during the follow-up. This unanticipated event prompted additional cardiac assessments, which revealed no significant changes. The event was attributed to a temporary increase in stress and resolved spontaneously.\n",
      "\n",
      "\n",
      "==================================================\n",
      "**Discharge Summary**\n",
      "\n",
      "**Patient Information:**\n",
      "- Name: Ms. Emily Turner\n",
      "- Age: 42 years\n",
      "- Gender: Female\n",
      "- Ethnicity: Caucasian\n",
      "- Occupation: Elementary School Teacher\n",
      "\n",
      "**Date of Admission:** [Insert Admission Date]  \n",
      "**Date of Discharge:** [Insert Discharge Date]  \n",
      "**Attending Physician:** [Insert Physician Name]  \n",
      "\n",
      "**Chief Complaints:**\n",
      "Ms. Turner presented with palpitations, unexplained weight loss, increased anxiety, heightened sensitivity to heat, and intermittent fatigue.\n",
      "\n",
      "**Medical History:**\n",
      "- No significant chronic illnesses.\n",
      "- Family history of autoimmune disorders, including Hashimoto thyroiditis and rheumatoid arthritis.\n",
      "- Increased psychosocial stress due to professional and family responsibilities.\n",
      "\n",
      "**Clinical Findings:**\n",
      "- **Cardiovascular Examination:**\n",
      "  - Elevated heart rate (>100 bpm), irregular rhythms, systolic murmur, S3 gallop, and mild peripheral edema.\n",
      "- **Endocrine Examination:**\n",
      "  - Diffuse thyroid enlargement consistent with hyperthyroidism and fine tremor in outstretched hands.\n",
      "- **Psychosocial Evaluation:**\n",
      "  - Signs of anxiety and restlessness.\n",
      "\n",
      "**Diagnostic Assessments:**\n",
      "- **Thyroid Function Tests:** Elevated free thyroxine (T4) and suppressed thyroid-stimulating hormone (TSH) confirmed hyperthyroidism.\n",
      "- **Echocardiogram:** Revealed impaired left ventricular function and signs of heart failure.\n",
      "- **Genetic Testing:** Identified specific markers associated with thyroid dysfunction and autoimmune disorders.\n",
      "\n",
      "**Diagnosis:**\n",
      "Thyrotoxic cardiomyopathy secondary to hyperthyroidism.\n",
      "\n",
      "**Therapeutic Interventions:**\n",
      "1. **Pharmacologic:**\n",
      "   - Methimazole (antithyroid medication) initiated at 10 mg daily, adjusted based on thyroid function tests.\n",
      "   - Propranolol (beta-blocker) prescribed at 40 mg twice daily for heart rate control.\n",
      "  \n",
      "2. **Self-Care Strategies:**\n",
      "   - Recommended stress-reduction techniques, adequate sleep, and a balanced diet.\n",
      "\n",
      "**Follow-Up and Outcomes:**\n",
      "- **Cardiac Function:** Improved left ventricular function and resolution of heart failure signs noted in follow-up echocardiograms.\n",
      "- **Heart Rate Control:** Stabilized within normal range with infrequent arrhythmias.\n",
      "- **Thyroid Function:** Normalized T4 and TSH levels confirmed successful management of hyperthyroidism.\n",
      "- **Patient-Reported Outcomes:** Reduced palpitations, anxiety, and fatigue, leading to enhanced quality of life.\n",
      "\n",
      "**Adverse Events:**\n",
      "- Mild gastrointestinal symptoms (nausea, upset stomach) managed with dose adjustments.\n",
      "- Brief palpitations and shortness of breath during follow-up attributed to temporary stress, resolved spontaneously.\n",
      "\n",
      "**Recommendations for Follow-Up:**\n",
      "- Continue regular monitoring of thyroid function and cardiac health.\n",
      "- Maintain adherence to prescribed medications and lifestyle modifications.\n",
      "- Schedule follow-up appointments with endocrinology and cardiology as needed.\n",
      "\n",
      "**Discharge Condition:**\n",
      "Ms. Turner is stable and has shown significant improvement in symptoms and overall health. She is advised to continue her current treatment plan and follow up as scheduled.\n",
      "\n",
      "**Physician's Signature:**  \n",
      "[Insert Signature]  \n",
      "**Date:** [Insert Date]\n",
      "==================================================\n",
      "==================================================\n",
      "\n",
      "\n",
      "\n",
      "{'filenameid': '33858880', 'n_words_cc': 1845, 'n_words_ds': 313, 'gen_orig_ratio': 0.16964769647696476}\n",
      "==================================================\n",
      "|       | mention_class   | term                                   | span_orig                                           | span_gen                                            |\n",
      "|------:|:----------------|:---------------------------------------|:----------------------------------------------------|:----------------------------------------------------|\n",
      "| 29470 | DISEASE         | Abdomen distended                      | None                                                | abdominal swelling                                  |\n",
      "| 29471 | DISEASE         | Ascites                                | ascites                                             | ascites                                             |\n",
      "| 29472 | DISEASE         | Biventricular congestive heart failure | biventricular failure                               | biventricular heart failure                         |\n",
      "| 29473 | DISEASE         | Cardiac Arrhythmia                     | arrhythmia                                          | None                                                |\n",
      "| 29474 | DISEASE         | Cardiomegaly                           | cardiomegaly                                        | None                                                |\n",
      "| 29475 | DISEASE         | Cardiomyopathies                       | cardiomyopathy                                      | Non-ischaemic cardiomyopathy                        |\n",
      "| 29476 | DISEASE         | Cardiomyopathies                       | non-ischaemic cardiomyopathy                        | Non-ischaemic cardiomyopathy                        |\n",
      "| 29477 | DISEASE         | Cardiomyopathy, Dilated                | tachycardia-related cardiomyopathy                  | None                                                |\n",
      "| 29478 | DISEASE         | Cardiotoxicity                         | cardiotoxicity                                      | None                                                |\n",
      "| 29479 | DISEASE         | Compression of spinal cord             | cauda equina/spinal cord compression                | None                                                |\n",
      "| 29480 | DISEASE         | Coughing                               | cough                                               | cough                                               |\n",
      "| 29481 | DISEASE         | Decompensated cardiac failure          | decompensated cardiac failure                       | None                                                |\n",
      "| 29482 | DISEASE         | Dyspepsia                              | dyspepsia                                           | None                                                |\n",
      "| 29483 | DISEASE         | Dyspnea                                | shortness of breath                                 | shortness of breath                                 |\n",
      "| 29484 | DISEASE         | Dyspnea                                | shortness of breath                                 | dyspnea                                             |\n",
      "| 29485 | DISEASE         | Dyspnea                                | shortness of breath                                 | shortness of breath                                 |\n",
      "| 29486 | DISEASE         | Dyspnea                                | shortness of breath                                 | dyspnea                                             |\n",
      "| 29487 | DISEASE         | Dyspnea                                | shortness of breath                                 | shortness of breath                                 |\n",
      "| 29488 | DISEASE         | Dyspnea                                | shortness of breath                                 | dyspnea                                             |\n",
      "| 29489 | DISEASE         | Edema                                  | oedema                                              | edema                                               |\n",
      "| 29490 | DISEASE         | Edema                                  | oedema                                              | edema                                               |\n",
      "| 29491 | DISEASE         | Fever                                  | fevers                                              | fever                                               |\n",
      "| 29492 | DISEASE         | Fibrosis                               | fibrosis                                            | None                                                |\n",
      "| 29493 | DISEASE         | Fibrosis                               | fibrosis                                            | None                                                |\n",
      "| 29494 | DISEASE         | Heart Ventricle                        | ventricular thrombi                                 | ventricular thrombi                                 |\n",
      "| 29495 | DISEASE         | Heart failure                          | cardiac and renal failure                           | heart failure                                       |\n",
      "| 29496 | DISEASE         | Heart failure                          | Heart failure                                       | heart failure                                       |\n",
      "| 29497 | DISEASE         | Heart failure                          | Heart failure                                       | heart failure                                       |\n",
      "| 29498 | DISEASE         | Heart failure                          | heart failure                                       | heart failure                                       |\n",
      "| 29499 | DISEASE         | Heart failure                          | heart failure                                       | heart failure                                       |\n",
      "| 29500 | DISEASE         | Hemorrhage                             | haemorrhage                                         | None                                                |\n",
      "| 29501 | DISEASE         | Heparin-induced thrombocytopenia       | heparin-induced thrombocytopenia                    | heparin-induced thrombocytopenia                    |\n",
      "| 29502 | DISEASE         | Heparin-induced thrombocytopenia       | heparin-induced thrombocytopenia                    | heparin-induced thrombocytopenia                    |\n",
      "| 29503 | DISEASE         | Heparin-induced thrombocytopenia       | heparin-induced thrombocytopenia                    | heparin-induced thrombocytopenia                    |\n",
      "| 29504 | DISEASE         | Hydronephrosis                         | hydronephrosis                                      | hydronephrosis                                      |\n",
      "| 29505 | DISEASE         | Hydronephrosis                         | hydronephrosis                                      | hydronephrosis                                      |\n",
      "| 29506 | DISEASE         | Hydronephrosis                         | hydronephrosis                                      | hydronephrosis                                      |\n",
      "| 29507 | DISEASE         | Hydronephrosis                         | hydronephrosis                                      | hydronephrosis                                      |\n",
      "| 29508 | DISEASE         | Hypokinesia                            | hypokinetic                                         | None                                                |\n",
      "| 29509 | DISEASE         | Hypoperfusion                          | hypoperfusion                                       | None                                                |\n",
      "| 29510 | DISEASE         | Infarction                             | infarction                                          | None                                                |\n",
      "| 29511 | DISEASE         | Infarction                             | infarcts                                            | None                                                |\n",
      "| 29512 | DISEASE         | Infarction                             | infarcts                                            | None                                                |\n",
      "| 29513 | DISEASE         | Infarction                             | infarcts                                            | None                                                |\n",
      "| 29514 | DISEASE         | Inflammation                           | inflammation                                        | None                                                |\n",
      "| 29515 | DISEASE         | Inflammation                           | inflammation                                        | None                                                |\n",
      "| 29516 | DISEASE         | Insidious                              | insidious                                           | None                                                |\n",
      "| 29517 | DISEASE         | Inverted T wave                        | T-wave inversion                                    | None                                                |\n",
      "| 29518 | DISEASE         | Kidney Failure                         | renal failure                                       | None                                                |\n",
      "| 29519 | DISEASE         | Kidney Failure                         | renal failure                                       | None                                                |\n",
      "| 29520 | DISEASE         | Kidney Failure, Chronic                | chronic renal failure                               | None                                                |\n",
      "| 29521 | DISEASE         | Laminated thrombus                     | Laminated thrombus                                  | None                                                |\n",
      "| 29522 | DISEASE         | Left Ventricular Hypertrophy           | LVH                                                 | None                                                |\n",
      "| 29523 | DISEASE         | Left Ventricular Hypertrophy           | LVH                                                 | None                                                |\n",
      "| 29524 | DISEASE         | Lethargy                               | lethargy                                            | None                                                |\n",
      "| 29525 | DISEASE         | Low Cardiac Output                     | low cardiac output                                  | None                                                |\n",
      "| 29526 | DISEASE         | Malaise                                | ill                                                 | None                                                |\n",
      "| 29527 | DISEASE         | Malignant Neoplasms                    | malignancy                                          | None                                                |\n",
      "| 29528 | CHEMICAL        | Mineralocorticoids                     | ACE inhibitor or mineralocorticoid                  | None                                                |\n",
      "| 29529 | DISEASE         | Mitral Valve Insufficiency             | mitral regurgitation                                | None                                                |\n",
      "| 29530 | DISEASE         | Mitral Valve Insufficiency             | mitral regurgitation                                | None                                                |\n",
      "| 29531 | DISEASE         | Myocarditis                            | myocarditis                                         | None                                                |\n",
      "| 29532 | DISEASE         | Myocarditis                            | myocarditis                                         | None                                                |\n",
      "| 29533 | DISEASE         | Myocarditis                            | myocardial inflammation                             | None                                                |\n",
      "| 29534 | DISEASE         | Myocardium                             | myocardial oedema                                   | None                                                |\n",
      "| 29535 | DISEASE         | Orthopnea                              | orthopnoea                                          | orthopnea                                           |\n",
      "| 29536 | DISEASE         | Palpitations                           | palpitations                                        | None                                                |\n",
      "| 29537 | DISEASE         | Pericardial effusion                   | pericardial effusion                                | None                                                |\n",
      "| 29538 | DISEASE         | Pericardial effusion                   | pericardial effusion                                | None                                                |\n",
      "| 29539 | DISEASE         | Pitting edema                          | pitting oedema                                      | None                                                |\n",
      "| 29540 | DISEASE         | Pleural effusion disorder              | pleural effusions                                   | None                                                |\n",
      "| 29541 | DISEASE         | Pneumonia                              | pneumonia                                           | None                                                |\n",
      "| 29542 | DISEASE         | Pulmonary Edema                        | pulmonary oedema                                    | pulmonary edema                                     |\n",
      "| 29543 | DISEASE         | Pulmonary Edema                        | pulmonary oedema                                    | pulmonary edema                                     |\n",
      "| 29544 | DISEASE         | Renal Insufficiency                    | impaired systolic function                          | None                                                |\n",
      "| 29545 | DISEASE         | Renal Insufficiency                    | impaired systolic function                          | None                                                |\n",
      "| 29546 | DISEASE         | Renal Insufficiency                    | renal impairment                                    | None                                                |\n",
      "| 29547 | DISEASE         | Right cardiac ventricular dilatation   | dilated right ventricle (RV) with                   | None                                                |\n",
      "| 29548 | DISEASE         | Sinus Tachycardia                      | sinus tachycardia                                   | Sinus tachycardia                                   |\n",
      "| 29549 | DISEASE         | Structure of hepatic vein              | IVC in hepatic veins                                | None                                                |\n",
      "| 29550 | DISEASE         | Sudden Cardiac Death                   | sudden cardiac death                                | None                                                |\n",
      "| 29551 | DISEASE         | Takotsubo Cardiomyopathy               | Takotsubo’ cardiomyopathy                           | None                                                |\n",
      "| 29552 | DISEASE         | Takotsubo Cardiomyopathy               | Takotsubo syndrome.5                                | None                                                |\n",
      "| 29553 | DISEASE         | Takotsubo Cardiomyopathy               | Takotsubo syndrome                                  | None                                                |\n",
      "| 29554 | DISEASE         | Takotsubo Cardiomyopathy               | Takotsubo                                           | None                                                |\n",
      "| 29555 | DISEASE         | Takotsubo Cardiomyopathy               | Takotsubo syndrome                                  | None                                                |\n",
      "| 29556 | DISEASE         | Thrombus                               | thrombi                                             | thrombi                                             |\n",
      "| 29557 | DISEASE         | Thrombus                               | thrombi                                             | thrombi                                             |\n",
      "| 29558 | DISEASE         | Thrombus                               | thrombi                                             | thrombi                                             |\n",
      "| 29559 | DISEASE         | Thrombus                               | thrombi                                             | thrombi                                             |\n",
      "| 29560 | DISEASE         | Thrombus                               | thrombi                                             | thrombi                                             |\n",
      "| 29561 | DISEASE         | Thrombus                               | thrombi                                             | thrombi                                             |\n",
      "| 29562 | DISEASE         | Thrombus                               | thrombi                                             | thrombi                                             |\n",
      "| 29563 | DISEASE         | Thrombus                               | thrombi                                             | thrombi                                             |\n",
      "| 29564 | DISEASE         | Thrombus of cardiac chamber            | intracardiac thrombus                               | None                                                |\n",
      "| 29565 | DISEASE         | Tremor                                 | tremor                                              | None                                                |\n",
      "| 29566 | DISEASE         | Tricuspid Valve Insufficiency          | tricuspid regurgitation                             | None                                                |\n",
      "| 29567 | DISEASE         | Tricuspid Valve Insufficiency          | tricuspid regurgitation                             | None                                                |\n",
      "| 29568 | DISEASE         | Uremic encephalopathy                  | uraemic encephalopathy                              | None                                                |\n",
      "| 29569 | DISEASE         | Urinary Retention                      | urinary retention                                   | urinary retention                                   |\n",
      "| 29570 | DISEASE         | Urinary tract obstruction              | obstructive uropathy                                | obstructive uropathy                                |\n",
      "| 29571 | DISEASE         | Ventricular hypertrophy                | ventricular hypertrophy                             | None                                                |\n",
      "| 29572 | DISEASE         | Weight Loss                            | weight loss                                         | weight loss                                         |\n",
      "| 29573 | CHEMICAL        | argatroban                             | argatroban                                          | argatroban                                          |\n",
      "| 29574 | CHEMICAL        | argatroban                             | argatroban                                          | argatroban                                          |\n",
      "| 29575 | CHEMICAL        | caffeine                               | caffeine                                            | None                                                |\n",
      "| 29576 | CHEMICAL        | carvedilol                             | carvedilol                                          | carvedilol                                          |\n",
      "| 29577 | CHEMICAL        | carvedilol                             | uptitrate carvedilol                                | carvedilol                                          |\n",
      "| 29578 | CHEMICAL        | creatinine                             | Creatinine                                          | creatinine                                          |\n",
      "| 29579 | CHEMICAL        | creatinine                             | Creatinine                                          | creatinine                                          |\n",
      "| 29580 | CHEMICAL        | creatinine                             | creatinine                                          | creatinine                                          |\n",
      "| 29581 | CHEMICAL        | creatinine                             | creatinine                                          | creatinine                                          |\n",
      "| 29582 | CHEMICAL        | ethanol                                | Alcohol                                             | None                                                |\n",
      "| 29583 | CHEMICAL        | furosemide                             | furosemide                                          | furosemide                                          |\n",
      "| 29584 | CHEMICAL        | furosemide                             | furosemide                                          | furosemide                                          |\n",
      "| 29585 | CHEMICAL        | furosemide                             | furosemide                                          | furosemide                                          |\n",
      "| 29586 | CHEMICAL        | furosemide                             | furosemide                                          | furosemide                                          |\n",
      "| 29587 | CHEMICAL        | gadolinium                             | gadolinium                                          | None                                                |\n",
      "| 29588 | CHEMICAL        | heparin                                | heparin                                             | heparin                                             |\n",
      "| 29589 | CHEMICAL        | heparin                                | heparin                                             | heparin                                             |\n",
      "| 29590 | CHEMICAL        | heparin                                | heparin                                             | heparin                                             |\n",
      "| 29591 | CHEMICAL        | heparin                                | heparin                                             | heparin                                             |\n",
      "| 29592 | CHEMICAL        | hydralazine                            | hydralazine                                         | hydralazine                                         |\n",
      "| 29593 | CHEMICAL        | isosorbide dinitrate                   | isosorbide dinitrate                                | isosorbide dinitrate                                |\n",
      "| 29594 | CHEMICAL        | lansoprazole                           | lansoprazole                                        | lansoprazole                                        |\n",
      "| 29595 | CHEMICAL        | norepinephrine                         | norepinephrine                                      | None                                                |\n",
      "| 29596 | CHEMICAL        | taurine                                | taurine                                             | None                                                |\n",
      "| 29597 | CHEMICAL        | urea                                   | urea                                                | urea                                                |\n",
      "| 29598 | CHEMICAL        | warfarin                               | warfarin                                            | warfarin                                            |\n",
      "| 29599 | CHEMICAL        | warfarin                               | warfarin                                            | warfarin                                            |\n",
      "| 29600 | DISEASE         | None                                   | embolic and hypoperfusion-related cerebral infarcts | decompensated heart failure                         |\n",
      "| 29601 | DISEASE         | None                                   | embolic and hypoperfusion-related cerebral infarcts | embolic and hypoperfusion-related cerebral infarcts |\n",
      "| 29602 | DISEASE         | None                                   | impairment of systolic function                     | decompensated heart failure                         |\n",
      "| 29603 | DISEASE         | None                                   | impairment of systolic function                     | embolic and hypoperfusion-related cerebral infarcts |\n",
      "| 29604 | DISEASE         | None                                   | mildly impaired systolic function                   | decompensated heart failure                         |\n",
      "| 29605 | DISEASE         | None                                   | mildly impaired systolic function                   | embolic and hypoperfusion-related cerebral infarcts |\n",
      "| 29606 | DISEASE         | None                                   | MRI brain/spinal cord/lumbar spine                  | decompensated heart failure                         |\n",
      "| 29607 | DISEASE         | None                                   | MRI brain/spinal cord/lumbar spine                  | embolic and hypoperfusion-related cerebral infarcts |\n",
      "| 29608 | DISEASE         | None                                   | cardioembolic                                       | decompensated heart failure                         |\n",
      "| 29609 | DISEASE         | None                                   | cardioembolic                                       | embolic and hypoperfusion-related cerebral infarcts |\n",
      "| 29610 | DISEASE         | None                                   | cardioembolic                                       | decompensated heart failure                         |\n",
      "| 29611 | DISEASE         | None                                   | cardioembolic                                       | embolic and hypoperfusion-related cerebral infarcts |\n",
      "| 29612 | DISEASE         | None                                   | euvolaemia                                          | decompensated heart failure                         |\n",
      "| 29613 | DISEASE         | None                                   | euvolaemia                                          | embolic and hypoperfusion-related cerebral infarcts |\n",
      "| 29614 | DISEASE         | None                                   | mildly impaired systolic function                   | decompensated heart failure                         |\n",
      "| 29615 | DISEASE         | None                                   | mildly impaired systolic function                   | embolic and hypoperfusion-related cerebral infarcts |\n",
      "==================================================\n",
      "A 21-year-old man initially presented with shortness of breath and abdominal swelling. He was found to be in renal failure with urinary retention and subsequent imaging confirmed severe bilateral hydronephrosis requiring bilateral nephrostomies. He described a 4-month history of progressive shortness of breath on exertion, orthopnoea, weight loss and general malaise. Three months prior to this he had been treated by his general practitioner with a course of oral antibiotics for a productive cough, fevers and shortness of breath. There was no significant past medical history and family history was not suspicious for cardiomyopathy or sudden cardiac death. He was an ex-smoker, having stopped 3 years earlier. Alcohol and illicit drug use were denied, however there was a history of regular ‘Energy drink’ drink consumption, specifically consuming an average of four 500 mL cans per day for approximately 2 years. Each can contains 160 mg of caffeine in addition to taurine and various other ingredients. Retrospectively, the patient recalls occasional symptoms of dyspepsia, tremor and a racing heartbeat but without seeking medical review. In the 3 months prior to admission he was unable to continue his university studies due to his lethargy and feelings of ill health.\n",
      "\n",
      "Creatinine on presentation was 562 μmol/L, with urea of 47.4 mmol/L. Bilateral nephrostomies were inserted on day 3 of admission, with little subsequent improvement in renal function. He did not require any cardiovascular or respiratory support. On examination he was found to be in decompensated cardiac failure with pitting oedema to his knees and ascites. Clinically, he was not in pulmonary oedema. ECG demonstrated minor non-specific findings. A transthoracic echocardiogram showed a dilated left ventricle (LV) with a severely reduced ejection fraction (EF), biplane EF 11% with no left ventricular hypertrophy (LVH), a dilated right ventricle (RV) with impaired systolic function, bi-atrial dilatation, mild mitral regurgitation, mild tricuspid regurgitation and a small localised pericardial effusion 0.4 cm in size. There were bilateral ventricular thrombi caused by stasis requiring systemic anticoagulation with intravenous unfractionated heparin.\n",
      "\n",
      "The patient was then transferred to a tertiary hospital with access to advanced mechanical circulatory support in the event of deterioration. His admission was complicated by subclinical embolic and hypoperfusion-related cerebral infarcts, uraemic encephalopathy requiring emergency haemodialysis and heparin-induced thrombocytopenia. Haemodialysis was initiated on the intensive care unit on day 9, requiring a small amount of norepinephrine vasopressor support initially (0.04 μg/kg/min) but no inotropic agents were required. At the time there was concern that initiation of dialysis might result in cardiovascular collapse, which fortunately did not occur. This suggests that the low cardiac output was likely to have been chronic over a period of months for such haemodynamic compensation to occur. Given his intracardiac thrombi and renal failure, he initially received anticoagulation with intravenous unfractionated heparin. On day 9 of unfractionated heparin treatment his platelet count was noted to be 70×109/L following a gradual decline over the previous week (lowest platelet count 26×109/L on day 12). A positive heparin-induced thrombocytopenia screen resulted in a switch to argatroban. The patient stabilised on the intensive care unit but remained in cardiac and renal failure requiring regular haemodialysis without improvement in cardiac function and remaining haemodynamically stable off vasopressor support and without any inotrope requirement.\n",
      "\n",
      "He was referred and subsequently transferred for consideration of combined cardiac and renal transplantation. While urological investigations were being carried out to assess the suitability for kidney transplantation, his urine output via nephrostomies and urinary bladder improved with stable renal chemistry and fluid status, allowing a break from dialysis. Invasive assessment of his cardiac output with right heart catheterisation indicated that this was adequate, so imminent cardiac transplantation or mechanical circulatory support was not required at the time.\n",
      "\n",
      "Fifty-eight days after his initial presentation he was discharged home from hospital with ongoing cardiology, renal and urology follow-up with a creatinine of 383 μmol/L. His repeat outpatient cardiac magnetic resonance (CMR) scan after 2 months showed improvement in LVEF to 18% and repeat transthoracic echocardiogram at 9 months post discharge showed further improvement of LVEF to 51% with normal right ventricular function. His CMR indicated that there was no scar, inflammation or oedema.\n",
      "\n",
      "\n",
      "Investigations\n",
      "\n",
      "Admission ECG showed sinus tachycardia with a ventricular rate of 135 bpm, QRS duration of 110 ms and a normal PR interval. There was T-wave inversion in leads I and aVL and left axis deviation.\n",
      "Blood tests.\n",
      "Plain film chest radiograph (5/12/19, day 3 of admission) showed cardiomegaly, no pleural effusions and no pulmonary oedema\n",
      "\n",
      "Transthoracic echocardiogram (1) (5/12/19) showed a dilated LV (LV diameter 7.2 cm) with severely reduced EF (11%). No LVH. Laminated thrombus in LV mid anteroseptal wall extending to apex, dilated left atrium (30 cm2), dilated RV (6.3 cm base) with impaired systolic function. Tricuspid annular plane systolic excursion 14 mm. RV S’ 0.09 m/s, dilated right atrium (24 cm2), small pericardial effusion 0.4 cm atrial side, mild tricuspid regurgitation, RV systolic pressure 32 mmHg+right atrial pressure, mild mitral regurgitation, other valves were normal.\n",
      "CMR imaging (1) (11/12/19): CMR imaging showed a non-ischaemic cardiomyopathy with global severely impaired LV and RV systolic function, with LVEF of 9% and RVEF of 16%, severe bi-atrial dilatation with multiple LV and RV thrombi noted. No myocardial fibrosis, infiltration or infarction.\n",
      "CMR imaging (2) (14/2/20): CMR imaging showed improving but still severely impaired global LV systolic function (LVEF 18%). The mid inferior lateral wall is relatively more hypokinetic and there is improvement in RV function (RVEF 33%). No myocardial oedema and no obvious thrombi although gadolinium was not used on this occasion.\n",
      "Transthoracic echocardiogram (2) (10/6/20) showed a normal LV cavity size (LV diameter 5.7 cm) with global moderate impairment of systolic function (LVEF 38%). Normal RV size and function, normal bi-atrial sizes.\n",
      "Transthoracic echocardiogram (3) (18/8/20) showed a normal LV cavity size with mildly impaired systolic function (LVEF 51%). Normal RV size and function, normal bi-atrial sizes.\n",
      "Right heart catheterisation.\n",
      "MRI brain/spinal cord/lumbar spine (17/12/19): Combination of cardioembolic and hypoperfusion acute infarcts. The extensive bilateral subcortical acute infarcts as described favour a cardioembolic aetiology whereas the bilateral internal border zone acute infarcts suggest a hypoperfusion aetiology. No cauda equina/spinal cord compression, normal spinal cord and lumbar spine.\n",
      "Ultrasound abdomen (6/12/19): Enlarged kidneys with severe hydronephrosis and ureteric dilatation seen bilaterally. Increased echogenicity of the renal cortex and diffuse cortical thinning, appearance suggestive of chronic/longstanding obstruction. The liver is moderately enlarged with mild increased echogenicity of the parenchyma. The IVC in hepatic veins are prominent in size, likely in keeping with cardiac history.\n",
      "Urodynamic studies (1/7/20): Bladder capacity 400 mL. Reflux to upper tracts increasing volume and lowering pressure. Bladder outline highly trabeculated with closed bladder neck. No loss of compliance measured (upper tracts compensating for this).\n",
      "Bladder biopsy (20/08/20): Bladder mucosa shows stromal oedema, moderate chronic inflammation and stromal haemorrhage. No malignancy and no smooth muscle in biopsy samples.\n",
      "\n",
      "\n",
      "Differential diagnosis\n",
      "\n",
      "This was a case of severe biventricular failure with biventricular thrombi of uncertain aetiology. A number of differential diagnoses were considered.\n",
      "\n",
      "First, a stress-induced or ‘Takotsubo’ cardiomyopathy was felt to be less likely in this case given an absence of a preceding emotional or physical stressor, although these stressors may not be present in up to one-third of patients with Takotsubo syndrome.5 The insidious onset, over months prior to admission, was also not typical for Takotsubo syndrome, which classically presents more acutely and left ventricular function often recovers more quickly (usually within 21 days of onset).6 Furthermore, our patient did not fulfil the revised Mayo Clinic criteria7 or the international Takotsubo diagnostic criteria,8 and transthoracic echocardiography did not show any of the characteristic features (transient hypokinesis, akinesis or dyskinesis of the left ventricular mid-segments with or without apical involvement or any regional wall motion abnormalities extending beyond a single epicardial vascular distribution).9 Finally, Takotsubo syndrome predominantly affects postmenopausal women, although there have been case reports of younger male patients.10\n",
      "\n",
      "Heart failure secondary to myocarditis was also considered, however again the insidious clinical course was not typical for acute fulminant myocarditis and the CMR scan did not show the typical myocardial inflammation or fibrosis associated with this condition. Heart failure secondary to metabolic disturbances resulting from chronic renal failure was also considered as a potential differential diagnosis.\n",
      "\n",
      "A tachycardia-related cardiomyopathy was excluded as there was no evidence of arrhythmia throughout the admission, during which the patient remained on cardiac monitoring. Given the history of chronic energy drink consumption, lack of significant past medical or family history, cardiac imaging findings and improvement with ceasing intake, energy drink-induced cardiotoxicity was felt to be the most likely cause.\n",
      "\n",
      "\n",
      "Treatment\n",
      "\n",
      "Initial medical treatment was with intravenous furosemide and antibiotics for a suspected community acquired pneumonia. The patient was anticoagulated with unfractionated heparin, later switched to argatroban and then warfarin due to heparin-induced thrombocytopenia.\n",
      "\n",
      "Bilateral nephrostomies were inserted 3 days after admission, with little subsequent improvement in renal function. He later required temporary haemodialysis and now remains a low clearance patient under renal and urology follow-up with bilateral nephrostomies and ureteric stents.\n",
      "\n",
      "After stabilisation he was discharged on the following medications: warfarin once daily, carvedilol 3.125 mg twice daily, furosemide 20 mg once daily, isosorbide dinitrate 20 mg twice daily, hydralazine 25 mg three times a day, lansoprazole and oral nutritional supplements. Persisting severe renal impairment prevented the introduction of ACE inhibitor or mineralocorticoid receptor antagonist.\n",
      "\n",
      "\n",
      "Outcome and follow-up\n",
      "\n",
      "Post discharge, the patient had a considerable increase in exercise tolerance without any symptoms of heart failure or palpitations (NYHA class I). The patient had maintained euvolaemia and haemodynamic stability. Renal function remained severely impaired (estimated glomerular filtration rate 18 mL/min), and we were able to uptitrate carvedilol to 6.25 mg twice daily during the follow-up period in addition to his other medications. At 9 months post-discharge, a repeat echocardiogram showed that the left ventricular size had normalised with mildly impaired systolic function (LVEF 51%). There was no evidence of the previous intracardiac thrombus.\n",
      "\n",
      "As mentioned previously, poor renal function has largely inhibited the use of best medical therapy for heart failure. However, despite this, the patient has continued to improve and recover ventricular function. This is likely to be due to avoidance of energy drinks. He is no longer under follow-up from the cardiac transplantation team due to his improvement. However, it is difficult to predict the clinical course of recovery or potential for relapse. It is likely that the patient will at some point require renal transplantation. He has undergone urodynamic studies and bladder biopsies, which have not conclusively identified the cause of obstructive uropathy but do indicate that future bladder reconstruction is likely to be required to protect a future renal graft.\n",
      "\n",
      "\n",
      "==================================================\n",
      "**Discharge Summary**\n",
      "\n",
      "**Patient Information:**\n",
      "- **Name:** [Patient Name]\n",
      "- **Age:** 21 years\n",
      "- **Gender:** Male\n",
      "- **Date of Admission:** [Admission Date]\n",
      "- **Date of Discharge:** [Discharge Date]\n",
      "\n",
      "**Admission Diagnosis:**\n",
      "- Severe biventricular heart failure with bilateral thrombi\n",
      "- Renal failure with urinary retention and severe bilateral hydronephrosis\n",
      "\n",
      "**History of Present Illness:**\n",
      "The patient presented with shortness of breath and abdominal swelling, having experienced a 4-month history of progressive dyspnea on exertion, orthopnea, weight loss, and malaise. He had a prior treatment for a productive cough and fever with antibiotics three months before admission. Notable lifestyle factors included a history of energy drink consumption (four 500 mL cans daily for 2 years) and no significant past medical or family history.\n",
      "\n",
      "**Clinical Findings:**\n",
      "Upon examination, the patient exhibited signs of decompensated heart failure, including pitting edema and ascites, but was not in pulmonary edema. Initial laboratory tests revealed elevated creatinine (562 μmol/L) and urea (47.4 mmol/L). Imaging studies confirmed severe bilateral hydronephrosis, leading to the placement of bilateral nephrostomies.\n",
      "\n",
      "**Investigations:**\n",
      "- **ECG:** Sinus tachycardia, minor non-specific findings.\n",
      "- **Echocardiogram:** Dilated left ventricle with severely reduced ejection fraction (EF 11%), bi-atrial dilatation, and bilateral ventricular thrombi.\n",
      "- **CMR:** Non-ischaemic cardiomyopathy with severely impaired LV and RV function, multiple thrombi noted.\n",
      "- **Brain MRI:** Subclinical embolic and hypoperfusion-related cerebral infarcts.\n",
      "\n",
      "**Treatment:**\n",
      "The patient was initially treated with intravenous furosemide and antibiotics. Anticoagulation was initiated with unfractionated heparin, later switched to argatroban due to heparin-induced thrombocytopenia. Bilateral nephrostomies were performed, and he required temporary hemodialysis. Medications at discharge included warfarin, carvedilol, furosemide, isosorbide dinitrate, hydralazine, lansoprazole, and oral nutritional supplements.\n",
      "\n",
      "**Outcome:**\n",
      "The patient was discharged 58 days post-admission with improved renal function (creatinine 383 μmol/L) and ongoing follow-up for cardiology, renal, and urology. Follow-up imaging showed improvement in left ventricular ejection fraction (LVEF) to 18% at 2 months and 51% at 9 months post-discharge. He reported increased exercise tolerance and no symptoms of heart failure.\n",
      "\n",
      "**Follow-Up Plan:**\n",
      "- Continued follow-up with cardiology, renal, and urology teams.\n",
      "- Monitoring of renal function and potential future renal transplantation.\n",
      "- Consideration for bladder reconstruction due to obstructive uropathy.\n",
      "\n",
      "**Signature:**\n",
      "[Physician's Name]  \n",
      "[Physician's Title]  \n",
      "[Date]\n",
      "==================================================\n",
      "==================================================\n",
      "\n",
      "\n",
      "\n",
      "{'filenameid': '37885296', 'n_words_cc': 1339, 'n_words_ds': 252, 'gen_orig_ratio': 0.1882001493651979}\n",
      "==================================================\n",
      "|       | mention_class   | term                        | span_orig                                   | span_gen                        |\n",
      "|------:|:----------------|:----------------------------|:--------------------------------------------|:--------------------------------|\n",
      "| 49135 | CHEMICAL        | ALK gene                    | None                                        | ALK                             |\n",
      "| 49136 | DISEASE         | Basal Cell Cancer           | basal cell skin cancer                      | None                            |\n",
      "| 49137 | DISEASE         | Basal cell carcinoma        | basal cell carcinoma                        | None                            |\n",
      "| 49138 | DISEASE         | Cardiac Myxofibrosarcoma    | myxofibrosarcoma of the heart               | None                            |\n",
      "| 49139 | DISEASE         | Complication                | embolic complications                       | embolic complications           |\n",
      "| 49140 | DISEASE         | Complication                | embolic complications                       | embolic complications           |\n",
      "| 49141 | CHEMICAL        | Endocardium                 | endocar-dium                                | None                            |\n",
      "| 49142 | DISEASE         | Fibromyxosarcoma            | myxofibrosarcoma                            | myxofibrosarcoma                |\n",
      "| 49143 | DISEASE         | Fibromyxosarcoma            | myxofibrosarcoma                            | myxofibrosarcoma                |\n",
      "| 49144 | DISEASE         | Fibromyxosarcoma            | myxofibrosarcoma                            | myxofibrosarcoma                |\n",
      "| 49145 | DISEASE         | Fibromyxosarcoma            | myxofibrosarcoma                            | myxofibrosarcoma                |\n",
      "| 49146 | DISEASE         | Fibrosis                    | fibrosis                                    | None                            |\n",
      "| 49147 | DISEASE         | Granuloma                   | granulomas                                  | None                            |\n",
      "| 49148 | DISEASE         | Hashimoto Disease           | HT                                          | None                            |\n",
      "| 49149 | DISEASE         | Heart failure               | heart failure                               | Heart failure                   |\n",
      "| 49150 | DISEASE         | Hemorrhage                  | hemorrhage                                  | None                            |\n",
      "| 49151 | DISEASE         | Hemorrhagic necrosis        | hemorrhagic necrosis                        | None                            |\n",
      "| 49152 | DISEASE         | Hydrops Fetalis             | HF                                          | HF                              |\n",
      "| 49153 | DISEASE         | Hypertensive disease        | hypertension                                | None                            |\n",
      "| 49154 | DISEASE         | Malignant Neoplasms         | Cancer                                      | None                            |\n",
      "| 49155 | DISEASE         | Malignant Neoplasms         | Cancer                                      | None                            |\n",
      "| 49156 | DISEASE         | Mitral Valve Stenosis       | mitral stenosis                             | mitral stenosis                 |\n",
      "| 49157 | DISEASE         | Mitral Valve Stenosis       | mitral stenosis                             | mitral stenosis                 |\n",
      "| 49158 | DISEASE         | Necrosis                    | necrotic                                    | None                            |\n",
      "| 49159 | DISEASE         | Necrosis                    | necrosis                                    | None                            |\n",
      "| 49160 | DISEASE         | Necrosis                    | necrosis                                    | None                            |\n",
      "| 49161 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49162 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49163 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49164 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49165 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49166 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49167 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49168 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49169 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49170 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49171 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49172 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49173 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49174 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49175 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49176 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49177 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49178 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49179 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49180 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49181 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49182 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49183 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49184 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49185 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49186 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49187 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49188 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49189 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49190 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49191 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49192 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49193 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49194 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49195 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49196 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49197 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49198 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49199 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49200 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49201 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49202 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49203 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49204 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49205 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49206 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49207 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49208 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49209 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49210 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49211 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49212 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49213 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49214 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49215 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49216 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49217 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49218 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49219 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49220 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49221 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49222 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49223 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49224 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49225 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49226 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49227 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49228 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49229 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49230 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49231 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49232 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49233 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49234 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49235 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49236 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49237 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49238 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49239 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49240 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49241 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49242 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49243 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49244 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49245 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49246 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49247 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49248 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49249 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49250 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49251 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49252 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49253 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49254 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49255 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49256 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49257 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49258 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49259 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49260 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49261 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49262 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49263 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49264 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49265 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49266 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49267 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49268 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49269 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49270 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49271 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49272 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49273 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49274 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49275 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49276 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49277 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49278 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49279 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49280 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49281 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49282 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49283 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49284 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49285 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49286 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49287 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49288 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49289 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49290 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49291 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49292 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49293 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49294 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49295 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49296 | DISEASE         | Neoplasms                   | Tumor                                       | tumor                           |\n",
      "| 49297 | DISEASE         | Neoplasms                   | Tumor                                       | tumor                           |\n",
      "| 49298 | DISEASE         | Neoplasms                   | Tumor                                       | tumor                           |\n",
      "| 49299 | DISEASE         | Neoplasms                   | Tumor                                       | tumor                           |\n",
      "| 49300 | DISEASE         | Neoplasms                   | Tumor                                       | tumor                           |\n",
      "| 49301 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49302 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49303 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49304 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49305 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49306 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49307 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49308 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49309 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49310 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49311 | DISEASE         | Neoplasms                   | tumors                                      | tumor                           |\n",
      "| 49312 | DISEASE         | Neoplasms                   | tumors                                      | tumor                           |\n",
      "| 49313 | DISEASE         | Neoplasms                   | tumors                                      | tumor                           |\n",
      "| 49314 | DISEASE         | Neoplasms                   | tumors                                      | tumor                           |\n",
      "| 49315 | DISEASE         | Neoplasms                   | tumors                                      | tumor                           |\n",
      "| 49316 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49317 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49318 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49319 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49320 | DISEASE         | Neoplasms                   | tumor                                       | tumor                           |\n",
      "| 49321 | DISEASE         | Obstruction                 | obstruction of the MV                       | None                            |\n",
      "| 49322 | DISEASE         | Obstruction                 | obstruction of the MV                       | None                            |\n",
      "| 49323 | DISEASE         | Postpericardiotomy Syndrome | postpericardiotomy syndrome                 | Postpericardiotomy syndrome     |\n",
      "| 49324 | DISEASE         | Pulmonary Edema             | pulmonary edema                             | None                            |\n",
      "| 49325 | DISEASE         | Pulmonary Hypertension      | failure and pulmonary hypertension          | None                            |\n",
      "| 49326 | DISEASE         | Sarcoma                     | Sarcoma                                     | None                            |\n",
      "| 49327 | DISEASE         | Skin Basal Cell Carcinoma   | basal cell skin cancer of the left shoulder | None                            |\n",
      "| 49328 | DISEASE         | None                        | None                                        | cancer of the left shoulder     |\n",
      "| 49329 | DISEASE         | None                        | None                                        | obstruction of the mitral       |\n",
      "| 49330 | DISEASE         | None                        | None                                        | obstruction of the mitral valve |\n",
      "==================================================\n",
      "A 40-year-old female patient with a history of basal cell skin cancer of the left shoulder presented for medical treatment for heart failure (HF) of a high functional class. Echocardiography revealed a mass in the cavity of the left atrium. Outflow was prevented from the left atrium and the orifice of the mitral valve (MV) was partially obturated, leading to the formation of critical mitral stenosis.\n",
      "\n",
      "An operation was planned to remove the formation in the left atrium. The mass was an oval lobular tissue of light yellow color, soft elastic consistency and 4.0 × 4.5 × 3.5 cm in size. Histological examination revealed a small cell tumor growing from the endocardium. There were notable areas of hypo- and hypercellularity in the tumor. Cells were spindle-shaped, without clear borders, and nuclei were round and elongated with finely dispersed chromatin and with single small nucleoli in separate cells. The tumor stroma was loose, myxoid, and vascularized with a few thin-walled vessels. Mildly diffuse and small-focal infiltration by small lymphocytes was observed.\n",
      "\n",
      "Immunohistochemical study of tumor cells revealed cytoplasmic expression of vimentin, smooth muscle actin, desmin, and pan-cytokeratin; Ki-67 was 5%. Low mitotic activity, a lack of invasive tumor growth, necrotic foci, and mild cellular atypia led to a diagnosis of an inflammatory myofibroblastic tumor of the heart.\n",
      "\n",
      "The early postoperative period was complicated by postpericardiotomy syndrome, which was treated successfully. Control echocardiography showed no intracavitary formations of the left atrium. The patient received a long course of nonsteroidal anti-inflammatory therapy in the postoperative period.\n",
      "\n",
      "After 2 years, the patient again exhibited signs of high-functional HF. Echocardiography revealed the formation of the left atrium with severe obstruction of the MV and with the formation of high pulmonary hypertension. With the consideration of the pos-sibility of embolic complications, an emergency operation was performed to remove the left atrium mass through the right atrium and the interatrial septum. The tumor resection was performed through a 2-atrial approach. The right atrium was opened, and access to the left atrium was gained through a small incision in the interatrial septum. The tumor was attached to the left atrium wall via a broad and long stalk, and it was not possible to remove it entirely because the tumor had infiltrated the pulmonary veins. Therefore, the tumor was removed with the maximum possible tissue capture, including the adjacent atrial tissue. A 3 × 3-cm xenopericardial patch was sutured to the defect on the posterior wall of the left atrium.\n",
      "\n",
      "The removed mass measured 5.0 × 4.0 × 2.5 cm, lobulated, partially covered with smooth endocar-dium, light yellow on section, with dark red and orange foci. On histological examination, the formation was a lobular tumor covered with endot-helium of polymorphic, atypical spindle-shaped, and rounded cells. The tumor stroma was myxomatous with extensive areas of necrosis and hemorrhage. An immunohistochemical examination of tumor cells revealed p53, vimentin, smooth muscle, MUC4, and MDM2. Focal expression of CD56 was observed, and Ki-67 was 20%. When we considered the pronounced cellular atypia, the high proliferative activity, and the presence of a necrosis zone, the patient was diagnosed with myxofibrosar-coma.\n",
      "\n",
      "The postoperative period proceeded without complications. The patient did not receive chemot-herapy or radiation therapy. The patient was regularly observed by an oncologist.\n",
      "\n",
      "One year after the above episode, the patient again began to exhibit symptoms of high-functional HF. Echocardiography revealed a formation occupying nearly all the left atrium cavity, tightly fused with the MV cusp. Severe mitral stenosis with failure and pulmonary hypertension with pulmonary artery pressure of 97 mm Hg were functionally determined.\n",
      "\n",
      "With the high risk of embolic complications, obstruction of the MV, and development of pulmonary edema, emergency surgical intervention was required. However, the size of the tumor, tumor invasion into the cusp of the MV, and a possible invasion into the myocardium did not allow resection of the tumor; therefore, a heart transplant was planned.\n",
      "\n",
      "During the heart transplant, the recipient’s heart was partially dissected, leaving the posterior wall of the left atrium intact, according to the Dreyfus technique. On inspection of the left atrium, a mass measuring 5 × 4 × 4 cm was detected, which was attached to the fibrous ring of the MV’s posterior leaflet without invading beyond the epicardium. The upper, lower, and anterior walls of the left atrium were removed, whereas the right and left pulmonary vein collectors were preserved. To ensure the complete removal of the tumor, a portion of the left atrium's wall was excised, and a cardioectomy was performed. The pulmonary vein collectors were severed at a distance of no less than 2 cm from the tumor’s spread zone. Palpation of the parietal pericardium revealed soft tissue consistency with no signs of densification.\n",
      "\n",
      "In the left atrium, an exophytic tumor was determined with an area of 7.0 × 3.5 cm of a lobed type with soft elastic consistency. The tumor was located along the lateral wall of the atrium, with transition to the anterior and posterior walls. The invasion of the tumor was also deter-mined to the anterior and posterior cusps of the MV in the form of protruding plaques measuring 1.0 × 0.1 cm.\n",
      "\n",
      "On histological examination, the tumor showed polymorphic cells with indistinct cell boundaries. Zones of hyper- and hypocellularity of the tumor were determined. The cytoplasm of the cells was a weakly basophilic, process-like, and homogeneous in most of the cells, with fine-grained appearance in some cells. Cell nuclei were polymorphic (from small, rounded forms to giant shapeless ones). Chromatin in the nuclei was fine-grained; in most cells, 1 or 2 large nucleoli were visualized. Mitotic activity was assessed as 5 mitoses per 10 high-power field. The tumor stroma was abundant and myxoid. Zones of hemorrhagic necrosis of the tumor and focal fibrin deposits on the surface were observed. The endocardium under the tumor was sharply thickened because of acellular fibrosis and hyalinosis. Lymphocyte-macrophage infiltrates were determined focally in the endocar-dium under the tumor. In the area of the posto-perative scar, granulomas from multinuclear giant cells of foreign bodies and lymphocytes around the suture material were observed. Tumor complexes were found in the resection margin of the endocardium. Under immunohistochemical examination, tumor cells showed MUC4, MDM2, and smooth muscle actin, and Ki-67 was 9.1%. The fluorescence in situ hybridization test showed the presence of amplification in the MDM2 gene.\n",
      "\n",
      "With these considerations, the patient was diagno-sed with myxofibrosarcoma of the heart with creeping growth along the endocardium without invasion into the myocardium, of grade 1 (3 points) per the French Federation of Cancer Centers Sarcoma Group, pT1R1 (pTNM, American Joint Committee on Cancer).\n",
      "\n",
      "An endomyocardial biopsy 14 days after HT revealed a crisis of antibody-mediated rejection grade 2, which was successfully stopped by day 30 after surgery. The patient is currently receiving standard immunosuppressive therapy. The control computed tomography scan of the heart with intravenous contrasting and positron emission tomography-computed tomography scan at 4 months after heart transplant did not show the presence of a tumor.\n",
      "\n",
      "With the consideration of possible ex juvantibus targeted therapy, we decided to try to identify the damage in possible molecular pathways of carcinogenesis. It is widely known that a subset of myxofibrosarcoma is associated with mutations in the ALK gene. In addition, this patient’s history of basal cell skin cancer and myxofibrosarcoma may be due to common pathways of carcinogenesis for these 2 tumors. The literature described data on mutations in the KRAS, PTEN, TP53, and RB1 genes in both basal cell carcinoma and myxofibrosarcoma.4,5 Using polymerase chain reaction and fluorescence in situ hybridization tests, we determined that this patient does not have amplification of the ALK, KRAS, TP53, and RB1 genes in the tumor. Thus, at present, we have no basis for conducting ex juvantibus targeted therapy. To identify mutant genes and possible subsequent targeted therapy, genome sequencing was recommended.\n",
      "\n",
      "\n",
      "==================================================\n",
      "**Discharge Summary**\n",
      "\n",
      "**Patient Information:**\n",
      "- **Name:** [Patient Name]\n",
      "- **Age:** 40 years\n",
      "- **Gender:** Female\n",
      "- **Medical History:** Basal cell skin cancer of the left shoulder\n",
      "\n",
      "**Admission Details:**\n",
      "- **Date of Admission:** [Admission Date]\n",
      "- **Date of Discharge:** [Discharge Date]\n",
      "- **Reason for Admission:** Heart failure (HF) of high functional class\n",
      "\n",
      "**Clinical Findings:**\n",
      "- Echocardiography revealed a mass in the left atrium, causing critical mitral stenosis and obstructing the outflow from the left atrium. \n",
      "\n",
      "**Surgical Interventions:**\n",
      "1. **Initial Operation:**\n",
      "   - **Procedure:** Resection of left atrial mass\n",
      "   - **Mass Characteristics:** Oval lobular tissue, light yellow, soft elastic consistency, measuring 4.0 × 4.5 × 3.5 cm.\n",
      "   - **Histological Findings:** Small cell tumor from the endocardium, diagnosed as inflammatory myofibroblastic tumor.\n",
      "   - **Postoperative Complications:** Postpericardiotomy syndrome, successfully treated.\n",
      "\n",
      "2. **Second Operation (2 years later):**\n",
      "   - **Indication:** Recurrence of high-functional HF and severe obstruction of the mitral valve.\n",
      "   - **Procedure:** Emergency resection of left atrial mass via right atrium and interatrial septum.\n",
      "   - **Mass Characteristics:** 5.0 × 4.0 × 2.5 cm, lobulated, partially covered with smooth endocardium.\n",
      "   - **Histological Findings:** Diagnosed as myxofibrosarcoma.\n",
      "\n",
      "3. **Heart Transplant:**\n",
      "   - **Indication:** Severe obstruction of the mitral valve and high risk of embolic complications.\n",
      "   - **Procedure:** Heart transplant performed using the Dreyfus technique, preserving the posterior wall of the left atrium.\n",
      "   - **Mass Characteristics:** 5 × 4 × 4 cm, exophytic tumor with invasion into the mitral valve cusps.\n",
      "   - **Histological Findings:** Diagnosed as myxofibrosarcoma, grade 1, with creeping growth along the endocardium.\n",
      "\n",
      "**Postoperative Course:**\n",
      "- The patient experienced a crisis of antibody-mediated rejection grade 2, successfully managed by day 30 post-surgery.\n",
      "- Currently receiving standard immunosuppressive therapy.\n",
      "\n",
      "**Follow-Up and Recommendations:**\n",
      "- Control imaging (CT and PET-CT) at 4 months post-transplant showed no tumor presence.\n",
      "- Genome sequencing recommended to identify potential mutations for targeted therapy, as no amplification of ALK, KRAS, TP53, and RB1 genes was found.\n",
      "\n",
      "**Current Status:**\n",
      "- The patient is stable and will continue regular follow-up with an oncologist and cardiologist.\n",
      "\n",
      "**Instructions for Care:**\n",
      "- Adhere to immunosuppressive therapy regimen.\n",
      "- Schedule regular follow-up appointments for monitoring heart function and potential tumor recurrence.\n",
      "\n",
      "**Physician's Signature:**\n",
      "[Physician Name]  \n",
      "[Date]  \n",
      "[Contact Information]\n",
      "==================================================\n",
      "==================================================\n",
      "\n",
      "\n",
      "\n",
      "{'filenameid': '30226919', 'n_words_cc': 1766, 'n_words_ds': 356, 'gen_orig_ratio': 0.2015855039637599}\n",
      "==================================================\n",
      "|      | mention_class   | term                                    | span_orig                              | span_gen                        |\n",
      "|-----:|:----------------|:----------------------------------------|:---------------------------------------|:--------------------------------|\n",
      "| 6228 | CHEMICAL        | 140                                     | 140                                    | None                            |\n",
      "| 6229 | DISEASE         | Absent pulse                            | pulseless                              | pulseless                       |\n",
      "| 6230 | DISEASE         | Absent pulse                            | pulseless                              | pulseless                       |\n",
      "| 6231 | DISEASE         | Akinesia                                | akinesia                               | None                            |\n",
      "| 6232 | DISEASE         | Akinesia                                | akinesia                               | None                            |\n",
      "| 6233 | DISEASE         | Anemia                                  | anemia                                 | Anemia                          |\n",
      "| 6234 | DISEASE         | Aneurysm                                | aneurysm                               | None                            |\n",
      "| 6235 | DISEASE         | Aneurysm                                | aneurysm                               | None                            |\n",
      "| 6236 | DISEASE         | Aneurysm                                | aneurysm                               | None                            |\n",
      "| 6237 | CHEMICAL        | Bicarbonates                            | bicarbonate                            | None                            |\n",
      "| 6238 | DISEASE         | Bradycardia                             | bradycardia                            | None                            |\n",
      "| 6239 | DISEASE         | Bronchopneumonia                        | bronchopneumonia                       | bronchopneumonia                |\n",
      "| 6240 | DISEASE         | Bronchopneumonia                        | bronchopneumonia                       | bronchopneumonia                |\n",
      "| 6241 | DISEASE         | Bronchopneumonia                        | bronchopneumonia                       | bronchopneumonia                |\n",
      "| 6242 | DISEASE         | Bronchopneumonia                        | bronchopneumonia                       | bronchopneumonia                |\n",
      "| 6243 | DISEASE         | Cachexia                                | cachexia                               | cachexia                        |\n",
      "| 6244 | DISEASE         | Cardiac Arrest                          | cardiac arrest                         | cardiac arrest                  |\n",
      "| 6245 | DISEASE         | Cardiac Arrest                          | cardiac arrest                         | cardiac arrest                  |\n",
      "| 6246 | DISEASE         | Cardiac Arrest                          | cardiac arrest                         | asystole                        |\n",
      "| 6247 | DISEASE         | Cardiac Arrest                          | cardiac arrest                         | cardiac arrest                  |\n",
      "| 6248 | DISEASE         | Cardiac Arrest                          | cardiac arrest                         | cardiac arrest                  |\n",
      "| 6249 | DISEASE         | Cardiac Arrest                          | cardiac arrest                         | asystole                        |\n",
      "| 6250 | DISEASE         | Cardiac Arrest                          | cardiac arrest                         | cardiac arrest                  |\n",
      "| 6251 | DISEASE         | Cardiac Arrest                          | cardiac arrest                         | cardiac arrest                  |\n",
      "| 6252 | DISEASE         | Cardiac Arrest                          | cardiac arrest                         | asystole                        |\n",
      "| 6253 | DISEASE         | Cardiac Arrest                          | asystole                               | cardiac arrest                  |\n",
      "| 6254 | DISEASE         | Cardiac Arrest                          | asystole                               | cardiac arrest                  |\n",
      "| 6255 | DISEASE         | Cardiac Arrest                          | asystole                               | asystole                        |\n",
      "| 6256 | DISEASE         | Cardiomegaly                            | cardiomegaly                           | cardiomegaly                    |\n",
      "| 6257 | DISEASE         | Cardiomegaly                            | cardiomegaly                           | cardiomegaly                    |\n",
      "| 6258 | DISEASE         | Cardiomegaly                            | cardiomegaly                           | cardiomegaly                    |\n",
      "| 6259 | DISEASE         | Cardiomegaly                            | enlargement of the heart               | cardiomegaly                    |\n",
      "| 6260 | DISEASE         | Chagas Disease                          | Chagas disease                         | None                            |\n",
      "| 6261 | DISEASE         | Chest Pain                              | chest pain                             | None                            |\n",
      "| 6262 | DISEASE         | Chest Pain                              | chest pain                             | None                            |\n",
      "| 6263 | CHEMICAL        | Cocci (bacteria)                        | cocci                                  | None                            |\n",
      "| 6264 | DISEASE         | Congestion                              | congestion                             | congestion                      |\n",
      "| 6265 | DISEASE         | Coughing                                | None                                   | cough                           |\n",
      "| 6266 | DISEASE         | Decompensation                          | heart failure decompensation           | heart failure decompensation    |\n",
      "| 6267 | CHEMICAL        | Decreased HDL cholesterol concentration | HDL-cholesterol                        | None                            |\n",
      "| 6268 | DISEASE         | Decreased translucency                  | opacity                                | opacity                         |\n",
      "| 6269 | CHEMICAL        | Desire for food                         | appetite                               | appetite                        |\n",
      "| 6270 | DISEASE         | Dizziness                               | dizziness                              | dizziness                       |\n",
      "| 6271 | DISEASE         | Dizziness                               | dizziness                              | dizziness                       |\n",
      "| 6272 | DISEASE         | Dry cough                               | dry cough                              | dry cough                       |\n",
      "| 6273 | DISEASE         | Dry cough                               | dry cough                              | dry cough                       |\n",
      "| 6274 | DISEASE         | Dyskinetic syndrome                     | dyskinesia                             | None                            |\n",
      "| 6275 | DISEASE         | Dyspepsia                               | dyspepsia                              | None                            |\n",
      "| 6276 | DISEASE         | Dyspnea                                 | dyspnea                                | dyspnea                         |\n",
      "| 6277 | DISEASE         | Dyspnea                                 | dyspnea                                | dyspnea                         |\n",
      "| 6278 | DISEASE         | Dyspnea                                 | dyspnea                                | dyspnea                         |\n",
      "| 6279 | DISEASE         | Dyspnea                                 | dyspnea                                | dyspnea                         |\n",
      "| 6280 | DISEASE         | Dyspnea                                 | dyspnea                                | dyspnea                         |\n",
      "| 6281 | DISEASE         | Dyspnea                                 | dyspnea                                | dyspnea                         |\n",
      "| 6282 | DISEASE         | Dyspnea                                 | dyspnea                                | dyspnea                         |\n",
      "| 6283 | DISEASE         | Dyspnea                                 | dyspnea                                | dyspnea                         |\n",
      "| 6284 | DISEASE         | Dyspnea                                 | dyspnea                                | dyspnea                         |\n",
      "| 6285 | DISEASE         | Dyspnea                                 | dyspnea                                | dyspnea                         |\n",
      "| 6286 | DISEASE         | Dyspnea                                 | dyspnea                                | dyspnea                         |\n",
      "| 6287 | DISEASE         | Dyspnea                                 | dyspnea                                | dyspnea                         |\n",
      "| 6288 | DISEASE         | Edema                                   | edema                                  | edema                           |\n",
      "| 6289 | DISEASE         | Edema                                   | edema                                  | edema                           |\n",
      "| 6290 | DISEASE         | Edema of lower extremity                | lower limb edema                       | lower limb edema                |\n",
      "| 6291 | DISEASE         | Fever                                   | fever                                  | None                            |\n",
      "| 6292 | DISEASE         | Fever                                   | hyperthermia                           | None                            |\n",
      "| 6293 | DISEASE         | Gastric ulcer                           | gastric ulcer                          | gastric ulcer                   |\n",
      "| 6294 | DISEASE         | Granulomatous                           | granulomatous                          | granulomatous                   |\n",
      "| 6295 | DISEASE         | Ground glass opacity                    | ground-glass opacity                   | None                            |\n",
      "| 6296 | DISEASE         | Heart Diseases                          | heart disease                          | heart disease                   |\n",
      "| 6297 | DISEASE         | Heart Diseases                          | heart disease                          | heart disease                   |\n",
      "| 6298 | DISEASE         | Heart Diseases                          | heart disease                          | heart disease                   |\n",
      "| 6299 | DISEASE         | Heart failure                           | heart failure                          | heart failure                   |\n",
      "| 6300 | DISEASE         | Hematemesis                             | hematemesis                            | None                            |\n",
      "| 6301 | DISEASE         | Hemorrhage                              | bleeding                               | None                            |\n",
      "| 6302 | DISEASE         | Hemorrhage                              | bleeding                               | None                            |\n",
      "| 6303 | DISEASE         | Hypertensive disease                    | hypertension                           | hypertension                    |\n",
      "| 6304 | DISEASE         | Hypertrophy                             | hypertrophy                            | None                            |\n",
      "| 6305 | DISEASE         | Hypertrophy                             | enlargement                            | None                            |\n",
      "| 6306 | DISEASE         | Hypoalbuminemia                         | hypoalbuminemia                        | None                            |\n",
      "| 6307 | DISEASE         | Hypotension                             | hypotension                            | hypotension                     |\n",
      "| 6308 | DISEASE         | Hypotension                             | hypotension                            | hypotension                     |\n",
      "| 6309 | DISEASE         | Leukocytosis                            | leukocytosis                           | leukocytosis                    |\n",
      "| 6310 | CHEMICAL        | Millimole per Liter                     | mmol/L                                 | None                            |\n",
      "| 6311 | DISEASE         | Mitral Valve Insufficiency              | mitral regurgitation                   | None                            |\n",
      "| 6312 | DISEASE         | Mitral Valve Insufficiency              | mitral valve regurgitation             | None                            |\n",
      "| 6313 | CHEMICAL        | Nanogram per Deciliter                  | ng/dL                                  | None                            |\n",
      "| 6314 | DISEASE         | Necrosis                                | necrosis                               | None                            |\n",
      "| 6315 | DISEASE         | Nonsustained Ventricular Tachycardia    | nonsustained ventricular tachycardia   | None                            |\n",
      "| 6316 | CHEMICAL        | Oxygen saturation measurement           | O2 saturation                          | None                            |\n",
      "| 6317 | CHEMICAL        | Oxygen saturation measurement           | O2 saturation                          | None                            |\n",
      "| 6318 | CHEMICAL        | Oxygen saturation measurement           | O2 saturation                          | None                            |\n",
      "| 6319 | DISEASE         | Palpitations                            | palpitations                           | palpitations                    |\n",
      "| 6320 | DISEASE         | Palpitations                            | palpitations                           | palpitations                    |\n",
      "| 6321 | DISEASE         | Pathological Dilatation                 | ectasia                                | None                            |\n",
      "| 6322 | DISEASE         | Pleural effusion disorder               | pleural effusion                       | None                            |\n",
      "| 6323 | DISEASE         | Pneumonia                               | pneumonia                              | pneumonia                       |\n",
      "| 6324 | DISEASE         | Pneumonia                               | pneumonia                              | pneumonia                       |\n",
      "| 6325 | DISEASE         | Pneumonia                               | pneumonia                              | pneumonia                       |\n",
      "| 6326 | DISEASE         | Pneumonia                               | pneumonia                              | pneumonia                       |\n",
      "| 6327 | DISEASE         | Premature ventricular contractions      | ventricular extrasystoles              | None                            |\n",
      "| 6328 | DISEASE         | Pulmonary congestion                    | pulmonary congestion                   | Pulmonary congestion            |\n",
      "| 6329 | DISEASE         | Pulmonary congestion                    | pulmonary congestion                   | Pulmonary congestion            |\n",
      "| 6330 | DISEASE         | Pulmonary congestion                    | pulmonary congestion                   | Pulmonary congestion            |\n",
      "| 6331 | DISEASE         | Shock                                   | shock                                  | None                            |\n",
      "| 6332 | DISEASE         | Shock                                   | shock                                  | None                            |\n",
      "| 6333 | DISEASE         | Standing position                       | orthostatic                            | None                            |\n",
      "| 6334 | DISEASE         | Syncope                                 | syncope                                | None                            |\n",
      "| 6335 | DISEASE         | Systemic arterial pressure              | complaints and arterial blood pressure | None                            |\n",
      "| 6336 | DISEASE         | Tachycardia                             | tachycardia                            | None                            |\n",
      "| 6337 | DISEASE         | Tachycardia, Ventricular                | ventricular tachycardia                | ventricular tachycardia         |\n",
      "| 6338 | DISEASE         | Tachycardia, Ventricular                | ventricular tachycardia                | ventricular tachycardia         |\n",
      "| 6339 | DISEASE         | Tachycardia, Ventricular                | ventricular tachycardia                | ventricular tachycardia         |\n",
      "| 6340 | DISEASE         | Tachycardia, Ventricular                | ventricular tachycardia                | ventricular tachycardia         |\n",
      "| 6341 | DISEASE         | Tachycardia, Ventricular                | ventricular tachycardia                | ventricular tachycardia         |\n",
      "| 6342 | DISEASE         | Tachypnea                               | tachypneic                             | tachypnea                       |\n",
      "| 6343 | DISEASE         | Tachypnea                               | tachypnea                              | tachypnea                       |\n",
      "| 6344 | DISEASE         | Upper gastrointestinal hemorrhage       | None                                   | upper gastrointestinal bleeding |\n",
      "| 6345 | DISEASE         | Weight Loss                             | weight loss                            | weight loss                     |\n",
      "| 6346 | CHEMICAL        | amiodarone                              | amiodarone                             | amiodarone                      |\n",
      "| 6347 | CHEMICAL        | amiodarone                              | amiodarone                             | amiodarone                      |\n",
      "| 6348 | CHEMICAL        | amiodarone                              | amiodarone                             | amiodarone                      |\n",
      "| 6349 | CHEMICAL        | amiodarone                              | amiodarone                             | amiodarone                      |\n",
      "| 6350 | CHEMICAL        | amiodarone                              | amiodarone                             | amiodarone                      |\n",
      "| 6351 | CHEMICAL        | amiodarone                              | amiodarone                             | amiodarone                      |\n",
      "| 6352 | CHEMICAL        | amiodarone                              | amiodarone                             | amiodarone                      |\n",
      "| 6353 | CHEMICAL        | carvedilol                              | carvedilol                             | None                            |\n",
      "| 6354 | CHEMICAL        | catheter device                         | O2 catheter                            | None                            |\n",
      "| 6355 | CHEMICAL        | ceftriaxone                             | ceftriaxone                            | ceftriaxone                     |\n",
      "| 6356 | CHEMICAL        | cholesterol                             | cholesterol                            | None                            |\n",
      "| 6357 | CHEMICAL        | cholesterol                             | cholesterol                            | None                            |\n",
      "| 6358 | CHEMICAL        | cholesterol                             | LDL-cholesterol                        | None                            |\n",
      "| 6359 | CHEMICAL        | clarithromycin                          | clarithromycin                         | clarithromycin                  |\n",
      "| 6360 | CHEMICAL        | creatinine                              | creatinine                             | None                            |\n",
      "| 6361 | CHEMICAL        | creatinine                              | creatinine                             | None                            |\n",
      "| 6362 | CHEMICAL        | creatinine                              | creatinine                             | None                            |\n",
      "| 6363 | CHEMICAL        | enalapril                               | enalapril                              | None                            |\n",
      "| 6364 | CHEMICAL        | enalapril                               | enalapril                              | None                            |\n",
      "| 6365 | CHEMICAL        | hydrochlorothiazide                     | hydrochlorothiazide                    | None                            |\n",
      "| 6366 | CHEMICAL        | hydrochlorothiazide                     | hydrochlorothiazide                    | None                            |\n",
      "| 6367 | CHEMICAL        | hydrochlorothiazide                     | hydrochlorothiazide                    | None                            |\n",
      "| 6368 | CHEMICAL        | levothyroxine                           | levothyroxine                          | None                            |\n",
      "| 6369 | CHEMICAL        | metoprolol                              | metoprolol                             | None                            |\n",
      "| 6370 | CHEMICAL        | potassium                               | potassium                              | None                            |\n",
      "| 6371 | CHEMICAL        | potassium                               | potassium                              | None                            |\n",
      "| 6372 | CHEMICAL        | potassium                               | potassium                              | None                            |\n",
      "| 6373 | CHEMICAL        | simvastatin                             | simvastatin                            | None                            |\n",
      "| 6374 | CHEMICAL        | sodium                                  | sodium                                 | None                            |\n",
      "| 6375 | CHEMICAL        | sodium                                  | sodium                                 | None                            |\n",
      "| 6376 | CHEMICAL        | sodium                                  | sodium                                 | None                            |\n",
      "| 6377 | CHEMICAL        | spironolactone                          | spironolactone                         | None                            |\n",
      "| 6378 | CHEMICAL        | urea                                    | urea                                   | None                            |\n",
      "| 6379 | CHEMICAL        | uric acid                               | uric acid                              | None                            |\n",
      "| 6380 | CHEMICAL        | warfarin                                | warfarin                               | None                            |\n",
      "| 6381 | CHEMICAL        | None                                    | ICD-T                                  | None                            |\n",
      "| 6382 | DISEASE         | None                                    | upper digestive bleeding               | decompensated heart failure     |\n",
      "| 6383 | DISEASE         | None                                    | upper digestive bleeding               | right atrial overload           |\n",
      "| 6384 | DISEASE         | None                                    | upper digestive bleeding               | sudden decline                  |\n",
      "| 6385 | DISEASE         | None                                    | ventricular septal thickness           | decompensated heart failure     |\n",
      "| 6386 | DISEASE         | None                                    | ventricular septal thickness           | right atrial overload           |\n",
      "| 6387 | DISEASE         | None                                    | ventricular septal thickness           | sudden decline                  |\n",
      "| 6388 | DISEASE         | None                                    | inferolateral wall aneurysm            | decompensated heart failure     |\n",
      "| 6389 | DISEASE         | None                                    | inferolateral wall aneurysm            | right atrial overload           |\n",
      "| 6390 | DISEASE         | None                                    | inferolateral wall aneurysm            | sudden decline                  |\n",
      "| 6391 | DISEASE         | None                                    | mg/dL.                                 | decompensated heart failure     |\n",
      "| 6392 | DISEASE         | None                                    | mg/dL.                                 | right atrial overload           |\n",
      "| 6393 | DISEASE         | None                                    | mg/dL.                                 | sudden decline                  |\n",
      "| 6394 | DISEASE         | None                                    | decompensated heart failure            | decompensated heart failure     |\n",
      "| 6395 | DISEASE         | None                                    | decompensated heart failure            | right atrial overload           |\n",
      "| 6396 | DISEASE         | None                                    | decompensated heart failure            | sudden decline                  |\n",
      "| 6397 | DISEASE         | None                                    | right atrial overload                  | decompensated heart failure     |\n",
      "| 6398 | DISEASE         | None                                    | right atrial overload                  | right atrial overload           |\n",
      "| 6399 | DISEASE         | None                                    | right atrial overload                  | sudden decline                  |\n",
      "| 6400 | DISEASE         | None                                    | consumptive syndrome                   | decompensated heart failure     |\n",
      "| 6401 | DISEASE         | None                                    | consumptive syndrome                   | right atrial overload           |\n",
      "| 6402 | DISEASE         | None                                    | consumptive syndrome                   | sudden decline                  |\n",
      "| 6403 | DISEASE         | None                                    | ill-defined malaise                    | decompensated heart failure     |\n",
      "| 6404 | DISEASE         | None                                    | ill-defined malaise                    | right atrial overload           |\n",
      "| 6405 | DISEASE         | None                                    | ill-defined malaise                    | sudden decline                  |\n",
      "==================================================\n",
      "The patient is a 60-year-old female with Chagas heart disease and cachexia, admitted due to heart failure decompensation attributed to bronchopneumonia. She eventually had a cardiac arrest with pulseless electrical activity after lung biopsy.\n",
      "\n",
      "The patient was being followed up at InCor since the age of 48 years, diagnosed with Chagas disease. She initially complained of palpitations, which subsided after amiodarone was prescribed. In addition, she had systemic arterial hypertension.\n",
      "\n",
      "Her laboratory tests revealed: potassium, 5.2 mEq/L; sodium, 144 mEq/L; creatinine, 0.8 mg/L; hemoglobin, 16.2 g/dL; hematocrit, 48%; glycemia, 87 mg/dL; cholesterol, 200 mg/dL; triglycerides, 53 mg/dL; TSH, 1.16 microIU/mL; free T4, 1.1 ng/dL; ALT, 8 IU/L; AST, 10 IU/L.\n",
      "\n",
      "At the time, the ECG revealed diffuse ventricular repolarization changes.\n",
      "\n",
      "The echocardiogram (August 2004) showed the following: aorta, 28 mm; left atrium, 52 mm; septal thickness, 11 mm; posterior wall, 7 mm; left ventricle (diast/syst), 71/62 mm; left ventricular ejection fraction (LVEF), 26%, with posterior (basal), inferior (basal) and lateral (basal) akinesia, and small apical aneurysm; right ventricle, 28 mm (dilated and hypokinetic); severe mitral regurgitation; and right ventricular systolic pressure, 65 mm Hg.\n",
      "\n",
      "The chest X-ray (2012) showed cardiomegaly.\n",
      "\n",
      "The Holter ECG at that time showed frequent ventricular extrasystoles and nonsustained ventricular tachycardia.\n",
      "\n",
      "The patient remained asymptomatic until 2013 (57 years of age) using hydrochlorothiazide (25 mg), spironolactone (25 mg), carvedilol (12.5 mg), enalapril (20 mg) and amiodarone (100 mg) daily. In April 2013, she had a resuscitated cardiac arrest, preceded by malaise and sustained ventricular tachycardia, receiving an implantable cardioverter defibrillator (ICD) with cardiac pacemaker programing for bradycardia episodes (ICD-T - ICD with antibradycardia and antitachycardia pacing and shock), being prescribed 600 mg of amiodarone daily.\n",
      "\n",
      "Five days before that episode, she had upper digestive bleeding with hematemesis, when endoscopy revealed gastric ulcer with no active bleeding, and clean base (Forrest III), with a lower risk for rebleeding.\n",
      "\n",
      "The patient experienced appropriate shock in May 2014. She was receiving an amiodarone dose lower than prescribed, thus the dose was increased, but the patient did not tolerate it because of dyspepsia. A cardiac electrophysiology study was indicated, aimed at the possible ablation of the sustained ventricular tachycardia pathways.\n",
      "\n",
      "The chest X-ray revealed pulmonary congestion and more severe cardiomegaly.\n",
      "\n",
      "The echocardiogram (August 4, 2014) revealed: aorta, 27 mm; left atrium, 43 mm; ventricular septal thickness, 9 mm, posterior wall, 8 mm; left ventricular diameters, 68/57 mm; LVEF, 30%. The left ventricle showed eccentric hypertrophy and reduced systolic function due to an inferolateral wall aneurysm (mid and basal segments) and an apical aneurysm. The right ventricle was normal. There was moderate mitral valve regurgitation. The pulmonary artery pressure was 25 mm Hg.\n",
      "\n",
      "Her coronary tomography angiography (July 28, 2014) evidenced no coronary lesion. The cardiac electrophysiology study (July 31, 2014) identified poorly-tolerated sustained ventricular tachycardia triggered by extra-stimuli, which required electric cardioversion. The electroanatomic mapping revealed a scar associated with low and slow late potentials in the lateral (mid and basal segments), antero-lateral (mid and basal segments) and inferolateral (mid and basal segments) walls. Because of the proximity to the circumflex sub-branches, the radiofrequency pulses were not delivered through the epicardium, but through the endocardium. After the procedure, the new stimuli no longer triggered ventricular tachycardia similar to that initially observed. However, several poorly tolerated tachycardias of different morphologies were triggered, requiring cardioversion.\n",
      "\n",
      "On outpatient follow-up (November 2014), the patient complained of dyspnea on exertion and dizziness when changing from supine to orthostatic position.\n",
      "\n",
      "Her physical examination (November 11, 2014) revealed: weight, 70 kg; height, 1.7 m; arterial blood pressure, 102/80 mmHg; heart rate, 68 bpm. The pulmonary auscultation was normal. On cardiac auscultation, her heart rhythm was regular with no abnormal heart sound, and a systolic heart murmur was heard over the mitral area (++/4+). The abdominal examination was normal. There was no edema, and her pulses were palpable and symmetrical. Because of her complaints and arterial blood pressure levels, hydrochlorothiazide was suspended, and the other medications, maintained.\n",
      "\n",
      "Her laboratory tests (October 2014) showed: hemoglobin, 13.2 g/dL; hematocrit, 43%; leukocytes, 7220/mm3 (normal differential count); platelets, 200000/mm3; total cholesterol, 180 mg/dL; HDL-cholesterol, 73 mg/dL; LDL-cholesterol, 88 mg/dL; triglycerides, 95 mg/dL; glycemia, 94 mg/dL; creatinine, 0.96 mg/dL; sodium, 141 mEq/L; potassium, 4.8 mEq/L; AST, 79 IU/L; ALT, 111 IU/L; uric acid, 4.2 mg/dL; C-reactive protein, 6.78 mg/L; TSH, 2.85 µg/mL; free T4, 1.62 mg/dL.\n",
      "\n",
      "On outpatient follow-up visits (October 2015 and March 18, 2016), she denied dyspnea, chest pain, palpitations and syncope, but complained of dizziness. The ICD/pacemaker assessment was normal.\n",
      "\n",
      "Her chest X-ray (2015) revealed pulmonary congestion and cardiomegaly.\n",
      "\n",
      "On September 22, 2016, the patient was admitted due to decompensated heart failure and bronchopneumonia. She reported progressive worsening of dyspnea, which was then triggered on mild exertion. She denied chest pain and fever, but reported dry cough, lack of appetite and weight loss. Her physical examination revealed an emaciated patient (53 kg), on regular general condition, tachypneic, with heart rate of 72 bpm, arterial blood pressure of 95/60 mm Hg, and O2 saturation of 92%. Her auscultation revealed rales over the pulmonary bases, rhythmic heart sounds, and systolic heart murmur over the mitral area (++++/6+). Her abdomen was flaccid, with a tender liver, palpated 2 cm from the costal margin. There was lower limb edema (+++/4+).\n",
      "\n",
      "The patient was using amiodarone (200 mg), enalapril (5 mg), hydrochlorothiazide (25 mg), levothyroxine (25 µg), metoprolol (100 mg), simvastatin (20 mg), warfarin (5 mg).\n",
      "\n",
      "Her ECG (September 22) showed: sinus rhythm; heart rate, 63 bpm; indirect signs of right atrial overload (Peñaloza-Tranchesi); low-voltage QRS complexes on the frontal plane; probable electrically inactive lateral area; left anterior-superior hemiblock. After a few days, the new ECG revealed an operational pacemaker with atrial stimulus propagating to the ventricle (AAI).\n",
      "\n",
      "Her chest X-ray (September 22, 2016) evidenced the presence of an ICD/pacemaker with electrodes in the left atrium and ventricle, pulmonary congestion, opacity area suggestive of pneumonia in the right pulmonary lower field (air bronchogram), elevation of the left main bronchus (suggestive of enlarged left atrium), and global enlargement of the heart area, attributed mainly to the right ventricle.\n",
      "\n",
      "Her laboratory tests (September 22) revealed: hemoglobin, 8.2 g/dL; hematocrit, 26%; leukocytes, 17500/mm3 (neutrophils 79%, eosinophils 0%, lymphocytes 15% and monocytes 6%); platelets, 344000/mm3; urea, 33 mg/dL; creatinine, 0.71 mg/dL; AST, 148 IU/L; ALT, 136 IU/L; gamma GT, 36 IU/L; alkaline phosphatase, 75 mg/dL; total proteins, 6.9 g/dL; albumin, 3.1 g/dL; C-reactive protein, 124.39 mg/L; sodium, 140 mEq/L; potassium, 3.6 mEq/L. Arterial blood gas analysis: pH, 7.54; pCO2, 31.1 mm Hg; pO2, 62.3 mmHg; O2 saturation, 93%; bicarbonate, 26.2 mmol/L; base excess, 3.9 mmol/L.\n",
      "\n",
      "Because of the diagnostic suspicion of pneumonia, ceftriaxone and clarithromycin were initiated.\n",
      "\n",
      "The dyspnea and edema improved, arterial hypotension episodes occurred, and the dry cough and mild hyperthermia (37.6ºC) persisted.\n",
      "\n",
      "Assessment of the ICD/pacemaker revealed 14 episodes of ventricular tachycardia in July 2016: 12 abolished by burst (high-frequency stimuli) and 2 abolished with 31-J shocks.\n",
      "\n",
      "Her echocardiogram (September 26, 2016) showed: aorta, 26 mm; left atrium, 60 mm; basal and mid right ventricle, 43 mm and 33 mm, respectively; ventricular septal thickness, 10 mm; posterior wall, 7 mm; left ventricle (diast/syst), 73/60 mm; LVEF, 40%. The atria were severely enlarged, the left ventricle was dilated with dyskinesia of the lateral wall (basal segment), akinesia of the inferior wall (basal segment), and apical aneurysm. The right ventricular function was normal. The mitral and tricuspid valves showed severe regurgitation due to inadequate leaflet coaptation. Systolic pulmonary artery pressure was estimated at 47 mmHg. No pericardial change was observed.\n",
      "\n",
      "On the days following admission, her laboratory tests continued to show leukocytosis (around 19000), anemia, hypoalbuminemia (1.9 g/dL) and elevated C-reactive protein (above 150 mg/L).\n",
      "\n",
      "A new chest X-ray detected an opaque nodule in the right base.\n",
      "\n",
      "Chest tomography (September 28, 2016) evidenced: pacemaker with endocavitary electrodes in the right chambers; dilation of the pulmonary trunk (41 mm); permeable trachea and main bronchi of normal caliber; diffuse thickening of the bronchial walls; enlarged pulmonary hila; and hilar calcifications that could be lymph node sequelae. There was an irregular nodule measuring 2.3 x 2.5 x 1.9 cm in the transition between the medial and lateral segments of the middle lobe, in addition to diffuse ground-glass opacity with septal thickening, mainly in the bases, compatible with congestion. Furthermore, there was a peripheral hyperdense area, close to the pleural surface of the right superior lobe, suggestive of subacute parenchymal bleeding or accumulation of amiodarone. The pulmonary vascularization was increased, and there was small bilateral pleural effusion. In the liver, low-density nodules were identified, but their assessment was limited due to lack of contrast media imaging. In addition, there were sparse nodular calcifications in the liver parenchyma, whose density was diffusely increased (suggestive of amiodarone deposition). Dilation of the inferior vena cava and of the hepatic veins, as well as ectasia of the gallbladder, was observed. No lymph node enlargement was identified. The heart was diffusely enlarged, with predominance of the left atrium.\n",
      "\n",
      "Because the patient was emaciated, had moderate reduction of the LVEF and altered pulmonary imaging, the search for consumptive syndrome causes other than heart failure began. Sputum tests (three samples on different days) were negative for acid-fast bacillus. The bacteriologic examination of the sputum revealed the usual local flora: Gram-positive bacilli, Gram-positive cocci, Gram-negative bacilli, Gram-negative diplococci and Gram-negative coccobacilli.\n",
      "\n",
      "The patient was submitted to biopsy of the pulmonary nodule (October 12, 2016), which revealed a granulomatous chronic inflammatory process with extensive area of necrosis. The search for fungi was negative and that for acid-fast bacillus was ongoing.\n",
      "\n",
      "On the night of October 12, 2016, 12 hours after the biopsy, the patient woke up complaining of ill-defined malaise. Her initial examination revealed arterial blood pressure of 50/40 mmHg, O2 saturation of 99% with O2 catheter, tachycardia and tachypnea. The patient had a cardiac arrest with pulseless electrical activity. She was resuscitated but developed asystole and died.\n",
      "\n",
      "\n",
      "==================================================\n",
      "**Discharge Summary**\n",
      "\n",
      "**Patient Information:**\n",
      "- Name: [Patient Name]\n",
      "- Age: 60 years\n",
      "- Gender: Female\n",
      "- Admission Date: September 22, 2016\n",
      "- Discharge Date: [Discharge Date]\n",
      "- Diagnosis: Chagas heart disease, cachexia, heart failure decompensation due to bronchopneumonia.\n",
      "\n",
      "**Clinical History:**\n",
      "The patient has a long-standing history of Chagas heart disease, diagnosed at age 48, with a previous presentation of palpitations managed with amiodarone. She also had systemic arterial hypertension. Over the years, she experienced multiple cardiac events, including a resuscitated cardiac arrest in April 2013, leading to the implantation of an ICD with pacemaker programming. The patient had episodes of upper gastrointestinal bleeding and underwent endoscopy revealing a gastric ulcer.\n",
      "\n",
      "In 2014, she experienced appropriate shocks from the ICD and underwent a cardiac electrophysiology study, which identified sustained ventricular tachycardia. Follow-up visits indicated persistent symptoms such as dyspnea and dizziness, with echocardiograms showing progressive heart failure.\n",
      "\n",
      "**Current Admission:**\n",
      "The patient was admitted on September 22, 2016, due to decompensated heart failure and bronchopneumonia. She presented with worsening dyspnea, dry cough, lack of appetite, and significant weight loss. Physical examination revealed an emaciated state, tachypnea, hypotension, and lower limb edema.\n",
      "\n",
      "**Investigations:**\n",
      "- **ECG:** Sinus rhythm with signs of right atrial overload and low-voltage QRS complexes.\n",
      "- **Chest X-ray:** Pulmonary congestion, opacity suggestive of pneumonia, and cardiomegaly.\n",
      "- **Laboratory Tests:** Anemia, leukocytosis, elevated C-reactive protein, and electrolyte imbalances.\n",
      "- **Chest Tomography:** Identified a pulmonary nodule and signs of congestion, with no lymph node enlargement.\n",
      "\n",
      "**Management:**\n",
      "The patient was started on ceftriaxone and clarithromycin for pneumonia. Despite initial improvement in dyspnea and edema, she continued to experience episodes of arterial hypotension and persistent cough.\n",
      "\n",
      "On October 12, 2016, a biopsy of the pulmonary nodule was performed, revealing a granulomatous chronic inflammatory process. The patient experienced a sudden decline in condition post-biopsy, leading to cardiac arrest with pulseless electrical activity. Resuscitation efforts were initiated, but the patient subsequently developed asystole and passed away.\n",
      "\n",
      "**Disposition:**\n",
      "The patient was discharged to the care of her family following the unfortunate event of her passing. The family was provided with information regarding her condition and the events leading to her hospitalization.\n",
      "\n",
      "**Follow-Up:**\n",
      "The family was advised to follow up with their primary care physician for bereavement support and any necessary medical follow-up regarding the patient's history of Chagas heart disease.\n",
      "\n",
      "**Prepared by:**\n",
      "[Your Name]\n",
      "[Your Title]\n",
      "[Date]\n",
      "==================================================\n",
      "==================================================\n",
      "\n",
      "\n",
      "\n",
      "{'filenameid': '33544806', 'n_words_cc': 1918, 'n_words_ds': 399, 'gen_orig_ratio': 0.20802919708029197}\n",
      "==================================================\n",
      "|       | mention_class   | term                                        | span_orig                                                 | span_gen                                        |\n",
      "|------:|:----------------|:--------------------------------------------|:----------------------------------------------------------|:------------------------------------------------|\n",
      "| 27262 | DISEASE         | Abdominal Pain                              | abdominal pain                                            | abdominal pain                                  |\n",
      "| 27263 | DISEASE         | Abdominal aseptic abscess                   | septic abscess                                            | None                                            |\n",
      "| 27264 | DISEASE         | Acute infectious disease                    | acute infection                                           | None                                            |\n",
      "| 27265 | CHEMICAL        | Angiotensin-Converting Enzyme Inhibitors    | ACE inhibitor                                             | None                                            |\n",
      "| 27266 | DISEASE         | Appendicitis                                | appendicitis                                              | appendicitis                                    |\n",
      "| 27267 | CHEMICAL        | Bilirubin                                   | bilirubin                                                 | bilirubin                                       |\n",
      "| 27268 | CHEMICAL        | Bilirubin                                   | bilirubin                                                 | bilirubin                                       |\n",
      "| 27269 | CHEMICAL        | Bilirubin                                   | bilirubin                                                 | bilirubin                                       |\n",
      "| 27270 | DISEASE         | Brain hemorrhage                            | brain hemorrhage                                          | brain hemorrhage                                |\n",
      "| 27271 | DISEASE         | Bronchopneumonia                            | bronchopneumonia                                          | None                                            |\n",
      "| 27272 | DISEASE         | Cardiac Tamponade                           | cardiac tamponade                                         | None                                            |\n",
      "| 27273 | DISEASE         | Cardiomyopathy, Familial Idiopathic         | idiopathic biventricular dilated cardiomyopathy           | idiopathic biventricular dilated cardiomyopathy |\n",
      "| 27274 | DISEASE         | Centrilobular hepatic necrosis              | Centrilobular liver necrosis                              | None                                            |\n",
      "| 27275 | DISEASE         | Cerebral Hemorrhage                         | cerebral hemorrhage                                       | cerebral hemorrhage                             |\n",
      "| 27276 | DISEASE         | Cerebral Hemorrhage                         | parenchymatous hemorrhages                                | cerebral hemorrhage                             |\n",
      "| 27277 | DISEASE         | Cerebral herniation                         | brain herniation                                          | None                                            |\n",
      "| 27278 | DISEASE         | Cerebrovascular accident                    | stroke                                                    | stroke                                          |\n",
      "| 27279 | DISEASE         | Cerebrovascular accident                    | stroke                                                    | strokes                                         |\n",
      "| 27280 | DISEASE         | Cerebrovascular accident                    | strokes                                                   | stroke                                          |\n",
      "| 27281 | DISEASE         | Cerebrovascular accident                    | strokes                                                   | strokes                                         |\n",
      "| 27282 | DISEASE         | Cerebrovascular accident                    | stroke                                                    | stroke                                          |\n",
      "| 27283 | DISEASE         | Cerebrovascular accident                    | stroke                                                    | strokes                                         |\n",
      "| 27284 | DISEASE         | Cessation of life                           | Death                                                     | death                                           |\n",
      "| 27285 | DISEASE         | Coronary Arteriosclerosis                   | coronarosclerosis                                         | None                                            |\n",
      "| 27286 | DISEASE         | Decompensation                              | kidney decompensation                                     | kidney decompensation                           |\n",
      "| 27287 | DISEASE         | Dehiscence                                  | dehiscence                                                | None                                            |\n",
      "| 27288 | DISEASE         | Dyspnea                                     | dyspnea                                                   | dyspnea                                         |\n",
      "| 27289 | DISEASE         | Fatigue                                     | fatigue                                                   | fatigue                                         |\n",
      "| 27290 | DISEASE         | Fever                                       | fever                                                     | None                                            |\n",
      "| 27291 | DISEASE         | Fever                                       | fever                                                     | None                                            |\n",
      "| 27292 | DISEASE         | Fibrosis                                    | fibrosis                                                  | None                                            |\n",
      "| 27293 | DISEASE         | Glomerulonephritis                          | glomerulonephritis                                        | None                                            |\n",
      "| 27294 | DISEASE         | Glomerulosclerosis (disorder)               | glomerular sclerosis                                      | None                                            |\n",
      "| 27295 | CHEMICAL        | Glutamates                                  | glutamate                                                 | None                                            |\n",
      "| 27296 | DISEASE         | Headache                                    | headache                                                  | headache                                        |\n",
      "| 27297 | DISEASE         | Headache                                    | headache                                                  | headache                                        |\n",
      "| 27298 | DISEASE         | Headache                                    | headache                                                  | headache                                        |\n",
      "| 27299 | DISEASE         | Heart Failure, Right-Sided                  | right heart failure                                       | right heart failure                             |\n",
      "| 27300 | DISEASE         | Heart Failure, Right-Sided                  | right heart failure                                       | right heart failure                             |\n",
      "| 27301 | DISEASE         | Heart failure                               | None                                                      | heart failure                                   |\n",
      "| 27302 | DISEASE         | Heart failure                               | None                                                      | heart failure                                   |\n",
      "| 27303 | DISEASE         | Hematoma                                    | hematoma                                                  | None                                            |\n",
      "| 27304 | DISEASE         | Hematuria                                   | hematuria                                                 | None                                            |\n",
      "| 27305 | DISEASE         | Hemianopsia                                 | hemianopsia                                               | None                                            |\n",
      "| 27306 | DISEASE         | Hemoptysis                                  | hemoptysis                                                | hemoptysis                                      |\n",
      "| 27307 | DISEASE         | Hemorrhage                                  | bleeding                                                  | None                                            |\n",
      "| 27308 | DISEASE         | Hemorrhage                                  | hemorrhage                                                | None                                            |\n",
      "| 27309 | DISEASE         | Hemorrhage                                  | hemorrhages                                               | None                                            |\n",
      "| 27310 | DISEASE         | Hemorrhage                                  | hemorrhages                                               | None                                            |\n",
      "| 27311 | DISEASE         | Hemorrhagic                                 | hemorrhagic                                               | Hemorrhagic lesions                             |\n",
      "| 27312 | DISEASE         | Hemorrhagic                                 | hemorrhagic                                               | Hemorrhagic lesions                             |\n",
      "| 27313 | DISEASE         | Hemorrhagic Stroke                          | hemorrhagic strokes                                       | None                                            |\n",
      "| 27314 | DISEASE         | Hepatorenal Syndrome                        | Hepato-renal failure                                      | None                                            |\n",
      "| 27315 | DISEASE         | Hepatosplenomegaly                          | hepatosplenomegaly                                        | Hepatosplenomegaly                              |\n",
      "| 27316 | DISEASE         | Hyperemia                                   | hyperemia                                                 | None                                            |\n",
      "| 27317 | DISEASE         | Hyperuricemia                               | None                                                      | hyperuricemia                                   |\n",
      "| 27318 | DISEASE         | Hypoproteinemia                             | hypoproteinemia                                           | None                                            |\n",
      "| 27319 | DISEASE         | Infarction                                  | infarction                                                | None                                            |\n",
      "| 27320 | DISEASE         | Ischemic stroke                             | ischemic stroke                                           | None                                            |\n",
      "| 27321 | DISEASE         | Kidney Failure                              | renal failure                                             | organ failure syndrome                          |\n",
      "| 27322 | DISEASE         | Kidney Failure                              | renal failure                                             | renal failure                                   |\n",
      "| 27323 | DISEASE         | Kidney Failure                              | renal failure                                             | renal failure                                   |\n",
      "| 27324 | DISEASE         | Kidney Failure                              | renal failure                                             | renal failure                                   |\n",
      "| 27325 | DISEASE         | Kidney Failure                              | renal failure                                             | organ failure syndrome                          |\n",
      "| 27326 | DISEASE         | Kidney Failure                              | renal failure                                             | renal failure                                   |\n",
      "| 27327 | DISEASE         | Kidney Failure                              | renal failure                                             | renal failure                                   |\n",
      "| 27328 | DISEASE         | Kidney Failure                              | renal failure                                             | renal failure                                   |\n",
      "| 27329 | CHEMICAL        | Lactates                                    | lactate                                                   | None                                            |\n",
      "| 27330 | DISEASE         | Left anterior fascicular block              | left fascicular hemiblock                                 | None                                            |\n",
      "| 27331 | DISEASE         | Mesangial proliferative glomerulonephritis  | None                                                      | mesangioproliferative glomerulonephritis        |\n",
      "| 27332 | DISEASE         | Multiple Organ Failure                      | multiple organ failure syndrome                           | multiple organ dysfunction                      |\n",
      "| 27333 | DISEASE         | Nephritis, Interstitial                     | Interstitial nephritis                                    | None                                            |\n",
      "| 27334 | DISEASE         | Nephroblastoma                              | Wilms’ tumor                                              | None                                            |\n",
      "| 27335 | DISEASE         | Neurologic Deficits                         | motor deficit                                             | None                                            |\n",
      "| 27336 | CHEMICAL        | Nitrites                                    | nitrites                                                  | None                                            |\n",
      "| 27337 | DISEASE         | Pancreatitis                                | pancreatitis                                              | pancreatitis                                    |\n",
      "| 27338 | DISEASE         | Peripheral edema                            | peripheral edema                                          | peripheral edema                                |\n",
      "| 27339 | DISEASE         | Peripheral edema                            | peripheral edema                                          | peripheral edema                                |\n",
      "| 27340 | DISEASE         | Peripheral edema                            | peripheral edema                                          | peripheral edema                                |\n",
      "| 27341 | DISEASE         | Peripheral edema                            | peripheral edema                                          | peripheral edema                                |\n",
      "| 27342 | DISEASE         | Pneumonia                                   | pneumoniae                                                | None                                            |\n",
      "| 27343 | DISEASE         | Porencephaly                                | porencephalia                                             | None                                            |\n",
      "| 27344 | DISEASE         | Proteinuria                                 | proteinuria                                               | None                                            |\n",
      "| 27345 | CHEMICAL        | Pyruvates                                   | pyruvate                                                  | None                                            |\n",
      "| 27346 | DISEASE         | Respiratory Distress Syndrome, Adult        | Acute respiratory distress syndrome                       | None                                            |\n",
      "| 27347 | DISEASE         | Respiratory Distress Syndrome, Adult        | ARDS                                                      | None                                            |\n",
      "| 27348 | DISEASE         | Right bundle branch block                   | right bundle branch block                                 | None                                            |\n",
      "| 27349 | DISEASE         | Right ventricular failure                   | None                                                      | Decompensated right heart failure               |\n",
      "| 27350 | DISEASE         | Segmental glomerulosclerosis                | extracapillary crescents and segmental glomerulosclerosis | None                                            |\n",
      "| 27351 | DISEASE         | Seizures                                    | seizures                                                  | None                                            |\n",
      "| 27352 | DISEASE         | Seizures                                    | seizures                                                  | None                                            |\n",
      "| 27353 | DISEASE         | Shock                                       | shock                                                     | shock                                           |\n",
      "| 27354 | DISEASE         | Shock                                       | shock                                                     | Shock                                           |\n",
      "| 27355 | DISEASE         | Shock                                       | shock                                                     | shock                                           |\n",
      "| 27356 | DISEASE         | Shock                                       | shock                                                     | shock                                           |\n",
      "| 27357 | DISEASE         | Shock                                       | shock                                                     | Shock                                           |\n",
      "| 27358 | DISEASE         | Shock                                       | shock                                                     | shock                                           |\n",
      "| 27359 | DISEASE         | Shock                                       | shock                                                     | shock                                           |\n",
      "| 27360 | DISEASE         | Shock                                       | shock                                                     | Shock                                           |\n",
      "| 27361 | DISEASE         | Shock                                       | shock                                                     | shock                                           |\n",
      "| 27362 | DISEASE         | Shock                                       | shock                                                     | shock                                           |\n",
      "| 27363 | DISEASE         | Shock                                       | shock                                                     | Shock                                           |\n",
      "| 27364 | DISEASE         | Shock                                       | shock                                                     | shock                                           |\n",
      "| 27365 | DISEASE         | Shock, Cardiogenic                          | cardiogenic shock                                         | None                                            |\n",
      "| 27366 | DISEASE         | Thrombosis                                  | thrombosis                                                | thrombosis                                      |\n",
      "| 27367 | DISEASE         | Thrombosis                                  | thrombosis                                                | thrombosis                                      |\n",
      "| 27368 | DISEASE         | Thrombosis                                  | thrombosis                                                | thrombosis                                      |\n",
      "| 27369 | DISEASE         | Thrombosis                                  | thrombosis                                                | thrombosis                                      |\n",
      "| 27370 | DISEASE         | Thrombosis                                  | thrombosis                                                | thrombosis                                      |\n",
      "| 27371 | DISEASE         | Thrombosis                                  | thrombosis                                                | thrombosis                                      |\n",
      "| 27372 | DISEASE         | Thrombosis                                  | thrombosis                                                | thrombosis                                      |\n",
      "| 27373 | DISEASE         | Thrombosis                                  | thrombosis                                                | thrombosis                                      |\n",
      "| 27374 | DISEASE         | Tricuspid Valve Insufficiency               | tricuspid regurgitation                                   | None                                            |\n",
      "| 27375 | DISEASE         | Tricuspid Valve Insufficiency               | tricuspid insufficiency                                   | None                                            |\n",
      "| 27376 | DISEASE         | Uremia                                      | uremia                                                    | uremia                                          |\n",
      "| 27377 | DISEASE         | Urine microscopy leukocytes present finding | leukocyturia                                              | None                                            |\n",
      "| 27378 | CHEMICAL        | acenocoumarol                               | Acenocoumarol                                             | Acenocoumarol                                   |\n",
      "| 27379 | CHEMICAL        | amlodipine                                  | Amlodipine                                                | Amlodipine                                      |\n",
      "| 27380 | CHEMICAL        | aspirin                                     | Aspirin                                                   | Aspirin                                         |\n",
      "| 27381 | CHEMICAL        | bisoprolol                                  | Bisoprolol                                                | None                                            |\n",
      "| 27382 | CHEMICAL        | calcium                                     | calcium                                                   | None                                            |\n",
      "| 27383 | CHEMICAL        | carvedilol                                  | Carvedilol                                                | Carvedilol                                      |\n",
      "| 27384 | CHEMICAL        | creatinine                                  | creatinine                                                | Creatinine                                      |\n",
      "| 27385 | CHEMICAL        | creatinine                                  | creatinine                                                | Creatinine                                      |\n",
      "| 27386 | CHEMICAL        | creatinine                                  | creatinine                                                | creatinine                                      |\n",
      "| 27387 | CHEMICAL        | creatinine                                  | creatinine                                                | Creatinine                                      |\n",
      "| 27388 | CHEMICAL        | creatinine                                  | creatinine                                                | Creatinine                                      |\n",
      "| 27389 | CHEMICAL        | creatinine                                  | creatinine                                                | creatinine                                      |\n",
      "| 27390 | CHEMICAL        | creatinine                                  | creatinine                                                | Creatinine                                      |\n",
      "| 27391 | CHEMICAL        | creatinine                                  | creatinine                                                | Creatinine                                      |\n",
      "| 27392 | CHEMICAL        | creatinine                                  | creatinine                                                | creatinine                                      |\n",
      "| 27393 | CHEMICAL        | creatinine                                  | creatinine                                                | Creatinine                                      |\n",
      "| 27394 | CHEMICAL        | creatinine                                  | creatinine                                                | Creatinine                                      |\n",
      "| 27395 | CHEMICAL        | creatinine                                  | creatinine                                                | creatinine                                      |\n",
      "| 27396 | CHEMICAL        | creatinine                                  | creatinine                                                | Creatinine                                      |\n",
      "| 27397 | CHEMICAL        | creatinine                                  | creatinine                                                | Creatinine                                      |\n",
      "| 27398 | CHEMICAL        | creatinine                                  | creatinine                                                | creatinine                                      |\n",
      "| 27399 | CHEMICAL        | creatinine                                  | creatinine                                                | Creatinine                                      |\n",
      "| 27400 | CHEMICAL        | creatinine                                  | creatinine                                                | Creatinine                                      |\n",
      "| 27401 | CHEMICAL        | creatinine                                  | creatinine                                                | creatinine                                      |\n",
      "| 27402 | CHEMICAL        | dobutamine                                  | Dobutamine                                                | None                                            |\n",
      "| 27403 | CHEMICAL        | enalapril                                   | Enalapril                                                 | Enalapril                                       |\n",
      "| 27404 | CHEMICAL        | enalapril                                   | Enalapril                                                 | Enalapril                                       |\n",
      "| 27405 | CHEMICAL        | furosemide                                  | Furosemide 40 mg QD                                       | Furosemide                                      |\n",
      "| 27406 | CHEMICAL        | heparin                                     | heparin                                                   | None                                            |\n",
      "| 27407 | CHEMICAL        | mannitol                                    | Mannitol                                                  | None                                            |\n",
      "| 27408 | CHEMICAL        | meropenem                                   | Meropenem                                                 | None                                            |\n",
      "| 27409 | CHEMICAL        | omeprazole                                  | Omeprazole                                                | Omeprazole                                      |\n",
      "| 27410 | CHEMICAL        | prussian blue insoluble                     | Prussian Blue                                             | None                                            |\n",
      "| 27411 | CHEMICAL        | sodium citrate                              | sodium citrate                                            | None                                            |\n",
      "| 27412 | CHEMICAL        | urea                                        | urea                                                      | None                                            |\n",
      "| 27413 | CHEMICAL        | uric acid                                   | uric acid                                                 | Uric acid                                       |\n",
      "| 27414 | CHEMICAL        | uric acid                                   | uric acid                                                 | Uric acid                                       |\n",
      "| 27415 | CHEMICAL        | vancomycin                                  | Vancomycin                                                | None                                            |\n",
      "| 27416 | CHEMICAL        | None                                        | 6.8                                                       | None                                            |\n",
      "| 27417 | DISEASE         | None                                        | MOFS                                                      | MOFS                                            |\n",
      "| 27418 | DISEASE         | None                                        | enlargement of the appendix                               | MOFS                                            |\n",
      "| 27419 | DISEASE         | None                                        | extracranial herniation                                   | MOFS                                            |\n",
      "| 27420 | DISEASE         | None                                        | Hypodense lesion                                          | MOFS                                            |\n",
      "| 27421 | DISEASE         | None                                        | LVAD                                                      | MOFS                                            |\n",
      "| 27422 | DISEASE         | None                                        | MOFS                                                      | MOFS                                            |\n",
      "| 27423 | DISEASE         | None                                        | terminal hemorrhagic pneumonia                            | MOFS                                            |\n",
      "==================================================\n",
      "Clinical history\n",
      "\n",
      "Four years before the admission described in this paper, a 13-year-old male patient, known to have idiopathic biventricular dilated cardiomyopathy, was registered in our Emergency Institute for Cardiovascular Diseases and Transplantation. He was included on the waiting list for heart transplantation. After two years, his condition worsened and presented the clinical picture of cardiogenic shock. At that time, he was urgently hospitalized, intubated and ventilated, with extracorporeal membrane oxygenation (ECMO) back-up. As the creatinine level was slightly elevated, he also needed renal support. A cf-LVAD was implanted at another clinic.\n",
      "\n",
      "In the early postoperative phase, the pump’s power consumption increased. This was an indicator of possible pump thrombosis. Unfractionated heparin and systemic thrombolysis with tissue plasminogen activator (tPA) was carried out. As the pump function did not improve, it was replaced with another pump six days after LVAD implantation. After another two weeks, a transient stroke and mild pancreatitis were diagnosed, without significant complications. In the early and late postoperative days, several bleeding episodes occurred, one with cardiac tamponade, which required reintervention.\n",
      "\n",
      "During hospitalization, the patient presented with a fever (38°C) and elevated serum levels of C-reactive protein (CRP >200 mg/dL; normal range <5 mg/dL). As a sputum culture was positive for Klebsiella pneumoniae and coliform bacilli, Meropenem and Vancomycin were administrated with good results.\n",
      "\n",
      "After obtaining normal LVAD function, progressively increasing systemic blood pressure required the long-term administration of Enalapril 20 mg bis in die (BID – twice a day) and Bisoprolol 5 mg quaque die (QD – once a day). As renal function improved after the LVAD implant, there was no need for diuretics at discharge.\n",
      "\n",
      "No other significant or uncontrolled events occurred in the first year. At 12 months after the LVAD implant, the patient suffered two episodes of brain hemorrhage, for which he was hospitalized and operated on twice in the Clinic of Neurosurgery, without sequelae. In the following six months, he had another three small hemorrhagic strokes causing hemianopsia, without motor deficit. He also showed repeated episodes of kidney decompensation, with serum creatinine levels up to 2.7 mg% (normal ranges 0.6–1.2 mg%). This was kept under control with diuretics.\n",
      "\n",
      "The patient neglected to have properly monitored coagulation parameters in the ambulatory and did not regularly control the blood pressure values.\n",
      "\n",
      "Present admission\n",
      "\n",
      "Clinical findings\n",
      "\n",
      "At 18 months after LVAD implant, the 17-year-old normosthenic male was hospitalized with the suspicion of acute appendicitis. We noted altered general status, intense abdominal pain, headache, dyspnea, and fatigue after limited physical effort. On admission, the patient was conscious, partially cooperative and without fever. Cardio-respiratory function was checked: pump sound was detected with cardiac auscultation, there was no palpable peripheral pulse, mild peripheral edema, no pulmonary crackles. The medium systolic blood pressure was 100 mmHg. On palpation of the abdomen, there was no muscular defense, but the liver was enlarged.\n",
      "\n",
      "The patient was undergoing therapy with anti-hypertensive medication, which included an angiotensin-converting enzyme (ACE) inhibitor (Enalapril 20 mg BID) and alpha–beta blocker (Carvedilol 12.5 mg BID). Long-term treatment with an antiaggregant (Aspirin 100 mg QD), an anticoagulant [Acenocoumarol QD for international normalized ratio (INR) 2–3], a diuretic (Furosemide 40 mg QD) and a proton pump inhibitor (Omeprazole 20 mg BID), was also declared.\n",
      "\n",
      "Laboratory examinations\n",
      "\n",
      "On admission, the hematological and serum biochemical analyses showed a compensated renal function (creatinine – 1.13 mg/dL, creatinine clearance – 98 mL/min, urea – 36.8 mg%), with mild elevated uric acid (9.81 mg%, with normal ranges of 3.5–7.2 mg/dL). Liver enzymes were within normal ranges, with serum glutamic–oxaloacetic transaminase (GOT) of 9 IU/L (normal ranges 5–34 IU/L) and glutamate–pyruvate transaminase (GPT) of 6 IU/L (normal value <55 IU/L), same as the value of total bilirubin (0.47 mg/dL).\n",
      "\n",
      "A slightly high level of serum procalcitonin (1 ng/mL, with normal range <0.5 ng/mL), and a normal value of lactate dehydrogenase (LDH), respectively 110 mg/dL, were also reported. An acute infection was dismissed by normal serum level of CRP (5 mg/dL) and total leukocytes, which were 6000/μL (normal values 3600–10 000/μL) [6].\n",
      "\n",
      "Coagulation parameters showed a poorly controlled risk of hemorrhage, with an INR value of 5.4, under anti-coagulant treatment (reference for INR: 2–3). This was associated with normal platelets (275 000/μL; normal range 150 000–450 000/μL) and low hemoglobin values (8.6 g/dL; normal ranges 11–17 g/dL).\n",
      "\n",
      "During hospitalization, the laboratory examinations indicated the progressive development of multiple organ failure syndrome (MOFS). Two weeks after admission, renal failure was proved by the following parameters: high creatinine (9.02 mg%); low creatinine clearance (10 mL/min; normal reference ranges 107–139 mL/min); uremia (235 mg%); hypoproteinemia (plasma proteins: 5 g/dL; normal values 6.4–8.3 g/dL); low plasma albumin (2.2 g/dL; normal values 3.5–5.2 g/dL); high uric acid (17.66 mg%). Liver enzymes were kept within normal ranges (GOT – 23 IU/L, GPT – 17 IU/L), with progressively increasing total bilirubin (2.02 mg/dL) and LDH (222 mg/dL) and normal values of leukocytes (9120/μL). Hemoglobin decreased to 6.8 g/L.\n",
      "\n",
      "The urine test detected hematuria, proteinuria and leukocyturia, without detection of nitrites, bilirubin, or urobilinogen and without modification of the urine density (1.025; normal values 1.005–1.030).\n",
      "\n",
      "Imagistic investigations\n",
      "\n",
      "On admission, chest X-rays showed no modifications of the lungs, a dilated heart and the LVAD in the apex of the LV. An electrocardiogram revealed left fascicular hemiblock and right bundle branch block, with a heart rate of 80 beats/min (bpm). The echocardiography showed dilatation of all ventricular and atrial cavities, with decreased ejection fraction (EF) of the LV at 10% (normal value >60%). Moderate hypokinetic right ventricle, mitral and tricuspid regurgitation was diagnosed, with properly working inflow cannula at the apex of the LV.\n",
      "\n",
      "Abdominal ultrasound examination detected hepatosplenomegaly and enlarged kidneys, with increased echogenicity of the renal cortex. A pseudonodular lesion was described at the lower splenic pole, without enlargement of the appendix. In the first days, the computed tomography (CT) examination of the cranial cavity did not show acute parenchymatous lesions but confirmed the patient’s history of repeated strokes. Through the 38/33 mm (centro-central/latero-lateral) right parietal craniotomy orifice, minimal extracranial herniation of the brain tissue was obvious. Hypodense lesion located at the level of the left lentiform nucleus and at the body of the left caudate nucleus, was suggestive of a healed ischemic stroke, with associated porencephalia.\n",
      "\n",
      "During the three months of hospitalization, CT scans performed during the seizures revealed new hemorrhagic outbreaks. In the last stages, chest X-ray showed diffuse veiling of both lung areas, which were treated as a bronchopneumonia.\n",
      "\n",
      "Diagnosis, therapy, and evolution\n",
      "\n",
      "Based on clinical and paraclinical examinations, the case was interpreted on admission as decompensated right heart failure with poor control of anticoagulation parameters in a patient with an LVAD implant.\n",
      "\n",
      "To prevent stroke and pump thrombosis in patients with LVAD implants, the systolic blood pressure should be maintained at a mean value of 70–80 mmHg. To achieve this, it was necessary to add the calcium blocker Amlodipine (10 mg QD) to the ACE inhibitor and alpha–beta blocker. The INR values were controlled with anticoagulants. Persistent headache with episodes of seizures and increased intracranial pressure were treated with osmotic diuretics (Mannitol) and neuroprotectors.\n",
      "\n",
      "Although an initial improvement was obtained, it was followed by the gradual deterioration of the general condition of the patient, with increased intensity of the headache. Hepato-renal failure occurred at two weeks after admission, followed by episodes of hemoptysis and worsening of peripheral edema. Blood pressure progressively collapsed, with gradual reduction of diuresis, up to 500 mL/day, and positive inotropic treatment with Dobutamine was needed.\n",
      "\n",
      "The LVAD controller indicated low flow alarms. The repeated echocardiography revealed significant dilatation of the ventricular and atrial cavities, with worsening of the right heart failure. Antibiotics, hepatoprotectives, gastroprotectives and analgesics, at progressively increasing doses, completed diuretic treatment on continuous infusion.\n",
      "\n",
      "At the final stage, MOFS occurred. Continuous veno-venous hemofiltration (CVVH) was initiated but, after 48 hours, the fatal cerebral hemorrhage was diagnosed. Death occurred three months after the final admission, 21 months after the LVAD implant.\n",
      "\n",
      "Autopsy findings\n",
      "\n",
      "The trephination orifices in the skull, which were performed over six months before the final admission, were identified in the occipital and temporal areas, with mild brain herniation. In the edematous brain parenchyma, reactive gliosis was confirmed under the microscope, as corresponding to these orifices. In the fronto-parietal area, multiple foci of parenchymatous hemorrhages were observed, the largest hematoma being 65×45 mm, which exerted mass effect over the median line. Multiple diapedesis hemorrhages were also seen (Figure ​(Figure1,1, D and E).\n",
      "\n",
      "Regarding the heart, the LVAD from the apex of the LV did not associate signs of thrombosis or dehiscence. Iatrogenic pericardial adherences were identified. The heart weight was 882 g, with dilatation of the cavities, causing secondary mitral and tricuspid insufficiency. No coronarosclerosis or thrombosis of the coronary arteries was observed. Histological findings consisted of marked fibrosis of the myocardium, along with a focus of septic abscess located at the level of the anterior wall of the LV.\n",
      "\n",
      "Examination of the lungs and respiratory tract revealed bilateral dystelectasia, which was clearly visible on the background of a brown parenchyma. Under the microscope, disseminated hemorrhages, with siderophages inside the alveolar spaces, which were colored in blue with Perls Prussian Blue staining, were admixed with neutrophils. Acute respiratory distress syndrome (ARDS) was proved by the presence of focal hyaline membranes upon alveolar septa, as indicators of shock lung.\n",
      "\n",
      "Centrilobular liver necrosis suggested the diagnosis of shock liver. The 380 g spleen showed, on the cut section, a 40×20×10 mm triangular, yellowish area, which was confirmed under the microscope as a superinfected splenic infarction.\n",
      "\n",
      "The enlarged kidneys (left – 380 g; right – 355 g) showed, on cut section, changes compatible with a diagnosis of shock kidney, i.e., medullary hyperemia and a pale, ischemic renal cortex. Microscopic analysis confirmed the diagnosis of shock kidney. Routine Hematoxylin–Eosin (HE) staining also revealed extensive glomerular changes, which consisted of an enlarged mesangial area, with focal glomerular sclerosis, highlighted in green with Masson’s trichrome staining. Crescentic proliferation of parietal cells of Bowman’s capsule was observed, without neutrophils. Interstitial nephritis was also documented.\n",
      "\n",
      "In paraffin-embedded kidney parenchyma tissue, IHC stainings were also performed. We used the cell–cell adhesion marker cluster of differentiation (CD) 44 (Dako©, Denmark, 1:50 dilution, sodium citrate pH 6 retrieval), Wilms’ tumor 1 (WT1) protein antibody (Dako©, Denmark, ready-to-use, high pH retrieval) and the stem cells-related markers CD133 (Millipore©, Denmark, 1:50 dilution, high pH retrieval) and octamer-binding transcription factor-3/4 (Oct-3/4) (Leica©, UK, 1:50 dilution, high pH retrieval). In the affected glomeruli, CD44 proved to mark the proliferated parietal cells, while WT1 positivity was clearly seen in the remnant podocytes and the mesangial cells. No positivity for CD133 or Oct-3/4 was highlighted.\n",
      "\n",
      "Based on the above-mentioned autopsy findings, renal failure was explained by a mesangioproliferative glomerulonephritis with extracapillary crescents and segmental glomerulosclerosis. Repeated hemorrhagic episodes, associated with terminal hemorrhagic pneumonia, also contributed to progressive degradation of the general status.\n",
      "\n",
      "\n",
      "==================================================\n",
      "**Discharge Summary**\n",
      "\n",
      "**Patient Information:**\n",
      "- Name: [Patient Name]\n",
      "- Age: 17 years\n",
      "- Gender: Male\n",
      "- Admission Date: [Admission Date]\n",
      "- Discharge Date: [Discharge Date]\n",
      "\n",
      "**Clinical History:**\n",
      "The patient has a history of idiopathic biventricular dilated cardiomyopathy and was placed on the heart transplantation waiting list four years prior to this admission. He underwent LVAD implantation two years ago due to worsening heart failure and cardiogenic shock. Postoperatively, he experienced complications including pump thrombosis, transient stroke, and mild pancreatitis. He was managed with anticoagulation and antihypertensive medications. Over the following year, he had episodes of brain hemorrhage and kidney decompensation, which were controlled with diuretics.\n",
      "\n",
      "**Present Admission:**\n",
      "The patient was admitted 18 months post-LVAD implantation with suspected acute appendicitis. Upon admission, he exhibited altered general status, abdominal pain, headache, dyspnea, and fatigue. He was conscious and cooperative, with mild peripheral edema and elevated blood pressure (100 mmHg). His medication regimen included Enalapril, Carvedilol, Aspirin, Acenocoumarol, Furosemide, and Omeprazole.\n",
      "\n",
      "**Laboratory Findings:**\n",
      "- Renal function: Creatinine 1.13 mg/dL, Creatinine clearance 98 mL/min\n",
      "- Mild hyperuricemia: Uric acid 9.81 mg/dL\n",
      "- Normal liver enzymes and bilirubin levels\n",
      "- INR: 5.4 (poorly controlled anticoagulation)\n",
      "- Hemoglobin: 8.6 g/dL\n",
      "\n",
      "During hospitalization, renal function deteriorated, leading to multiple organ failure syndrome (MOFS). Hematological parameters indicated worsening renal failure, with creatinine rising to 9.02 mg/dL and uremia at 235 mg/dL. \n",
      "\n",
      "**Imaging Studies:**\n",
      "- Chest X-ray: Dilated heart, LVAD in place, no lung modifications\n",
      "- Echocardiography: Severe LV dilatation, EF 10%, right heart failure\n",
      "- Abdominal ultrasound: Hepatosplenomegaly, enlarged kidneys\n",
      "- CT scan: No acute lesions but evidence of previous strokes\n",
      "\n",
      "**Diagnosis:**\n",
      "Decompensated right heart failure with poorly controlled anticoagulation in a patient with LVAD.\n",
      "\n",
      "**Therapeutic Interventions:**\n",
      "The patient was treated with Amlodipine to manage blood pressure, and anticoagulation was adjusted. Despite initial improvement, the patient's condition deteriorated, leading to episodes of hemoptysis, worsening peripheral edema, and progressive renal failure. Continuous veno-venous hemofiltration (CVVH) was initiated, but the patient ultimately succumbed to fatal cerebral hemorrhage three months after admission.\n",
      "\n",
      "**Autopsy Findings:**\n",
      "Autopsy revealed significant findings including:\n",
      "- Hemorrhagic lesions in the brain\n",
      "- LVAD without signs of thrombosis\n",
      "- Shock liver and shock kidney changes\n",
      "- Evidence of mesangioproliferative glomerulonephritis\n",
      "\n",
      "**Conclusion:**\n",
      "The patient experienced a complex clinical course characterized by heart failure, renal failure, and multiple organ dysfunction, ultimately leading to death. The findings underscore the challenges faced in managing patients with LVADs and the importance of careful monitoring of anticoagulation and overall health status.\n",
      "\n",
      "**Follow-Up:**\n",
      "The family has been informed of the findings and the clinical course. Further genetic counseling and management strategies will be discussed in future appointments.\n",
      "\n",
      "**Prepared by:**\n",
      "[Physician's Name]\n",
      "[Title]\n",
      "[Date]\n",
      "==================================================\n",
      "==================================================\n",
      "\n",
      "\n",
      "\n",
      "{'filenameid': '38545376', 'n_words_cc': 1560, 'n_words_ds': 326, 'gen_orig_ratio': 0.20897435897435898}\n",
      "==================================================\n",
      "|       | mention_class   | term                                 | span_orig                           | span_gen                        |\n",
      "|------:|:----------------|:-------------------------------------|:------------------------------------|:--------------------------------|\n",
      "| 51526 | CHEMICAL        | Adrenal Cortex Hormones              | corticosteroids                     | corticosteroids                 |\n",
      "| 51527 | CHEMICAL        | Adrenal Cortex Hormones              | corticosteroids                     | corticosteroids                 |\n",
      "| 51528 | CHEMICAL        | Adrenal Cortex Hormones              | corticosteroids                     | corticosteroids                 |\n",
      "| 51529 | CHEMICAL        | Aerosols                             | aerosols                            | aerosols                        |\n",
      "| 51530 | CHEMICAL        | Aerosols                             | aerosols                            | aerosols                        |\n",
      "| 51531 | DISEASE         | Agitation                            | agitation                           | None                            |\n",
      "| 51532 | DISEASE         | Agitation                            | agitation                           | None                            |\n",
      "| 51533 | DISEASE         | Arthritis                            | arthritis                           | arthritis                       |\n",
      "| 51534 | DISEASE         | Arthritis                            | arthritis                           | arthritis                       |\n",
      "| 51535 | DISEASE         | Asthenia                             | asthenia                            | asthenia                        |\n",
      "| 51536 | DISEASE         | Asthenia                             | asthenia                            | asthenia                        |\n",
      "| 51537 | DISEASE         | Asthma                               | asthma                              | None                            |\n",
      "| 51538 | DISEASE         | Asthma                               | asthma                              | None                            |\n",
      "| 51539 | DISEASE         | Atrial Fibrillation                  | atrial fibrillation                 | Atrial fibrillation             |\n",
      "| 51540 | DISEASE         | Atrial Fibrillation                  | atrial fibrillation                 | Atrial fibrillation             |\n",
      "| 51541 | DISEASE         | Atrial Fibrillation                  | atrial fibrillation                 | Atrial fibrillation             |\n",
      "| 51542 | DISEASE         | Autoimmune Diseases                  | autoimmune diseases                 | None                            |\n",
      "| 51543 | CHEMICAL        | Bilirubin                            | bilirubin                           | Bilirubin                       |\n",
      "| 51544 | CHEMICAL        | Bilirubin                            | bilirubin                           | Bilirubin                       |\n",
      "| 51545 | CHEMICAL        | Blood urea nitrogen measurement      | blood urea nitrogen                 | None                            |\n",
      "| 51546 | DISEASE         | Communicable Diseases                | None                                | infection                       |\n",
      "| 51547 | DISEASE         | Confusion                            | confusion                           | None                            |\n",
      "| 51548 | DISEASE         | Confusion                            | confusion                           | None                            |\n",
      "| 51549 | DISEASE         | Diarrhea                             | diarrhea                            | diarrhea                        |\n",
      "| 51550 | DISEASE         | Diarrhea                             | diarrheal                           | diarrhea                        |\n",
      "| 51551 | DISEASE         | Diarrhea                             | diarrhea                            | diarrhea                        |\n",
      "| 51552 | DISEASE         | Dyspnea                              | shortness of breath                 | shortness of breath             |\n",
      "| 51553 | DISEASE         | Dyspnea                              | shortness of breath                 | shortness of breath             |\n",
      "| 51554 | DISEASE         | Edema                                | edemas                              | edema                           |\n",
      "| 51555 | DISEASE         | Edema                                | edemas                              | edema                           |\n",
      "| 51556 | DISEASE         | Exanthema                            | rash                                | rash                            |\n",
      "| 51557 | DISEASE         | Exanthema                            | rash                                | rash                            |\n",
      "| 51558 | DISEASE         | Fever                                | fever                               | fever                           |\n",
      "| 51559 | DISEASE         | Fever                                | fever                               | fever                           |\n",
      "| 51560 | DISEASE         | Heart failure                        | heart failure                       | None                            |\n",
      "| 51561 | DISEASE         | Heart murmur                         | murmurs                             | murmurs                         |\n",
      "| 51562 | DISEASE         | Hepatosplenomegaly                   | hepatosplenomegaly                  | Hepatosplenomegaly              |\n",
      "| 51563 | DISEASE         | Hepatosplenomegaly                   | Hepatosplenomegaly                  | Hepatosplenomegaly              |\n",
      "| 51564 | DISEASE         | Hypersensitivity                     | allergies                           | None                            |\n",
      "| 51565 | DISEASE         | Hypersensitivity                     | allergies                           | None                            |\n",
      "| 51566 | CHEMICAL        | Inspiration function                 | inhalations                         | inhalations                     |\n",
      "| 51567 | DISEASE         | Lupus Vulgaris                       | lupus                               | None                            |\n",
      "| 51568 | DISEASE         | Lymphoproliferative Disorders        | lymphoproliferative syndrome        | None                            |\n",
      "| 51569 | DISEASE         | Lymphoproliferative Disorders        | lymphoproliferative syndrome        | None                            |\n",
      "| 51570 | DISEASE         | Oliguria                             | oliguria                            | oliguria                        |\n",
      "| 51571 | DISEASE         | Oliguria                             | oliguria                            | oliguria                        |\n",
      "| 51572 | DISEASE         | Pulmonary Hypertension               | pulmonary hypertension              | None                            |\n",
      "| 51573 | DISEASE         | Pulmonary Thromboembolisms           | pulmonary thromboembolism           | pulmonary thromboembolism       |\n",
      "| 51574 | DISEASE         | Respiratory Distress Syndrome, Adult | acute respiratory distress syndrome | ARDS                            |\n",
      "| 51575 | DISEASE         | Respiratory Distress Syndrome, Adult | ARDS                                | ARDS                            |\n",
      "| 51576 | DISEASE         | Septic Shock                         | Septic shock                        | None                            |\n",
      "| 51577 | DISEASE         | Septic Shock                         | septic shock                        | None                            |\n",
      "| 51578 | DISEASE         | Ventricular Dysfunction              | biventricular dysfunction           | None                            |\n",
      "| 51579 | CHEMICAL        | acetaminophen                        | paracetamol                         | Paracetamol                     |\n",
      "| 51580 | CHEMICAL        | acetaminophen                        | paracetamol                         | Paracetamol                     |\n",
      "| 51581 | CHEMICAL        | acetaminophen                        | Paracetamol                         | Paracetamol                     |\n",
      "| 51582 | CHEMICAL        | alanine                              | alanine                             | None                            |\n",
      "| 51583 | CHEMICAL        | amiodarone                           | amiodaron                           | amiodarone                      |\n",
      "| 51584 | CHEMICAL        | amiodarone                           | amiodaron                           | amiodarone                      |\n",
      "| 51585 | CHEMICAL        | aspartate                            | aspartate                           | None                            |\n",
      "| 51586 | CHEMICAL        | azithromycin                         | azithromycin                        | azithromycin                    |\n",
      "| 51587 | CHEMICAL        | azithromycin                         | azithromycin                        | azithromycin                    |\n",
      "| 51588 | CHEMICAL        | azithromycin                         | azithromycin                        | azithromycin                    |\n",
      "| 51589 | CHEMICAL        | ciprofloxacin                        | ciprofloxacin                       | ciprofloxacin                   |\n",
      "| 51590 | CHEMICAL        | ciprofloxacin                        | ciprofloxacin                       | ciprofloxacin                   |\n",
      "| 51591 | CHEMICAL        | creatinine                           | creatinine                          | creatinine                      |\n",
      "| 51592 | CHEMICAL        | daptomycin                           | daptomycin                          | None                            |\n",
      "| 51593 | CHEMICAL        | daptomycin                           | Daptomycin                          | None                            |\n",
      "| 51594 | CHEMICAL        | dexamethasone                        | dexamethasone                       | Dexamethasone                   |\n",
      "| 51595 | CHEMICAL        | dexamethasone                        | dexamethasone                       | Dexamethasone                   |\n",
      "| 51596 | CHEMICAL        | dexamethasone                        | Dexamethasone                       | Dexamethasone                   |\n",
      "| 51597 | CHEMICAL        | epinephrine                          | adrenalin                           | None                            |\n",
      "| 51598 | CHEMICAL        | epinephrine                          | Adrenalin                           | None                            |\n",
      "| 51599 | CHEMICAL        | fluconazole                          | fluconazole                         | None                            |\n",
      "| 51600 | CHEMICAL        | fluconazole                          | fluconazole                         | None                            |\n",
      "| 51601 | CHEMICAL        | fluticasone / salmeterol             | salmeterol 25 mcg/fluticasone       | salmeterol 25 mcg/fluticasone   |\n",
      "| 51602 | CHEMICAL        | furosemide                           | furosemide                          | furosemide                      |\n",
      "| 51603 | CHEMICAL        | furosemide                           | furosemide                          | furosemide                      |\n",
      "| 51604 | CHEMICAL        | furosemide                           | Furosemide                          | furosemide                      |\n",
      "| 51605 | CHEMICAL        | imipenem                             | imipenem 1 g/8                      | imipenem                        |\n",
      "| 51606 | CHEMICAL        | imipenem                             | imipenem                            | imipenem                        |\n",
      "| 51607 | CHEMICAL        | imipenem                             | imipenem 1 g/8                      | imipenem                        |\n",
      "| 51608 | CHEMICAL        | lactic acid                          | lactic acid                         | None                            |\n",
      "| 51609 | CHEMICAL        | levosimendan                         | levosimendan                        | levosimendan                    |\n",
      "| 51610 | CHEMICAL        | levosimendan                         | levosimendan                        | levosimendan                    |\n",
      "| 51611 | CHEMICAL        | levosimendan                         | Levosimendan                        | levosimendan                    |\n",
      "| 51612 | CHEMICAL        | linezolid                            | linezolid                           | linezolid                       |\n",
      "| 51613 | CHEMICAL        | linezolid                            | linezolid                           | linezolid                       |\n",
      "| 51614 | CHEMICAL        | linezolid                            | linezolid                           | linezolid                       |\n",
      "| 51615 | CHEMICAL        | norepinephrine                       | norepinephrine                      | norepinephrine                  |\n",
      "| 51616 | CHEMICAL        | norepinephrine                       | norepinephrine                      | norepinephrine                  |\n",
      "| 51617 | CHEMICAL        | norepinephrine                       | Norepinephrine                      | norepinephrine                  |\n",
      "| 51618 | CHEMICAL        | oxygen                               | oxygen                              | Oxygen                          |\n",
      "| 51619 | CHEMICAL        | oxygen                               | oxygen                              | oxygen                          |\n",
      "| 51620 | CHEMICAL        | oxygen                               | oxygen                              | oxygen                          |\n",
      "| 51621 | CHEMICAL        | oxygen                               | oxygen                              | Oxygen                          |\n",
      "| 51622 | CHEMICAL        | oxygen                               | oxygen                              | oxygen                          |\n",
      "| 51623 | CHEMICAL        | oxygen                               | oxygen                              | oxygen                          |\n",
      "| 51624 | CHEMICAL        | oxygen                               | oxygen                              | Oxygen                          |\n",
      "| 51625 | CHEMICAL        | oxygen                               | oxygen                              | oxygen                          |\n",
      "| 51626 | CHEMICAL        | oxygen                               | oxygen                              | oxygen                          |\n",
      "| 51627 | CHEMICAL        | uric acid                            | uric acid                           | None                            |\n",
      "| 51628 | CHEMICAL        | None                                 | mg.dl                               | None                            |\n",
      "| 51629 | CHEMICAL        | None                                 | mg.dl −1                            | None                            |\n",
      "| 51630 | CHEMICAL        | None                                 | 0.5-2 mmol.l                        | None                            |\n",
      "| 51631 | CHEMICAL        | None                                 | mg/12                               | None                            |\n",
      "| 51632 | CHEMICAL        | None                                 | FiO                                 | None                            |\n",
      "| 51633 | CHEMICAL        | None                                 | mg/12                               | None                            |\n",
      "| 51634 | CHEMICAL        | None                                 | mg/12                               | None                            |\n",
      "| 51635 | CHEMICAL        | None                                 | mg/12                               | None                            |\n",
      "| 51636 | CHEMICAL        | None                                 | mg/8                                | None                            |\n",
      "| 51637 | DISEASE         | None                                 | arthromyalgia                       | arthromyalgia                   |\n",
      "| 51638 | DISEASE         | None                                 | arthromyalgia                       | peri-pancreatic lymphadenopathy |\n",
      "| 51639 | DISEASE         | None                                 | peri-pancreatic lymphadenopathy     | arthromyalgia                   |\n",
      "| 51640 | DISEASE         | None                                 | peri-pancreatic lymphadenopathy     | peri-pancreatic lymphadenopathy |\n",
      "| 51641 | DISEASE         | None                                 | arthromyalgia                       | arthromyalgia                   |\n",
      "| 51642 | DISEASE         | None                                 | arthromyalgia                       | peri-pancreatic lymphadenopathy |\n",
      "==================================================\n",
      "Patient information\n",
      "The patient was a 16-year-old Spanish adolescent, Caucasian, with no allergies, with mild intermittent extrinsic asthma treated with corticosteroids and aerosols (salmeterol 25 mcg/fluticasone 250 mcg two inhalations twice a day). He has no relevant past interventions and no medical, family or psychosocial history (including genetic) of interest. He presented with general discomfort, asthenia and fever (38°C) for three days and was treated with paracetamol 1g/8 hours and azithromycin 500 mg/24 hours for three days at home. After seven days, he came to the emergency department with persistence of symptoms, shortness of breath, arthromyalgia and diarrhea (two diarrheal stools without pathological products).\n",
      "\n",
      "Clinical findings\n",
      "Physical examination revealed a bad general condition. He was dehydrated (dry mucous membranes), but aware, oriented and collaborative. Blood pressure was 70/30 mmHg, heart rate was 110 bpm, respiratory rate was 18 bpm, SpO 2 98% and axillary temperature was 38.5°C. Lung auscultation found bibasilar crackles and heart auscultation found no murmurs. He had hepatosplenomegaly, oliguria, no edemas, no cutaneous rash and no arthritis. He had diuresis of 170 ml in 12 hours. The results of laboratory testing were: white blood cell count 10200 μL −1 (4000-11500 μL −1), with 8420 (1800-8000 μL −1) neutrophils, hemoglobin 12.5 g.dl −1 (13-17.5 g.dl −1), platelet count 104000 μL −1 (140000-450000 μL −1), serum C-reactive protein level 269.4 mg.l −1 (<5 mg.l −1), alanine aminotransferase level 81 U/L (7-49 U/L), aspartate aminotransferase level 71 U/L (13-40 U/L), total bilirubin level 3.30 mg.dl −1 (0.2-1 mg.dl −1), direct bilirubin level 2.73 mg.dl −1 (<0.3 mg.dl −1), high sensitiviry cardiac troponin I 1135 ng.l −1, blood urea nitrogen 48 mg.dl −1 (20-50 mg.dl −1), creatinine 2.72 mg.dl −1 (0.7-1.3 mg.dl −1), erythrocyte sedimentation rate of 12 mm/h (<15 mm/h), procalcitonin 1.96 ng.ml −1 (<0.1 ng.ml −1), arterial pH 7.32 (7.35-7.45), pCO 2 50.2 mmHg (35-45), pO 2 92 (75-100) mmHg, HCO 3 23 mmol/L (22-26 mmol/L), SpO 2 98% (96-100%), lactic acid 2.2 mmol.l −1 (0.5-2 mmol.l −1), ferritin 655.4 ng.ml −1 (22-322 ng.ml −1), triglycerides 161 mg/dL (22-150 mg/dL), uric acid 11.3 mg/dL (4.4-7.6 mg/dL), prothrombin activity 64.7% (70-130%), international normalized ratio 1.28 (0.8-1.2), activated partial thromboplastin time (aPTT) 28.9 seconds (20.6-31 seconds), aPTT ratio 1.16 (0.8-1.2) and D-dimer 7.500 ng/mL (220-500 ng/mL).\n",
      "\n",
      "Diagnostic assessment\n",
      "A nasopharyngeal swab and reverse transcriptase-polymerase chain reaction (RT-PCR) for COVID-19 (Cepheid-Xpert ® Xpress CoV-2 plus) was negative, but COVID-19 serology was IgM negative and IgG positive. Microbiological screening (urine, blood, sputum and stool culture), serological tests (virus, parasites, fungi and bacteria), and a Mantoux test were carried out. His thoracoabdominal CT scan showed multiple para-aortic and peri-pancreatic lymphadenopathy (compatible with lymphoproliferative syndrome as the most likely diagnosis) and acute respiratory distress syndrome (ARDS). There was no sign of pulmonary thromboembolism, but there were signs of pulmonary hypertension. He was admitted to the ICU and treated with broad spectrum antibiotics (imipenem 1 g/8 h, linezolid 600 mg/12 h) and a low dose of norepinephrine (0.05 mcg/kg/min).\n",
      "\n",
      "An investigation of lymphoproliferative syndrome considering the possibility of MAS secondary to COVID-19 was carried out, including autoimmune tests. Protein electrophoresis showed an inflammatory pattern and a direct Coombs test was negative. A bone marrow biopsy showed reactive cells, without atypical cellularity, discarding lymphoproliferative or MAS. Tests for autoimmune diseases revealed a low level of C3 and positivity for lupus anticoagulant. The rest of the antibody tests were negative.\n",
      "\n",
      "Microbiological screening, serological test and Mantoux were all negative, supporting the theory of an exaggerated systemic inflammatory response due to COVID-19. Septic shock was ruled out, so we decided to withdraw antibiotics. Only a rectal swab was positive for COVID-19.\n",
      "\n",
      "During his time in hospital, the patient presented with acute confusion and agitation. He had no meningeal signs on examination. Cranial CT scan was normal and symptoms remitted within 24 hours.\n",
      "\n",
      "An electrocardiograph showed atrial fibrillation and diffuse T wave inversion. Transthoracic echocardiography (TTE) was performed regularly, due to elevated cardiac enzymes. The first TTE was normal, but on the third day of admission demonstrated moderate biventricular dysfunction that progressed to severe in the following 24 hours, and atrial fibrillation.\n",
      "\n",
      "Therapeutic intervention\n",
      "From the beginning our patient was treated with a nasal cannula at 3 liters/minute for five days and a venturi mask at 40% FiO 2 for four days. Also, broad spectrum antibiotics (at the beginning, 1 g/8 h imipenem and 600 mg/12 h linezolid for six days, and on the third day of admission, 500 mg/24 h daptomycin and 200 mg/24 h fluconazole were added to the regimen) and a low dose of norepinephrine (0.05 mcg/kg/min) were administered.\n",
      "\n",
      "When the possibility of a septic shock was ruled out, antibiotics were withdrawn and 8 mg/24 hours dexamethasone was started to try to contain the cytokine storm. The dose was increased to 12 mg when he suffered with confusion, agitation and heart failure. The patient was treated with adrenalin up to 0.1 mcg/kg/min, 12.5 mg/24 hours levosimendan and 20 mg/8-12 hours furosemide for eight days. A bolus of 150 mg amiodaron followed by an infusion of 600 mg in 24 hours was administered when atrial fibrillation was targeted. He was given enoxaparin 60 mg/24 hours during the first days and then it was increased to 60 mg/12 hours.\n",
      "\n",
      "A new TTE that was performed four hours after levosimendan was initiated showed a moderate improvement in left ventricular function and a slight improvement in right ventricular function. In 12 hours, the cardiac function returned to normal and sinus rhythm was recovered.\n",
      "\n",
      "\n",
      "Outcomes\n",
      "Hemodynamic support therapy was withdrawn, and oxygen therapy, furosemide and dexamethasone were progressively reduced. He didn’t have any adverse events with the medication; it was well tolerated.\n",
      "\n",
      "In a few days, the clinical picture resolved and the patient was discharged to the Internal Medicine ward. The evolution of his condition was very favorable. He was afebrile, hemodynamically stable, with good food tolerance and without other clinical symptoms. Microbiological screening was repeated by Internal Medicine and a stool culture was positive for group B Salmonella species. The patient had no symptoms, but ciprofloxacin was administered for seven days and then he was discharged hemodynamically stable, eupneic and with oxygen saturation of 99% with oxygen supply of 0.28%. Two weeks later he left the hospital.\n",
      "\n",
      "Timeline with information from the current episode of care.\n",
      "Initial patient assessment\t- A 16-year-old Spanish adolescent, Caucasian, no allergies, extrinsic asthma treated with corticosteroids and aerosols occasionally.\n",
      "- No relevant past interventions and no medical, family or psychosocial history (including genetic) of interest.\n",
      "- Blood pressure 70/30 mmHg, heart rate 110 bpm, respiratory rate 18 bpm, axillary temperature 38.5°C.\n",
      "- Lung auscultation: bibasilar crackles.\n",
      "- Heart auscultation without murmurs.\n",
      "- Hepatosplenomegaly, oliguria, no edemas, no cutaneous rash and no arthritis.\n",
      "- Diuresis 170 ml in 12 hours.\n",
      "- General discomfort, asthenia and fever (38°C) for three days.\n",
      "- He was treated with paracetamol and azithromycin at home.\n",
      "- Six days after, he came to the emergency department with persistence of symptoms, shortness of breath, arthromyalgia and diarrhea.\n",
      "Diagnostic evaluation and therapeutic interventions\t- Nasopharyngeal swab RT-PCR and serology of COVID-19.\n",
      "- Blood test, protein electrophoresis.\n",
      "- Thoracoabdominal CT scan.\n",
      "- Microbiological screening and serological test.\n",
      "- Bone marrow biopsy.\n",
      "- Autoimmune test.\n",
      "- Cranial CT scan.\n",
      "- Electrocardiograph, transthoracic echocardiography.\n",
      "- Paracetamol 1 g/8 h and azithromycin 500 mg/24 h for three days.\n",
      "- Broad spectrum antibiotics (imipenem 1 g/8 h, linezolid 600 mg/12 h for six days). Daptomycin 500 mg/24 h and fluconazole 200 mg/24 h were added on the third day of admission.\n",
      "- Nasal cannula 3 liters/minute for five days and then venturi mask at 40% for four days.\n",
      "- Norepinephrine 0.05 μcg/kg/min for four days.\n",
      "- Dexamethasone 8 mg/24 h for three days and later 12 mg/24 h for four days.\n",
      "- Enoxaparin 60 mg/24 h for three days and then 60mg/12h until discharge.\n",
      "- Adrenalin 0.1 μcg/kg/min for two days.\n",
      "- Levosimendan 12.5 mg in 24 hours.\n",
      "- Furosemide 20 mg/8-12 h for eight days.\n",
      "- Bolus of amiodaron 150 mg, followed of an infusion of 600 mg in 24 h.\n",
      "Outcomes and follow-up\t- After a good recovery in ICU, the patient was discharged to the Internal Medicine ward.\n",
      "- He was afebrile, hemodynamically stable, without antibiotics and decreasing dosage of corticosteroids.\n",
      "- A new stool culture was positive for group B Salmonella species.\n",
      "- He had no symptoms, but ciprofloxacin was administered for seven days and then he was discharged.\n",
      "- In a follow-up visit to the Internal Medicine clinic he remained asymptomatic and without sequelae.\n",
      "- Cardiac magnetic resonance imaging was performed, which was normal.\n",
      "\n",
      "\n",
      "==================================================\n",
      "**Discharge Summary**\n",
      "\n",
      "**Patient Information:**\n",
      "- **Name:** [Patient's Name]\n",
      "- **Age:** 16 years\n",
      "- **Gender:** Male\n",
      "- **Ethnicity:** Caucasian\n",
      "- **Allergies:** None\n",
      "- **Medical History:** Mild intermittent extrinsic asthma, treated with corticosteroids and aerosols (salmeterol 25 mcg/fluticasone 250 mcg, two inhalations twice daily). No relevant past interventions or significant medical, family, or psychosocial history.\n",
      "\n",
      "**Admission Details:**\n",
      "- **Date of Admission:** [Admission Date]\n",
      "- **Date of Discharge:** [Discharge Date]\n",
      "- **Presenting Complaints:** General discomfort, asthenia, fever (38°C) for three days, shortness of breath, arthromyalgia, and diarrhea (two stools without pathological products).\n",
      "\n",
      "**Clinical Findings:**\n",
      "- **Vital Signs on Admission:**\n",
      "  - Blood Pressure: 70/30 mmHg\n",
      "  - Heart Rate: 110 bpm\n",
      "  - Respiratory Rate: 18 bpm\n",
      "  - Temperature: 38.5°C\n",
      "  - SpO2: 98%\n",
      "- **Physical Examination:**\n",
      "  - General condition: Poor, dehydrated (dry mucous membranes), but alert and oriented.\n",
      "  - Lung auscultation: Bibasilar crackles.\n",
      "  - Heart auscultation: No murmurs.\n",
      "  - Hepatosplenomegaly, oliguria, no edema, no rash, no arthritis.\n",
      "  - Diuresis: 170 ml in 12 hours.\n",
      "\n",
      "**Laboratory and Diagnostic Tests:**\n",
      "- **Laboratory Results:**\n",
      "  - White Blood Cell Count: 10,200 μL −1\n",
      "  - Neutrophils: 8,420\n",
      "  - Hemoglobin: 12.5 g/dL\n",
      "  - Platelet Count: 104,000 μL −1\n",
      "  - C-reactive Protein: 269.4 mg/L\n",
      "  - Liver Function Tests: Elevated ALT and AST.\n",
      "  - Bilirubin: Total 3.30 mg/dL, Direct 2.73 mg/dL.\n",
      "  - Cardiac Troponin I: 1135 ng/L.\n",
      "  - Renal Function: Elevated BUN and creatinine.\n",
      "  - Arterial Blood Gas: pH 7.32, pCO2 50.2 mmHg, pO2 92 mmHg.\n",
      "  - Lactic Acid: 2.2 mmol/L.\n",
      "  - Ferritin: 655.4 ng/mL.\n",
      "  - D-dimer: 7,500 ng/mL.\n",
      "- **Imaging:**\n",
      "  - Thoracoabdominal CT: Multiple para-aortic and peri-pancreatic lymphadenopathy, signs of ARDS, no pulmonary thromboembolism.\n",
      "  - Cranial CT: Normal.\n",
      "- **Microbiological Tests:** Negative for COVID-19 via RT-PCR; stool culture positive for group B Salmonella species.\n",
      "\n",
      "**Therapeutic Interventions:**\n",
      "- **Initial Treatment:**\n",
      "  - Paracetamol and azithromycin at home.\n",
      "  - ICU admission with broad-spectrum antibiotics (imipenem, linezolid) and norepinephrine.\n",
      "  - Oxygen therapy via nasal cannula and venturi mask.\n",
      "  - Dexamethasone for cytokine storm management.\n",
      "  - Cardiac support with levosimendan and furosemide.\n",
      "  - Atrial fibrillation management with amiodarone.\n",
      "  \n",
      "**Outcomes:**\n",
      "- The patient showed significant improvement in clinical status, hemodynamic stability, and resolution of symptoms.\n",
      "- Transferred to Internal Medicine ward, remained afebrile and stable.\n",
      "- Completed a course of ciprofloxacin for Salmonella infection.\n",
      "- Follow-up cardiac MRI was normal.\n",
      "\n",
      "**Discharge Condition:**\n",
      "- The patient was discharged hemodynamically stable, eupneic, and with oxygen saturation of 99% on 0.28% oxygen supply. \n",
      "\n",
      "**Follow-Up:**\n",
      "- Scheduled follow-up in Internal Medicine clinic; patient remains asymptomatic and without sequelae.\n",
      "\n",
      "**Physician's Signature:**\n",
      "[Physician's Name]  \n",
      "[Date]  \n",
      "[Contact Information]\n",
      "==================================================\n",
      "==================================================\n",
      "\n",
      "\n",
      "\n",
      "{'filenameid': '33263366', 'n_words_cc': 1400, 'n_words_ds': 305, 'gen_orig_ratio': 0.21785714285714286}\n",
      "==================================================\n",
      "|       | mention_class   | term                                       | span_orig                                  | span_gen              |\n",
      "|------:|:----------------|:-------------------------------------------|:-------------------------------------------|:----------------------|\n",
      "| 25203 | DISEASE         | Aneurysm                                   | aneurysm                                   | aneurysm              |\n",
      "| 25204 | DISEASE         | Aneurysm                                   | aneurysm                                   | aneurysm              |\n",
      "| 25205 | DISEASE         | Aneurysm                                   | aneurysm                                   | aneurysm              |\n",
      "| 25206 | DISEASE         | Aneurysm                                   | aneurysm                                   | aneurysm              |\n",
      "| 25207 | DISEASE         | Aneurysm                                   | aneurysm                                   | aneurysm              |\n",
      "| 25208 | DISEASE         | Aneurysm                                   | aneurysm                                   | aneurysm              |\n",
      "| 25209 | DISEASE         | Aneurysm                                   | aneurysm                                   | aneurysm              |\n",
      "| 25210 | DISEASE         | Aneurysm                                   | aneurysm                                   | aneurysm              |\n",
      "| 25211 | DISEASE         | Angulated                                  | angulation                                 | None                  |\n",
      "| 25212 | DISEASE         | Chest Pain                                 | None                                       | chest pain            |\n",
      "| 25213 | DISEASE         | Dyslipidemias                              | dyslipidemia                               | Dyslipidemia          |\n",
      "| 25214 | DISEASE         | Dyspnea                                    | None                                       | shortness of breath   |\n",
      "| 25215 | DISEASE         | Hypertensive disease                       | hypertension                               | Hypertension          |\n",
      "| 25216 | DISEASE         | Myocardial Infarction                      | None                                       | myocardial infarction |\n",
      "| 25217 | DISEASE         | ST segment elevation myocardial infarction | ST-segment elevation myocardial infarction | None                  |\n",
      "| 25218 | DISEASE         | Tethered                                   | tether                                     | None                  |\n",
      "| 25219 | DISEASE         | Transcatheter Aortic Valve Replacement     | transcatheter aortic valve replacement     | None                  |\n",
      "| 25220 | DISEASE         | Ventricular aneurysm                       | ventricular aneurysm                       | ventricular aneurysm  |\n",
      "| 25221 | CHEMICAL        | nicotine                                   | nicotine                                   | Nicotine              |\n",
      "| 25222 | CHEMICAL        | warfarin                                   | warfarin                                   | warfarin              |\n",
      "==================================================\n",
      "We present a 55-year-old woman with a history of ST-segment elevation myocardial infarction 2 years before the operation that was treated by percutaneous coronary intervention with implantation of a drug-eluting stent into the left anterior descending artery. Further medical history included hypertension, dyslipidemia, nicotine abuse (20-pack-years), and implantation of a defibrillator. \n",
      "\n",
      "Despite successful implantation of a drug-eluting stent, she developed an anteroapical left ventricular aneurysm. Under optimal medical treatment according to the guidelines, her New York Heart Association functional class was 3, with a left ventricular ejection fraction of approximately 30% right before the operation. Her EuroSCORE II was 1.86% and her NT-proBNP plasma levels were 820 pg/ml. \n",
      "\n",
      "We performed the LIVETM procedure: 4 anchors were implanted via a left lateral thoracotomy to exclude the left ventricular scar. The surgical procedure was carried out as planned.\n",
      "\n",
      "A computed tomography angiographic scan demonstrates the morphology of the scar. Magnetic resonance imaging, which would have shown the distribution of scar tissue even more clearly, was not possible due to her status after placement of an implantable cardioverter defibrillator.\n",
      "\n",
      "A 14-Fr introducer sheath is brought into the right internal jugular vein and advanced into the right atrium. A standard Swan-Ganz catheter is then used to place a wire that will guide a snare into the pulmonary artery. Next, the lateral wall of the aneurysm is tapped with a needle that is advanced into the right ventricle. Over the needle a wire is inserted, and a 6-Fr sheath is brought into the right ventricle. The guidewire is then advanced through the 6-Fr sheath, into the snare and recovered through the 14-Fr sheath. Over this wire, the first anchor is placed to the right ventricular side of the interventricular septum. Then an epicardial anchor is placed as a counterpart over the tether of the right ventricular (RV) anchor that has been retrieved through the thoracotomy. The anchors are then approximated.\n",
      "\n",
      "We place standard 6-Fr sheaths via the femoral artery and vein. We perform left ventricular angiography to visualize the extent of the aneurysm to determine the position of the thoracotomy.\n",
      "\n",
      "We open the chest in the left 5th interspace. Compared to the thoracotomy for transapical transcatheter aortic valve replacement, this access is more dorsal, more cranial, and somewhat longer. We place stay sutures and insert a soft tissue retractor. The double lumen tube keeps the lung deflated and out of the way. The pericardial window is created anterior to the phrenic nerve. A 4/0 Prolene suture armed with Teflon felt on a snare is placed in the center of the aneurysm to facilitate manipulation of the heart while keeping the incision small. By moving the snare, we identify the landmarks and bring them into the incision. These landmarks include the left anterior descending artery, the lateral border of the scar, and the apex of the LV.\n",
      "\n",
      "At the same time that we perform the thoracotomy, we bring the 14-Fr introducer sheath into the right internal jugular vein. Next, we perform RV angiography with a standard pigtail catheter and mark the RV apex, the landing zone for the first anchor. Then, we use a standard Swan-Ganz catheter to place a wire that will guide a snare into the common pulmonary artery.\n",
      "\n",
      "The entry kit consists of an 18G straight needle connected to a Tuohy-Borst valve. A pressure line is attached to the assembly to enable continuous measurement of blood pressure at the tip of the needle. A standard 0.32 wire is loaded into the valve, and a syringe with diluted contrast medium is attached to confirm proper positioning of the needle once the RV has been entered.\n",
      "\n",
      "The white line represents the pressure at the tip of the entry needle. It starts with atmospheric pressure, becomes congruent with the arterial pressure once the LV is entered, and dampens briefly as the ventricular septum is reached; it finally displays a typical RV pressure curve. At this point, the wire is advanced into the RV cavity, and a small amount of dye is injected to rule out misplacement of the needle and the wire in the pericardium. \n",
      "\n",
      "It is extremely important to choose the point of septal puncture properly because it becomes the final position of the first anchor. We need to feel a strong resistance as we push the needle through the septum, because this resistance confirms that the needle is passing through the scar tissue (only this scar tissue will provide adequate support for the anchors). If the position of the needle is confirmed to be satisfactory, the entry kit is withdrawn and only the wire is left in place. We introduce a 6-Fr sheath into the RV over the wire. The end of the sheath is radiopaque for easier visualization under fluoroscopy and to allow for precise manipulation of the tip close to the septum. \n",
      "\n",
      "Once the sheath is in place, an Ampatz right modified (AR MOD) catheter is brought into the RV with its tip close to the septum and the opening pointing toward the RV outflow tract. Later, this catheter allows for a 0.18 guidewire to travel toward the pulmonary valve while staying close to the septum, thereby avoiding entanglement with the tricuspid valve or the papillary muscles. \n",
      "\n",
      "The wire is then caught by the snare. As soon as the wire is caught, it is drawn into the 14-Fr sheath and used to pull the tip of the 6-Fr sheath into the 14-Fr sheath. During this step, the anesthesiologist observes the tricuspid valve closely via transesophageal echocardiography to detect any change in valve function, which would indicate entanglement of the wire or the sheath in the tricuspid valve apparatus. \n",
      "\n",
      "Once the 2 sheaths are joined together, the heart is protected from damage caused by any moving wire. The AR MOD catheter is advanced into the 6 Fr sheath until it exits the 14 Fr sheath in the neck. Now we prepare the first anchor. The tip of the anchor can accommodate the 0.18 wire exiting the AR MOD catheter. The angulation of the anchor relative to the tip of the delivery device can be controlled by the handle of the delivery device. The anchor’s tether is now introduced over the wire into the tip of the AR MOD catheter. The combination of the tether, the wire, and the AR MOD catheter is then advanced toward the radiopaque tip of the 6-Fr sheath. Once the tether of the anchor exits the 6 Fr sheath through the lateral thoracotomy, the anchor can be pulled against the tip of the 6-Fr sheath. Then the whole assembly can be brought close to the septum. At this point, the anchor is still fully controllable and could still be completely removed. \n",
      "\n",
      "Once the position is deemed satisfactory, the 6-Fr sheath is removed, and the delivery tool is disconnected from the anchor, which is held in place by a continuous gentle pull only on the tether. Now the epicardial anchor is mounted on the tether. The 2 anchors are approximated using a force gauge under fluoroscopic control. The system is set to a force of approximately 2 newtons; any greater force could cause the anchor to cut through the scar tissue over time. With that move, the implantation of the first pair of anchors is completed. A second pair of anchors is placed using the same procedure. \n",
      "\n",
      "The most apical section of the aneurysm is not yet excluded. To achieve that goal, we use a modified anchor. Instead of an opening for a wire, the tip of the tether of this anchor carries a curved needle that can be brought directly from behind through the scar. The second anchor is installed and then approximated in the same fashion as the other anchors. A second pair of anchors is placed in the same way to exclude the apex completely.\n",
      "\n",
      "Chest tubes are placed and the 14-Fr sheath is removed. The chest is then closed in layers. \n",
      "\n",
      "\n",
      "Outcome\n",
      "\n",
      "The patient´s postoperative course was uneventful. After we removed the chest tubes, we started anticoagulation with warfarin that continued for 6 months. Transthoracic echocardiography prior to discharge showed a left ventricular ejection fraction of approximately 40%. The postoperative course was uneventful; the patient was discharged home on the 7th postoperative day. \n",
      "\n",
      "\n",
      "==================================================\n",
      "**Discharge Summary**\n",
      "\n",
      "**Patient Information:**\n",
      "- Name: [Patient Name]\n",
      "- Age: 55 years\n",
      "- Gender: Female\n",
      "- Admission Date: [Admission Date]\n",
      "- Discharge Date: [Discharge Date]\n",
      "\n",
      "**Medical History:**\n",
      "- ST-segment elevation myocardial infarction (2 years prior)\n",
      "- Percutaneous coronary intervention with drug-eluting stent placement in the left anterior descending artery\n",
      "- Hypertension\n",
      "- Dyslipidemia\n",
      "- Nicotine abuse (20-pack-years)\n",
      "- Implantation of a defibrillator\n",
      "\n",
      "**Presenting Condition:**\n",
      "The patient presented with an anteroapical left ventricular aneurysm despite prior successful stent implantation. Under optimal medical treatment, her New York Heart Association functional class was 3, with a left ventricular ejection fraction of approximately 30%. Preoperative EuroSCORE II was 1.86%, and NT-proBNP plasma levels were 820 pg/ml.\n",
      "\n",
      "**Surgical Procedure:**\n",
      "The patient underwent the LIVETM procedure, which involved:\n",
      "- Implantation of 4 anchors via left lateral thoracotomy to exclude the left ventricular scar.\n",
      "- Preoperative imaging included a computed tomography angiogram to assess scar morphology; magnetic resonance imaging was not performed due to the presence of an implantable cardioverter defibrillator.\n",
      "\n",
      "**Surgical Technique:**\n",
      "- A 14-Fr introducer sheath was placed in the right internal jugular vein, and a Swan-Ganz catheter was used to guide a wire into the pulmonary artery.\n",
      "- The lateral wall of the aneurysm was accessed, and a series of anchors were placed to secure the right ventricular side of the interventricular septum.\n",
      "- Left ventricular angiography was performed to visualize the aneurysm extent.\n",
      "- A left thoracotomy was performed, and a pericardial window was created.\n",
      "- Anchors were placed and approximated under fluoroscopic guidance.\n",
      "\n",
      "**Postoperative Course:**\n",
      "The patient's postoperative recovery was uneventful. Chest tubes were removed, and anticoagulation therapy with warfarin was initiated, to continue for 6 months. \n",
      "\n",
      "**Follow-Up:**\n",
      "Transthoracic echocardiography prior to discharge indicated a left ventricular ejection fraction of approximately 40%. The patient was discharged home on the 7th postoperative day in stable condition.\n",
      "\n",
      "**Instructions at Discharge:**\n",
      "- Continue anticoagulation therapy as prescribed.\n",
      "- Follow up with cardiology for ongoing management of heart function and monitoring.\n",
      "- Report any signs of complications such as chest pain, shortness of breath, or unusual swelling.\n",
      "\n",
      "**Physician's Signature:**\n",
      "[Physician Name]  \n",
      "[Title]  \n",
      "[Date]\n",
      "==================================================\n",
      "==================================================\n",
      "\n",
      "\n",
      "\n",
      "{'filenameid': '31378248', 'n_words_cc': 1901, 'n_words_ds': 418, 'gen_orig_ratio': 0.21988427143608627}\n",
      "==================================================\n",
      "|       | mention_class   | term                                      | span_orig                                  | span_gen                           |\n",
      "|------:|:----------------|:------------------------------------------|:-------------------------------------------|:-----------------------------------|\n",
      "| 13035 | DISEASE         | ATRIAL ENLARGEMENT                        | atrial enlargement                         | None                               |\n",
      "| 13036 | DISEASE         | ATRIAL ENLARGEMENT                        | atrial enlargement                         | None                               |\n",
      "| 13037 | DISEASE         | Abdomen distended                         | abdominal distention                       | None                               |\n",
      "| 13038 | DISEASE         | Acute Coronary Syndrome                   | acute coronary syndrome                    | None                               |\n",
      "| 13039 | DISEASE         | Acute Coronary Syndrome                   | acute coronary syndrome                    | None                               |\n",
      "| 13040 | DISEASE         | Acute myocardial infarction               | acute myocardial infarction                | None                               |\n",
      "| 13041 | DISEASE         | Amyloidosis                               | amyloidosis                                | None                               |\n",
      "| 13042 | DISEASE         | Aortic Valve Insufficiency                | aortic regurgitation                       | None                               |\n",
      "| 13043 | DISEASE         | Aortic Valve Stenosis                     | aortic stenosis                            | None                               |\n",
      "| 13044 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13045 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | Atrial fibrillation                |\n",
      "| 13046 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13047 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13048 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13049 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | Atrial fibrillation                |\n",
      "| 13050 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13051 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13052 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13053 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | Atrial fibrillation                |\n",
      "| 13054 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13055 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13056 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13057 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | Atrial fibrillation                |\n",
      "| 13058 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13059 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13060 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13061 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | Atrial fibrillation                |\n",
      "| 13062 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13063 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13064 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13065 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | Atrial fibrillation                |\n",
      "| 13066 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13067 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13068 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13069 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | Atrial fibrillation                |\n",
      "| 13070 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13071 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13072 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13073 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | Atrial fibrillation                |\n",
      "| 13074 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13075 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13076 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13077 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | Atrial fibrillation                |\n",
      "| 13078 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13079 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13080 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13081 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | Atrial fibrillation                |\n",
      "| 13082 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13083 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13084 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13085 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | Atrial fibrillation                |\n",
      "| 13086 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13087 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13088 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13089 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | Atrial fibrillation                |\n",
      "| 13090 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13091 | DISEASE         | Atrial Fibrillation                       | atrial fibrillation                        | atrial fibrillation                |\n",
      "| 13092 | DISEASE         | Atrial Flutter                            | atrial flutter                             | None                               |\n",
      "| 13093 | DISEASE         | Blocking                                  | beta blockade                              | None                               |\n",
      "| 13094 | DISEASE         | Cardiac Arrhythmia                        | arrhythmia                                 | None                               |\n",
      "| 13095 | DISEASE         | Cardiac Arrhythmia                        | arrhythmia                                 | None                               |\n",
      "| 13096 | DISEASE         | Cardiac Arrhythmia                        | arrhythmia                                 | None                               |\n",
      "| 13097 | DISEASE         | Cardiomegaly                              | cardiomegaly                               | cardiomegaly                       |\n",
      "| 13098 | DISEASE         | Cardiotoxicity                            | cardiac toxicities                         | None                               |\n",
      "| 13099 | DISEASE         | Cerebrovascular accident                  | stroke                                     | None                               |\n",
      "| 13100 | DISEASE         | Chest Pain                                | chest pain                                 | None                               |\n",
      "| 13101 | DISEASE         | Chills                                    | chills                                     | chills                             |\n",
      "| 13102 | DISEASE         | Chronic Obstructive Airway Disease        | chronic obstructive pulmonary disease      | None                               |\n",
      "| 13103 | DISEASE         | Congestive heart failure                  | CHF                                        | None                               |\n",
      "| 13104 | DISEASE         | Congestive heart failure                  | CHF                                        | None                               |\n",
      "| 13105 | DISEASE         | Congestive heart failure                  | CHF                                        | None                               |\n",
      "| 13106 | DISEASE         | Congestive heart failure                  | CHF                                        | None                               |\n",
      "| 13107 | DISEASE         | Congestive heart failure                  | CHF                                        | None                               |\n",
      "| 13108 | DISEASE         | Coronary Arteriosclerosis                 | Coronary artery disease                    | None                               |\n",
      "| 13109 | DISEASE         | Coughing                                  | cough                                      | None                               |\n",
      "| 13110 | DISEASE         | Depressed mood                            | depressed                                  | None                               |\n",
      "| 13111 | DISEASE         | Dizziness                                 | dizziness                                  | dizziness                          |\n",
      "| 13112 | DISEASE         | Dyspnea                                   | dyspnea                                    | dyspnea                            |\n",
      "| 13113 | DISEASE         | Dyspnea                                   | dyspnea                                    | dyspnea                            |\n",
      "| 13114 | DISEASE         | Dyspnea                                   | dyspnea                                    | dyspnea                            |\n",
      "| 13115 | DISEASE         | Dyspnea                                   | dyspnea                                    | dyspnea                            |\n",
      "| 13116 | DISEASE         | Dyspnea                                   | dyspnea                                    | dyspnea                            |\n",
      "| 13117 | DISEASE         | Dyspnea                                   | dyspnea                                    | dyspnea                            |\n",
      "| 13118 | DISEASE         | Dyspnea                                   | dyspnea                                    | dyspnea                            |\n",
      "| 13119 | DISEASE         | Dyspnea                                   | dyspnea                                    | dyspnea                            |\n",
      "| 13120 | DISEASE         | Dyspnea                                   | dyspnea                                    | dyspnea                            |\n",
      "| 13121 | DISEASE         | Dyspnea                                   | dyspnea                                    | dyspnea                            |\n",
      "| 13122 | DISEASE         | Dyspnea                                   | dyspnea                                    | dyspnea                            |\n",
      "| 13123 | DISEASE         | Dyspnea                                   | dyspnea                                    | dyspnea                            |\n",
      "| 13124 | DISEASE         | Dyspnea                                   | dyspnea                                    | dyspnea                            |\n",
      "| 13125 | DISEASE         | Dyspnea                                   | dyspnea                                    | dyspnea                            |\n",
      "| 13126 | DISEASE         | Dyspnea                                   | dyspnea                                    | dyspnea                            |\n",
      "| 13127 | DISEASE         | Dyspnea                                   | dyspnea                                    | dyspnea                            |\n",
      "| 13128 | DISEASE         | Dyspnea                                   | dyspnea                                    | dyspnea                            |\n",
      "| 13129 | DISEASE         | Dyspnea                                   | dyspnea                                    | dyspnea                            |\n",
      "| 13130 | DISEASE         | Edema                                     | edema                                      | None                               |\n",
      "| 13131 | DISEASE         | Edema of lower extremity                  | lower extremity pitting edema              | lower extremity pitting edema      |\n",
      "| 13132 | DISEASE         | Electrocardiogram abnormal (finding)      | ECG abnormalities                          | None                               |\n",
      "| 13133 | DISEASE         | Fever                                     | fever                                      | None                               |\n",
      "| 13134 | DISEASE         | Fibrosis                                  | fibrosis                                   | None                               |\n",
      "| 13135 | DISEASE         | Fluid overload                            | volume overload secondary                  | None                               |\n",
      "| 13136 | DISEASE         | Giant cell myocarditis                    | giant-cell myocarditis                     | None                               |\n",
      "| 13137 | DISEASE         | Heart Ventricle                           | ventricular hypokinesis                    | None                               |\n",
      "| 13138 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13139 | DISEASE         | Heart failure                             | heart failure                              | Heart failure                      |\n",
      "| 13140 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13141 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13142 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13143 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13144 | DISEASE         | Heart failure                             | heart failure                              | Heart failure                      |\n",
      "| 13145 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13146 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13147 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13148 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13149 | DISEASE         | Heart failure                             | heart failure                              | Heart failure                      |\n",
      "| 13150 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13151 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13152 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13153 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13154 | DISEASE         | Heart failure                             | heart failure                              | Heart failure                      |\n",
      "| 13155 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13156 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13157 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13158 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13159 | DISEASE         | Heart failure                             | heart failure                              | Heart failure                      |\n",
      "| 13160 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13161 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13162 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13163 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13164 | DISEASE         | Heart failure                             | heart failure                              | Heart failure                      |\n",
      "| 13165 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13166 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13167 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13168 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13169 | DISEASE         | Heart failure                             | heart failure                              | Heart failure                      |\n",
      "| 13170 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13171 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13172 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13173 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13174 | DISEASE         | Heart failure                             | heart failure                              | Heart failure                      |\n",
      "| 13175 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13176 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13177 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13178 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13179 | DISEASE         | Heart failure                             | heart failure                              | Heart failure                      |\n",
      "| 13180 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13181 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13182 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13183 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13184 | DISEASE         | Heart failure                             | heart failure                              | Heart failure                      |\n",
      "| 13185 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13186 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13187 | DISEASE         | Heart failure                             | heart failure                              | heart failure                      |\n",
      "| 13188 | DISEASE         | Hemochromatosis                           | hemochromatosis                            | None                               |\n",
      "| 13189 | DISEASE         | Hemorrhage                                | bleeding                                   | None                               |\n",
      "| 13190 | DISEASE         | Hepatotoxicity                            | hepatotoxicity                             | None                               |\n",
      "| 13191 | DISEASE         | Hypersensitivity                          | allergies                                  | allergies                          |\n",
      "| 13192 | DISEASE         | Hypertrophy                               | hypertrophy                                | None                               |\n",
      "| 13193 | DISEASE         | Hyponatremia                              | Hyponatremia                               | None                               |\n",
      "| 13194 | DISEASE         | Ischemia                                  | ischemia                                   | None                               |\n",
      "| 13195 | DISEASE         | Ischemia                                  | ischemia                                   | None                               |\n",
      "| 13196 | DISEASE         | Jugular venous engorgement                | jugular venous distension                  | Jugular venous distension          |\n",
      "| 13197 | DISEASE         | Jugular venous engorgement                | jugular venous distension                  | Jugular venous distension          |\n",
      "| 13198 | DISEASE         | Left Ventricular Function                 | left ventricular systolic function         | None                               |\n",
      "| 13199 | DISEASE         | Left Ventricular Hypertrophy              | left ventricular hypertrophy               | None                               |\n",
      "| 13200 | DISEASE         | Left Ventricular Hypertrophy              | mildemoderate left ventricular enlargement | None                               |\n",
      "| 13201 | DISEASE         | Left atrial hypertrophy                   | left atrial enlargement                    | left atrial enlargement            |\n",
      "| 13202 | DISEASE         | Left atrial hypertrophy                   | left atrial enlargement                    | left atrial enlargement            |\n",
      "| 13203 | DISEASE         | Lightheadedness                           | lightheadedness                            | lightheadedness                    |\n",
      "| 13204 | CHEMICAL        | Millimole per Liter                       | mmol/L                                     | None                               |\n",
      "| 13205 | DISEASE         | Mitral Valve Insufficiency                | mitral regurgitation                       | None                               |\n",
      "| 13206 | DISEASE         | Mitral Valve Insufficiency                | mitral regurgitation                       | None                               |\n",
      "| 13207 | DISEASE         | Mitral Valve Insufficiency                | mitral regurgitation                       | None                               |\n",
      "| 13208 | DISEASE         | Mitral Valve Insufficiency                | mitral regurgitation                       | None                               |\n",
      "| 13209 | DISEASE         | Mitral Valve Insufficiency                | mitral regurgitation                       | None                               |\n",
      "| 13210 | DISEASE         | Nasal congestion (finding)                | nasal congestion                           | None                               |\n",
      "| 13211 | DISEASE         | Night sweats                              | night sweats                               | night sweats                       |\n",
      "| 13212 | DISEASE         | Obesity                                   | obesity                                    | Obesity                            |\n",
      "| 13213 | DISEASE         | Orthopnea                                 | orthopnea                                  | None                               |\n",
      "| 13214 | DISEASE         | Palpitations                              | palpitations                               | palpitations                       |\n",
      "| 13215 | DISEASE         | Paroxysmal nocturnal dyspnea              | paroxysmal nocturnal dyspnea               | None                               |\n",
      "| 13216 | DISEASE         | Pericarditis, Constrictive                | constrictive pericarditis                  | None                               |\n",
      "| 13217 | DISEASE         | Pharyngitis                               | sore throat                                | None                               |\n",
      "| 13218 | DISEASE         | Pneumonia                                 | pneumonia                                  | None                               |\n",
      "| 13219 | DISEASE         | Pneumothorax                              | pneumothorax                               | None                               |\n",
      "| 13220 | DISEASE         | Premature coronary artery atherosclerosis | premature coronary artery disease          | premature coronary artery disease  |\n",
      "| 13221 | DISEASE         | Pulmonary Edema                           | pulmonary edema                            | None                               |\n",
      "| 13222 | DISEASE         | Pulmonary Embolism                        | pulmonary embolus                          | None                               |\n",
      "| 13223 | DISEASE         | Pulmonary toxicity                        | pulmonary toxicity                         | None                               |\n",
      "| 13224 | DISEASE         | Respiratory rate                          | respiratory illness                        | None                               |\n",
      "| 13225 | DISEASE         | Right Ventricular Hypertrophy             | right ventricular enlargement              | right ventricular enlargement      |\n",
      "| 13226 | DISEASE         | Shock                                     | shock                                      | None                               |\n",
      "| 13227 | DISEASE         | Sinus pain                                | sinus pain                                 | None                               |\n",
      "| 13228 | CHEMICAL        | Smoking                                   | smoking                                    | None                               |\n",
      "| 13229 | DISEASE         | Sudden Cardiac Death                      | sudden cardiac death                       | None                               |\n",
      "| 13230 | DISEASE         | Tachyarrhythmia                           | tachyarrhythmia                            | None                               |\n",
      "| 13231 | DISEASE         | Tachycardia-induced cardiomyopathy        | tachycardia-induced cardiomyopathy         | tachycardia-induced cardiomyopathy |\n",
      "| 13232 | DISEASE         | Tachycardia-induced cardiomyopathy        | Tachycardia-induced cardiomyopathy         | tachycardia-induced cardiomyopathy |\n",
      "| 13233 | CHEMICAL        | Tartrates                                 | tartrate                                   | None                               |\n",
      "| 13234 | DISEASE         | Thyroid dysfunction                       | thyroid dysfunction                        | None                               |\n",
      "| 13235 | DISEASE         | Tissue membrane                           | membranous VSD                             | None                               |\n",
      "| 13236 | DISEASE         | Tricuspid Valve Insufficiency             | mitral and tricuspid regurgitation         | mitral and tricuspid regurgitation |\n",
      "| 13237 | DISEASE         | Tricuspid Valve Insufficiency             | tricuspid regurgitation                    | mitral and tricuspid regurgitation |\n",
      "| 13238 | DISEASE         | Tricuspid Valve Insufficiency             | tricuspid regurgitation                    | mitral and tricuspid regurgitation |\n",
      "| 13239 | DISEASE         | Tricuspid Valve Insufficiency             | tricuspid regurgitation                    | mitral and tricuspid regurgitation |\n",
      "| 13240 | DISEASE         | Tricuspid Valve Insufficiency             | tricuspid regurgitation                    | mitral and tricuspid regurgitation |\n",
      "| 13241 | DISEASE         | Ventricular Septal Defects                | congenital ventricular septal defect       | ventricular septal defect          |\n",
      "| 13242 | DISEASE         | Ventricular enlargement                   | ventricular enlargement                    | None                               |\n",
      "| 13243 | DISEASE         | Weight Gain                               | weight gain                                | weight gain                        |\n",
      "| 13244 | DISEASE         | Weight Gain                               | weight gain                                | weight gain                        |\n",
      "| 13245 | DISEASE         | Weight Loss                               | weight loss                                | None                               |\n",
      "| 13246 | DISEASE         | Wheezing                                  | wheezing                                   | None                               |\n",
      "| 13247 | CHEMICAL        | amiodarone                                | amiodarone                                 | Amiodarone                         |\n",
      "| 13248 | CHEMICAL        | amiodarone                                | amiodarone                                 | amiodarone                         |\n",
      "| 13249 | CHEMICAL        | amiodarone                                | Amiodarone                                 | Amiodarone                         |\n",
      "| 13250 | CHEMICAL        | amiodarone                                | Amiodarone                                 | amiodarone                         |\n",
      "| 13251 | CHEMICAL        | amiodarone                                | amiodarone                                 | Amiodarone                         |\n",
      "| 13252 | CHEMICAL        | amiodarone                                | amiodarone                                 | amiodarone                         |\n",
      "| 13253 | CHEMICAL        | amiodarone                                | amiodarone                                 | Amiodarone                         |\n",
      "| 13254 | CHEMICAL        | amiodarone                                | amiodarone                                 | amiodarone                         |\n",
      "| 13255 | CHEMICAL        | apixaban                                  | apixaban                                   | apixaban                           |\n",
      "| 13256 | CHEMICAL        | aspirin                                   | Aspirin                                    | None                               |\n",
      "| 13257 | CHEMICAL        | atenolol                                  | atenolol                                   | None                               |\n",
      "| 13258 | CHEMICAL        | bisoprolol                                | bisoprolol                                 | None                               |\n",
      "| 13259 | CHEMICAL        | carvedilol                                | carvedilol                                 | carvedilol                         |\n",
      "| 13260 | CHEMICAL        | carvedilol                                | carvedilol                                 | carvedilol                         |\n",
      "| 13261 | CHEMICAL        | carvedilol                                | carvedilol                                 | carvedilol                         |\n",
      "| 13262 | CHEMICAL        | carvedilol                                | Carvedilol                                 | carvedilol                         |\n",
      "| 13263 | CHEMICAL        | carvedilol                                | carvedilol                                 | carvedilol                         |\n",
      "| 13264 | CHEMICAL        | carvedilol                                | carvedilol                                 | carvedilol                         |\n",
      "| 13265 | CHEMICAL        | carvedilol                                | carvedilol                                 | carvedilol                         |\n",
      "| 13266 | CHEMICAL        | cholesterol                               | cholesterol                                | Cholesterol                        |\n",
      "| 13267 | CHEMICAL        | clopidogrel                               | clopidogrel                                | None                               |\n",
      "| 13268 | CHEMICAL        | creatinine                                | creatinine                                 | Creatinine                         |\n",
      "| 13269 | CHEMICAL        | creatinine                                | creatinine                                 | Creatinine                         |\n",
      "| 13270 | CHEMICAL        | ethanol                                   | alcohol                                    | Alcohol                            |\n",
      "| 13271 | CHEMICAL        | fexofenadine                              | fexofenadine                               | Fexofenadine                       |\n",
      "| 13272 | CHEMICAL        | furosemide                                | furosemide                                 | furosemide                         |\n",
      "| 13273 | CHEMICAL        | furosemide                                | Furosemide                                 | furosemide                         |\n",
      "| 13274 | CHEMICAL        | furosemide                                | furosemide                                 | furosemide                         |\n",
      "| 13275 | CHEMICAL        | furosemide                                | furosemide                                 | furosemide                         |\n",
      "| 13276 | CHEMICAL        | glucose                                   | glucose                                    | None                               |\n",
      "| 13277 | CHEMICAL        | lisinopril                                | lisinopril                                 | lisinopril                         |\n",
      "| 13278 | CHEMICAL        | metoprolol                                | metoprolol                                 | None                               |\n",
      "| 13279 | CHEMICAL        | metoprolol succinate                      | metoprolol succinate                       | None                               |\n",
      "| 13280 | CHEMICAL        | metoprolol succinate                      | metoprolol succinate                       | None                               |\n",
      "| 13281 | CHEMICAL        | metoprolol tartrate                       | metoprolol tartrate                        | metoprolol tartrate                |\n",
      "| 13282 | CHEMICAL        | metoprolol tartrate                       | metoprolol tartrate                        | metoprolol tartrate                |\n",
      "| 13283 | CHEMICAL        | sodium                                    | sodium                                     | Sodium                             |\n",
      "| 13284 | DISEASE         | thromboembolic                            | thromboembolic                             | None                               |\n",
      "| 13285 | CHEMICAL        | None                                      | extended-release succinate                 | None                               |\n",
      "| 13286 | CHEMICAL        | None                                      | uptitrated                                 | None                               |\n",
      "| 13287 | CHEMICAL        | None                                      | uptitrated                                 | None                               |\n",
      "| 13288 | DISEASE         | None                                      | left ventricular hypokinesis               | left ventricular hypokinesis       |\n",
      "==================================================\n",
      "A 50-year-old man presented to his primary care provider with a 2-week history of progressively worsening dyspnea on exertion and chest discomfort while in the flat position. He described his dyspnea as a feeling of “breathing through a straw.” Additional symptoms included a weight gain of 5 kg in the prior 3 weeks, increased abdominal girth, and paroxysmal nocturnal dyspnea. He also noticed a decline in exercise tolerance from a prior ability to ascend 9 flights of stairs to tolerating only a few steps. He denied fevers, chills, night sweats, palpitations, lightheadedness, or dizziness. He had no recent upper respiratory illness symptoms, such as nasal congestion, sore throat, cough, or sinus pain. His medical history was notable for a small, congenital ventricular septal defect (VSD), obesity (body mass index, 35 kg/m2) and seasonal allergies. His only medication included fexofenadine. He never used tobacco products and reported an average alcohol intake of 2 to 3 beverages per week. In terms of family history, he has a brother with a history of atrial fibrillation; otherwise, there was no family medical history of heart failure or premature coronary artery disease. On physical examination, he was tachycardic with a heart rate of 148 beats per minute with an irregularly irregular rhythm, bibasilar crackles, abdominal distention, jugular venous distension, hepatojugular reflux, and 1+, symmetric, bilateral lower extremity pitting edema.\n",
      "\n",
      "The clinical findings are not suggestive of chronic obstructive pulmonary disease. There is no history of smoking and no wheezing on physical examination. His symptoms are consistent with a classic presentation of CHF. Patients with volume overload secondary to CHF often demonstrate dyspnea on exertion, weight gain, orthopnea, and paroxysmal nocturnal dyspnea. He also has physical examination findings of bibasilar crackles, pitting edema, and abdominal distension. The progressive nature of dyspnea is less consistent with pulmonary embolus or an acute coronary syndrome. Although constrictive pericarditis can manifest with jugular venous distension and chest discomfort in the flat position, he does not have pleuritic chest pain, fever, or a friction rub on physical examination.\n",
      "\n",
      "His laboratory studies were the following: hemoglobin, 16.0 g/dL; sodium, 143 mmol/L; creatinine, 1.2 mg/dL; low density lipoprotein, 77 U/L; high density lipoprotein, 54 mg/dL, triglycerides, 88 mg/dL; total cholesterol, 137 mg/dL; thyroid stimulating hormone (TSH), 2.0 mlU/L. An electrocardiogram (ECG) showed atrial fibrillation with rapid ventricular response (RVR) at rate of 148 beats per minute (bpm) without ST-T segment changes suggestive of ischemia. Chest radiography demonstrated new mild cardiomegaly.\n",
      "\n",
      "Right heart catheterization would provide additional hemodynamic information including cardiac output, filling pressures, and central venous pressure; however, it is not routinely indicated in new diagnosis of heart failure. A TTE is a first-line diagnostic test in new cases of heart failure to assess for left ventricular ejection fraction (LVEF) and structural changes, such as wall motion abnormalities or ventricular dilatation or hypertrophy. Cardiac magnetic resonance imaging can be used to evaluate assess wall motion abnormalities, function, and myocardial tissue perfusion, injury, infiltration, fibrosis, and viability, but is not an appropriate initial test. Endomyocardial biopsies are reserved for patients with progressively worsening heart failure despite appropriate medical therapy, for whom amyloidosis, hemochromatosis, or giant-cell myocarditis is suspected. Coronary angiogram can be considered in new diagnoses of heart failure to determine whether there is an ischemic etiology or reversible ischemia, especially in patients with risk factors. However, angiography would not be the first diagnostic test.\n",
      "\n",
      "His TTE showed an LVEF of 25% with severe generalized left ventricular hypokinesis, moderate right ventricular enlargement with moderate reduction in right ventricular systolic function, right ventricular systolic pressure of 56 mm Hg, severe left atrial enlargement, and mitral and tricuspid annulus dilatation with secondary functional severe mitral and tricuspid regurgitation. There was no change in his congenital VSD. At the time of the study, he was notably tachycardic (132 bpm). An ECG 1 year ago showed an LVEF of 60%, no regional wall motion abnormalities, normal right ventricular size and systolic function, small membranous VSD with restrictive left-to-right shunt, mild tricuspid regurgitation, mild mitral regurgitation, trivial aortic stenosis, and trivial aortic regurgitation.\n",
      "\n",
      "His clinical symptomatology of CHF and LVEF less than 50% classifies the diagnosis of heart failure with reduced ejection fraction (HFrEF).\n",
      "\n",
      "Along with a TTE, initial diagnostic evaluation for acute CHF presentations should include a 12-lead ECG to evaluate for acute myocardial infarction, tachyarrhythmia, conduction abnormalities, or left ventricular hypertrophy. A chest radiography should be obtained to evaluate for an acute cardiopulmonary process such as pneumonia, pulmonary edema, or pneumothorax. Other initial laboratory studies should include a complete blood cell count (CBC) with differential, electrolyte levels, creatinine, N-terminal-pro b-type natriuretic peptide, troponin level, urinalysis, lipid panel and TSH. Coronary artery disease causes approximately two thirds of CHF, and an acute coronary syndrome should be suggested as a cause of new-onset heart failure if there are elevated troponin levels, new ECG abnormalities, an acute onset of symptoms, or concurrent signs and symptoms of systemic hypoperfusion.1 Hyponatremia, if present, is a poor prognostic factor.2\n",
      "\n",
      "The patient also had an ECG Holter monitor revealing of atrial fibrillation with heart rates varying from 93–179 bpm (average, 126 bpm) with RVR occurring 99.9% of the time captured. He reported dyspnea while in atrial fibrillation with RVR. He was given furosemide and metoprolol tartrate by his primary care physician with plans to titrate to heart rates slower than 110 bpm.\n",
      "\n",
      "Three beta blockers with beta-1 activity have been shown to decrease mortality in heart failure: carvedilol, bisoprolol, and metoprolol succinate. A switch to atenolol would not be appropriate. There is some debate as to whether carvedilol is superior to metoprolol in mortality reduction, as shown by the COMET trial in 2003.3 In this study, carvedilol had better reduction in mortality rate compared with metoprolol tartrate. Carvedilol has alpha blockade properties that is speculated to be beneficial by facilitating vasodilation, glucose uptake, and insulin sensitivity. Of note, because the COMET trial used the tartrate formulation instead of the extended-release succinate form, a definite superiority between metoprolol succinate and carvedilol cannot be determined. Beta blocker dose response relationship to reduction in mortality has been shown; patients should be uptitrated on beta blockers as tolerated in HFrEF and until rate control is achieved in atrial fibrillation. Furosemide is a more appropriate diuretic than hydrochlorothiazide. Dosing should be based on volume status; however, there is no dose-dependent relationship to mortality outcomes. ICD placement consideration is indicated for primary prophylaxis against sudden cardiac death in patients with New York Heart Association Class II or III HFrEF with LVEF less than 35% after 3 months of optimal medical management. However, patients should be on optimal medical treatment and treated for reversible underlying etiologies before ICD implantation consideration. Similarly, mitral valve replacement is not indicated at this time, as his severe mitral regurgitation is functional and could improve with treatment of reversible causes. The 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society recommends long-term anticoagulation based on thromboembolic risk as determined by the CHA2DS2-VASC Score. This patient began taking long-term apixaban considering his moderate risk stratification (CHA2DS2-VASC score of 1 for heart failure, or 0.6% stroke per year risk), low LVEF with ventricular dilatation, and low bleeding risk. He transitioned to carvedilol for beta blockade, started taking lisinopril, and continued with furosemide as directed by his cardiologist.\n",
      "\n",
      "His HFrEF was thought to be most likely due to tachycardia-induced cardiomyopathy. Initial clues were new reduced LVEF with generalized hypokinesis in the setting of a new diagnosis of atrial fibrillation with predominant RVR on ECG Holter monitoring.\n",
      "\n",
      "On a return visit to his primary care physician, the patient had persistently elevated heart rates to the 130-bpm range despite being uptitrated on carvedilol therapy. His in-clinic blood pressure was 104/81 mm Hg.\n",
      "\n",
      "Tachycardia-induced cardiomyopathy results from prolonged elevated heart rate, which is often reversible upon control of the arrhythmia or heart rate. The goal of initial therapy is to achieve rate control. Increasing beta blockade would be an option for achieving rate control in this patient. However, rate control may be difficult to achieve with beta blockade in patients with rapid ventricular rates and new reduction of ejection fraction (EF)das in this case. Therefore, early electrical cardioversion is warranted to reduce the risk of further progression of HFrEF. Pacemaker placement is not indicated. ICD referral may be warranted at a later time, if left ventricular systolic function does not recover after appropriate medical therapy. Aspirin and clopidogrel are not indicated in heart failure or atrial fibrillation.\n",
      "\n",
      "Because of this patient’s markedly depressed EF, a TEE-guided direct cardioversion was pursued urgently; it was successful after the third synchronous shock of 100, 120, and 150 J. The TEE also showed severe left atrial enlargement, along with previously seen severe mitral regurgitation and severe tricuspid regurgitation. An ECG after cardioversion showed sinus rhythm with a heart rate of 94 bpm with premature atrial complexes.\n",
      "\n",
      "Although direct electric cardioversion is an effective way to revert to sinus rhythm, there is a high rate of atrial fibrillation recurrence, with as few as 23% of patients remaining in sinus rhythm after 1 year. Risk factors for reverting back to arrhythmia included duration of arrhythmia, atrial fibrillation (vs atrial flutter), and age. The patient was started on amiodarone after his cardioversion because of his severe left atrial enlargement and concern for early relapse.\n",
      "\n",
      "Amiodarone can cause adverse effects of long-term use, including pulmonary toxicity, thyroid dysfunction, hepatotoxicity. The risks and benefits of continuing the drug should be discussed with the patient. Baseline tests include chest radiography, pulmonary function tests, thyroid function tests, and transaminases. Hematologic, renal, and cardiac toxicities are uncommon; thus, CBC/peripheral smear/lactic acid dehydrogenase, sodium/potassium/creatinine, ECG Holter and ambulatory blood pressure monitoring, and cardiac catheterization are not routine studies before starting amiodarone.\n",
      "\n",
      "Repeated TTE 2 months later showed a significantly improved EF of 52%, with mildemoderate left ventricular enlargement, mild generalized hypokinesis, and borderline right ventricular enlargement with borderline decreased systolic function and estimated right ventricular systolic pressure of 32 mm Hg. The degree of mitral regurgitation had improved to mildemoderate severity and tricuspid regurgitation was trivial. The patient had a weight loss of 15 kg while taking furosemide and overall symptomatic improvement with increased exercise capacity.\n",
      "\n",
      "Four months later, a repeated TTE revealed a decline in EF to 35%−40 %, with substantial beat-to-beat variability, return of atrial fibrillation with RVR, moderate left ventricular hypokinesis, borderline decrease in right ventricular systolic function, and mild to moderate mitral regurgitation and tricuspid regurgitation. His heart rate was 111 bpm. He underwent repeat direct current cardioversion. Follow-up TTE 2 months after repeated direct current cardioversion showed improvement of his EF again to 61% without regional wall motion abnormalities and a mildly enlarged left ventricle. Long-term therapy with amiodarone was discussed with this patient, but not pursued because of potential adverse effects.\n",
      "\n",
      "Given recurrent episodes of atrial fibrillation, and subsequent reduced EF with each of these episodes, the decision was made to pursue a rhythm control strategy, and the patient underwent atrial fibrillation ablative therapy. He remained asymptomatic 6 months later, with no recurrent episodes, and maintained his left ventricular systolic function (EF = 61%).\n",
      "\n",
      "\n",
      "==================================================\n",
      "**Discharge Summary**\n",
      "\n",
      "**Patient Information:**\n",
      "- Name: [Patient Name]\n",
      "- Age: 50 years\n",
      "- Gender: Male\n",
      "- Date of Admission: [Admission Date]\n",
      "- Date of Discharge: [Discharge Date]\n",
      "\n",
      "**Chief Complaint:**\n",
      "Progressively worsening dyspnea on exertion and chest discomfort.\n",
      "\n",
      "**History of Present Illness:**\n",
      "The patient presented with a 2-week history of dyspnea described as \"breathing through a straw,\" accompanied by chest discomfort while lying flat. He reported a weight gain of 5 kg over the past 3 weeks, increased abdominal girth, and episodes of paroxysmal nocturnal dyspnea. His exercise tolerance declined significantly, from being able to ascend 9 flights of stairs to only tolerating a few steps. He denied any fevers, chills, night sweats, palpitations, lightheadedness, or dizziness, and had no recent upper respiratory symptoms.\n",
      "\n",
      "**Past Medical History:**\n",
      "- Congenital ventricular septal defect (VSD)\n",
      "- Obesity (BMI: 35 kg/m²)\n",
      "- Seasonal allergies\n",
      "\n",
      "**Medications:**\n",
      "- Fexofenadine\n",
      "\n",
      "**Social History:**\n",
      "- Non-smoker\n",
      "- Alcohol intake: 2-3 beverages per week\n",
      "\n",
      "**Family History:**\n",
      "- Brother with atrial fibrillation; no family history of heart failure or premature coronary artery disease.\n",
      "\n",
      "**Physical Examination:**\n",
      "- Vital Signs: Tachycardic at 148 bpm, irregularly irregular rhythm\n",
      "- Respiratory: Bibasilar crackles\n",
      "- Cardiovascular: Jugular venous distension, hepatojugular reflux\n",
      "- Abdomen: Distended\n",
      "- Extremities: 1+ symmetric bilateral lower extremity pitting edema\n",
      "\n",
      "**Diagnostic Studies:**\n",
      "- **Laboratory Results:**\n",
      "  - Hemoglobin: 16.0 g/dL\n",
      "  - Sodium: 143 mmol/L\n",
      "  - Creatinine: 1.2 mg/dL\n",
      "  - Lipid Panel: LDL 77 U/L, HDL 54 mg/dL, Triglycerides 88 mg/dL, Total Cholesterol 137 mg/dL\n",
      "  - TSH: 2.0 mlU/L\n",
      "\n",
      "- **Electrocardiogram (ECG):** Atrial fibrillation with rapid ventricular response (RVR) at 148 bpm, no ischemic changes.\n",
      "- **Chest Radiography:** Mild cardiomegaly.\n",
      "- **Transthoracic Echocardiogram (TTE):** LVEF 25%, severe left ventricular hypokinesis, moderate right ventricular enlargement, severe left atrial enlargement, functional severe mitral and tricuspid regurgitation.\n",
      "\n",
      "**Diagnosis:**\n",
      "Heart failure with reduced ejection fraction (HFrEF) likely due to tachycardia-induced cardiomyopathy.\n",
      "\n",
      "**Treatment:**\n",
      "- Initiated on furosemide and metoprolol tartrate for heart failure management.\n",
      "- Transitioned to carvedilol for beta blockade.\n",
      "- Started on lisinopril and long-term apixaban for anticoagulation.\n",
      "- Underwent successful TEE-guided direct cardioversion after unsuccessful attempts with medication.\n",
      "- Amiodarone was initiated post-cardioversion due to severe left atrial enlargement.\n",
      "\n",
      "**Follow-Up:**\n",
      "- Repeated TTE showed improvement in EF to 52% after 2 months, but subsequent decline to 35-40% with recurrent atrial fibrillation episodes.\n",
      "- Underwent repeat direct current cardioversion, followed by a rhythm control strategy with atrial fibrillation ablative therapy.\n",
      "- At 6-month follow-up, the patient remained asymptomatic with maintained EF of 61%.\n",
      "\n",
      "**Plan:**\n",
      "- Continue monitoring cardiac function and adjust medications as necessary.\n",
      "- Discuss potential long-term effects of amiodarone and consider alternatives if needed.\n",
      "- Schedule regular follow-up appointments to monitor heart failure status and rhythm control.\n",
      "\n",
      "**Discharge Instructions:**\n",
      "- Adhere to prescribed medication regimen.\n",
      "- Monitor weight and report any significant changes.\n",
      "- Maintain follow-up appointments with cardiology and primary care.\n",
      "- Educate on signs of worsening heart failure and when to seek medical attention.\n",
      "\n",
      "**Physician's Signature:**\n",
      "[Physician Name, Title]  \n",
      "[Date]\n",
      "==================================================\n",
      "==================================================\n",
      "\n",
      "\n",
      "\n",
      "{'filenameid': '35456383', 'n_words_cc': 1545, 'n_words_ds': 341, 'gen_orig_ratio': 0.22071197411003235}\n",
      "==================================================\n",
      "|       | mention_class   | term                                   | span_orig                                               | span_gen                         |\n",
      "|------:|:----------------|:---------------------------------------|:--------------------------------------------------------|:---------------------------------|\n",
      "| 38266 | CHEMICAL        | Amino Acids                            | aminoacids                                              | None                             |\n",
      "| 38267 | CHEMICAL        | Amino Acids                            | aminoacids                                              | None                             |\n",
      "| 38268 | DISEASE         | Amyloidosis                            | Amyloidosis                                             | None                             |\n",
      "| 38269 | DISEASE         | Ascites                                | ascites                                                 | ascites                          |\n",
      "| 38270 | DISEASE         | Atrial Premature Complexes             | premature supraventricular beats                        | premature supraventricular beats |\n",
      "| 38271 | DISEASE         | Atrioventricular Block                 | AV block                                                | AV block                         |\n",
      "| 38272 | DISEASE         | Atrioventricular Block                 | AV block                                                | AV block                         |\n",
      "| 38273 | DISEASE         | Atrioventricular Block                 | AV block                                                | AV block                         |\n",
      "| 38274 | DISEASE         | Atrioventricular Block                 | AV block                                                | AV block                         |\n",
      "| 38275 | DISEASE         | Bifascicular block                     | bifascicular block                                      | Bifascicular block               |\n",
      "| 38276 | CHEMICAL        | Bilirubin                              | bilirubin                                               | None                             |\n",
      "| 38277 | CHEMICAL        | Bilirubin                              | bilirubin                                               | None                             |\n",
      "| 38278 | DISEASE         | Bradycardia                            | None                                                    | bradycardia                      |\n",
      "| 38279 | DISEASE         | Bundle-Branch Block                    | None                                                    | bundle branch block              |\n",
      "| 38280 | DISEASE         | Cardiac sarcoidosis                    | Cardiac sarcoidosis                                     | None                             |\n",
      "| 38281 | DISEASE         | Cardiomyopathies                       | cardiomyopathy                                          | cardiomyopathy                   |\n",
      "| 38282 | DISEASE         | Cerebrovascular accident               | stroke                                                  | stroke                           |\n",
      "| 38283 | DISEASE         | Cessation of life                      | death                                                   | death                            |\n",
      "| 38284 | DISEASE         | Congestive heart failure               | CHF                                                     | congestive heart failure         |\n",
      "| 38285 | DISEASE         | Congestive heart failure               | CHF                                                     | CHF                              |\n",
      "| 38286 | DISEASE         | Congestive heart failure               | CHF                                                     | CHF                              |\n",
      "| 38287 | DISEASE         | Congestive heart failure               | CHF                                                     | CHF                              |\n",
      "| 38288 | DISEASE         | Congestive heart failure               | CHF                                                     | congestive heart failure         |\n",
      "| 38289 | DISEASE         | Congestive heart failure               | CHF                                                     | CHF                              |\n",
      "| 38290 | DISEASE         | Congestive heart failure               | CHF                                                     | CHF                              |\n",
      "| 38291 | DISEASE         | Congestive heart failure               | CHF                                                     | CHF                              |\n",
      "| 38292 | DISEASE         | Congestive heart failure               | CHF                                                     | congestive heart failure         |\n",
      "| 38293 | DISEASE         | Congestive heart failure               | CHF                                                     | CHF                              |\n",
      "| 38294 | DISEASE         | Congestive heart failure               | CHF                                                     | CHF                              |\n",
      "| 38295 | DISEASE         | Congestive heart failure               | CHF                                                     | CHF                              |\n",
      "| 38296 | DISEASE         | Congestive heart failure               | CHF                                                     | congestive heart failure         |\n",
      "| 38297 | DISEASE         | Congestive heart failure               | CHF                                                     | CHF                              |\n",
      "| 38298 | DISEASE         | Congestive heart failure               | CHF                                                     | CHF                              |\n",
      "| 38299 | DISEASE         | Congestive heart failure               | CHF                                                     | CHF                              |\n",
      "| 38300 | DISEASE         | Depressive disorder                    | depressive disorder                                     | depressive disorder              |\n",
      "| 38301 | CHEMICAL        | Desmosine                              | DES                                                     | DES                              |\n",
      "| 38302 | CHEMICAL        | Desmosine                              | DES                                                     | DES                              |\n",
      "| 38303 | DISEASE         | Diastolic dysfunction                  | None                                                    | diastolic dysfunction            |\n",
      "| 38304 | DISEASE         | Eosinophilia                           | eosinophilia                                            | None                             |\n",
      "| 38305 | DISEASE         | Fatty degeneration                     | steatosis                                               | None                             |\n",
      "| 38306 | DISEASE         | Heart failure                          | heart failure                                           | None                             |\n",
      "| 38307 | DISEASE         | Hemochromatosis                        | hemochromatosis                                         | hemochromatosis                  |\n",
      "| 38308 | DISEASE         | Hemochromatosis                        | hemochromatosis                                         | Heterozygous hemochromatosis     |\n",
      "| 38309 | DISEASE         | Hemochromatosis                        | hemochromatosis                                         | hemochromatosis                  |\n",
      "| 38310 | DISEASE         | Hemochromatosis                        | hemochromatosis                                         | hemochromatosis                  |\n",
      "| 38311 | DISEASE         | Hemochromatosis                        | hemochromatosis                                         | Heterozygous hemochromatosis     |\n",
      "| 38312 | DISEASE         | Hemochromatosis                        | hemochromatosis                                         | hemochromatosis                  |\n",
      "| 38313 | DISEASE         | Hemochromatosis                        | hemochromatosis                                         | hemochromatosis                  |\n",
      "| 38314 | DISEASE         | Hemochromatosis                        | hemochromatosis                                         | Heterozygous hemochromatosis     |\n",
      "| 38315 | DISEASE         | Hemochromatosis                        | hemochromatosis                                         | hemochromatosis                  |\n",
      "| 38316 | DISEASE         | Hemochromatosis                        | hemochromatosis                                         | hemochromatosis                  |\n",
      "| 38317 | DISEASE         | Hemochromatosis                        | hemochromatosis                                         | Heterozygous hemochromatosis     |\n",
      "| 38318 | DISEASE         | Hemochromatosis                        | hemochromatosis                                         | hemochromatosis                  |\n",
      "| 38319 | DISEASE         | Hemochromatosis                        | hemochromatosis                                         | hemochromatosis                  |\n",
      "| 38320 | DISEASE         | Hemochromatosis                        | hemochromatosis                                         | Heterozygous hemochromatosis     |\n",
      "| 38321 | DISEASE         | Hemochromatosis                        | hemochromatosis                                         | hemochromatosis                  |\n",
      "| 38322 | DISEASE         | Hemochromatosis                        | hemochromatosis                                         | hemochromatosis                  |\n",
      "| 38323 | DISEASE         | Hemochromatosis                        | hemochromatosis                                         | Heterozygous hemochromatosis     |\n",
      "| 38324 | DISEASE         | Hemochromatosis                        | hemochromatosis                                         | hemochromatosis                  |\n",
      "| 38325 | DISEASE         | Hemochromatosis                        | hemosiderosis                                           | hemochromatosis                  |\n",
      "| 38326 | DISEASE         | Hemochromatosis                        | hemosiderosis                                           | Heterozygous hemochromatosis     |\n",
      "| 38327 | DISEASE         | Hemochromatosis                        | hemosiderosis                                           | hemochromatosis                  |\n",
      "| 38328 | DISEASE         | Hemosiderin                            | hemosiderin                                             | hemosiderin                      |\n",
      "| 38329 | DISEASE         | Hepatomegaly                           | enlargement of the liver                                | hepatomegaly                     |\n",
      "| 38330 | DISEASE         | Hepatomegaly                           | enlargement of the liver                                | hepatomegaly                     |\n",
      "| 38331 | DISEASE         | Hepatomegaly                           | hepatomegaly                                            | hepatomegaly                     |\n",
      "| 38332 | DISEASE         | Hepatomegaly                           | hepatomegaly                                            | hepatomegaly                     |\n",
      "| 38333 | DISEASE         | Hepatomegaly                           | liver enlargement                                       | hepatomegaly                     |\n",
      "| 38334 | DISEASE         | Hepatomegaly                           | liver enlargement                                       | hepatomegaly                     |\n",
      "| 38335 | DISEASE         | Hepatomegaly                           | hepatomegaly                                            | hepatomegaly                     |\n",
      "| 38336 | DISEASE         | Hepatomegaly                           | hepatomegaly                                            | hepatomegaly                     |\n",
      "| 38337 | DISEASE         | Hereditary hemochromatosis             | Hereditary hemochromatosis                              | None                             |\n",
      "| 38338 | DISEASE         | Hydrothorax                            | hydrothorax                                             | hydrothorax                      |\n",
      "| 38339 | DISEASE         | Hyperpigmentation                      | hyperpigmentated                                        | None                             |\n",
      "| 38340 | DISEASE         | Hyperpigmentation                      | hyperpigmentation                                       | None                             |\n",
      "| 38341 | DISEASE         | Hypertrophy                            | hypertrophy                                             | None                             |\n",
      "| 38342 | DISEASE         | Idioventricular rhythm                 | ventricular rhythm abnormalities                        | ventricular rhythm abnormalities |\n",
      "| 38343 | CHEMICAL        | Latex Fixation Tests                   | LA                                                      | None                             |\n",
      "| 38344 | CHEMICAL        | Latex Fixation Tests                   | LA                                                      | None                             |\n",
      "| 38345 | DISEASE         | Lipodystrophy                          | fatty dystrophy                                         | None                             |\n",
      "| 38346 | DISEASE         | Loeffler's Endocarditis                | Loeffler endocarditis                                   | None                             |\n",
      "| 38347 | DISEASE         | Mediastinal lymphadenopathy            | mediastinum lymphadenopathy                             | None                             |\n",
      "| 38348 | DISEASE         | Pericardial effusion - noninflammatory | hydropericardium                                        | None                             |\n",
      "| 38349 | DISEASE         | Peripheral edema                       | peripheral edema                                        | None                             |\n",
      "| 38350 | DISEASE         | Presyncope                             | presyncope                                              | None                             |\n",
      "| 38351 | DISEASE         | Pulmonary congestion                   | pulmonary congestion                                    | None                             |\n",
      "| 38352 | DISEASE         | Right bundle branch block              | right bundle brunch block                               | None                             |\n",
      "| 38353 | DISEASE         | Rough endoplasmic reticulum            | hyperplasia of the granular endoplasmic reticulum       | None                             |\n",
      "| 38354 | DISEASE         | Sarcoidosis                            | sarcoidosis                                             | None                             |\n",
      "| 38355 | DISEASE         | Sclerosis                              | vein sclerosis                                          | None                             |\n",
      "| 38356 | CHEMICAL        | Smoke                                  | smoke                                                   | smoke                            |\n",
      "| 38357 | DISEASE         | Thrombosis                             | thrombosis                                              | None                             |\n",
      "| 38358 | DISEASE         | Vascular Diseases                      | cholangiopathy                                          | None                             |\n",
      "| 38359 | DISEASE         | Ventricular hypertrophy                | None                                                    | ventricular hypertrophy          |\n",
      "| 38360 | CHEMICAL        | bisoprolol                             | bisoprolol                                              | bisoprolol                       |\n",
      "| 38361 | CHEMICAL        | creatine                               | creatine                                                | None                             |\n",
      "| 38362 | CHEMICAL        | ethanol                                | alcohol                                                 | alcohol                          |\n",
      "| 38363 | CHEMICAL        | gadolinium                             | gadolinium                                              | gadolinium                       |\n",
      "| 38364 | CHEMICAL        | iron                                   | iron                                                    | iron                             |\n",
      "| 38365 | CHEMICAL        | iron                                   | iron                                                    | iron                             |\n",
      "| 38366 | CHEMICAL        | iron                                   | iron                                                    | iron                             |\n",
      "| 38367 | CHEMICAL        | iron                                   | iron                                                    | iron                             |\n",
      "| 38368 | CHEMICAL        | iron                                   | iron                                                    | iron                             |\n",
      "| 38369 | CHEMICAL        | iron                                   | iron                                                    | iron                             |\n",
      "| 38370 | CHEMICAL        | iron                                   | iron                                                    | iron                             |\n",
      "| 38371 | CHEMICAL        | iron                                   | iron                                                    | iron                             |\n",
      "| 38372 | CHEMICAL        | iron                                   | iron                                                    | iron                             |\n",
      "| 38373 | CHEMICAL        | iron                                   | iron                                                    | iron                             |\n",
      "| 38374 | CHEMICAL        | iron                                   | iron                                                    | iron                             |\n",
      "| 38375 | CHEMICAL        | iron                                   | iron                                                    | iron                             |\n",
      "| 38376 | CHEMICAL        | milligram/day                          | mg/day                                                  | None                             |\n",
      "| 38377 | CHEMICAL        | paroxetine                             | paroxetine                                              | paroxetine                       |\n",
      "| 38378 | CHEMICAL        | spironolactone                         | spironolactone                                          | spironolactone                   |\n",
      "| 38379 | CHEMICAL        | torsemide                              | None                                                    | torasemide                       |\n",
      "| 38380 | CHEMICAL        | None                                   | Arg454Trp                                               | lappaconitine hydrobromide       |\n",
      "| 38381 | CHEMICAL        | None                                   | Lappaconitine hydrobromide                              | lappaconitine hydrobromide       |\n",
      "| 38382 | DISEASE         | None                                   | complaints of episodes of greyout in the eyes           | None                             |\n",
      "| 38383 | DISEASE         | None                                   | PSBs                                                    | None                             |\n",
      "| 38384 | DISEASE         | None                                   | hydropic                                                | None                             |\n",
      "| 38385 | DISEASE         | None                                   | dystrophy of hepatocytes of zones 2 and 3 of the acinus | None                             |\n",
      "| 38386 | DISEASE         | None                                   | bilirubinostasis                                        | None                             |\n",
      "| 38387 | DISEASE         | None                                   | deterioration or heart failure                          | None                             |\n",
      "==================================================\n",
      "A 28 year-old male was referred to the clinic in February 2019 with complaints of episodes of greyout in the eyes, accompanied by a decrease of the heart rate to 40 BPM, and reduced tolerance for physical exertion. The patient underwent clinical examination including collection of venous blood samples for DNA-diagnostics, blood tests (full blood count, biochemical panel and international normalized ratio, INR), electrocardiography (ECG), 24-h ECG monitoring, echocardiography (ECHO), chest computed tomography (CT), liver magnetic resonance imaging (MRI), and liver biopsy (hematoxylin and eosin staining, Van Gieson staining, Perles staining).\n",
      "\n",
      "Whole exome sequencing (WES) for the proband’s DNA was performed using a SureSelect All Exons V7 library preparation kit (Agilent Technologies, Santa Clara, California, USA) followed by next-generation sequencing on an Illumina platform (NextSeq 550, Illumina, San Diego, CA, USA). Reads were aligned to the human genome build GRCh37/UCSC hg19 and the variant calling with an automatic module EMSEMPLE_VEP with the following analyze of the sequence variants using a custom-developed bioinformatics pipeline. Confirmation of genetic findings in proband was performed by capillary Sanger resequencing on an ABI 3730XL DNA Analyzer according to the manufacturer’s instructions (Thermo Fisher Scientific, Waltham, MA, USA). The direct capillary Sanger resequencing with alternative oligoprimers was performed for the coding exons and flanking 100 bp of intronic areas of the HFE gene to avoid an occasional loss of the second rare variant on NGS testing.\n",
      "\n",
      "Pathogenicity assessment of all variants confirmed by Sanger re-sequencing was performed according to ACMG (2015) criteria (on behalf of the ACMG Laboratory Quality Assurance Committee) [5].\n",
      "\n",
      "The study was performed in concordance with the Declaration of Helsinki in its current form and approved by the Sechenov University Local Ethics Committee (protocol № 11–15 from 16 February 2019), Moscow, Russia. Voluntary informed consent was obtained from the patient.\n",
      "\n",
      "Significant events in the patient’s family history were found in the mother’s male lineage: a fatal stroke at 50 years of age in an uncle; the death of the grandfather at 53 years of age. No other family members were affected by RCM. The patient did not smoke, drink alcohol, or follow any special diet. He has worked out regularly at the gym (moderate exercise). From 23 years of age (2014), complete right bundle brunch block (RBBB) on the ECG and frequent premature supraventricular beats (PSBs) appeared. Since 2017, there have been episodes of transient II degree, type 2 AV block, accompanied by presyncope. From this period, the patient started taking paroxetine 20 mg/day due to depressive disorder. In November 2018 there was an episode of CHF decompensation with ascites, hydrothorax, hydropericardium, which required hospitalization in the emergency department. A bit later, a transient III degree AV block was registered. The ECHO revealed moderate hypertrophy of the left ventricle (LV, septum, and posterior wall 1.4 cm), left atrium (LA) dilatation up to 112 mL and diastolic dysfunction with a restrictive filling pattern. Ejection fraction (EF) of LV was preserved (66%). To rule out the glycogen storage disease, the activity of lysosomal enzymes was assessed: all indexes were normal. As well, a cardiac MRI was performed: LV EF 53%, interventricular septum 1.2 cm, LA 200 mL, diffuse accumulation of contrast with thickened endocardium (3–4 mm) of both left and right ventricles, site of intramyocardial late gadolinium enhancement (LGE) in LV were observed.\n",
      "\n",
      "On examination in our clinic, the patient had a regular pulse (110 BPM), BP was 140/80 mm Hg. A single hyperpigmentated site (3 cm) was on the forearm skin. Physical examination revealed enlargement of the liver (+2 cm from the costal margin). No signs of pulmonary congestion or peripheral edema were found.\n",
      "\n",
      "Blood tests including full blood count, biochemical panel (including creatine kinase) and INR were normal except for an increase in serum iron level (40.9 μmol/L, normal range 9–31), transferrin saturation percentage (85.2%) and slightly elevated liver function tests (AST 39 U/L, ALT 63 U/L). The ECG showed bifascicular block. The ECHO confirmed the presence of restrictive cardiomyopathy with hyperechogenic and layered LV myocardium, which could be the sign of storage disease. Chest CT was normal, without any signs of mediastinum lymphadenopathy. Liver MRI confirmed hepatomegaly.\n",
      "\n",
      "Early onset of symptoms, their gradual and steady progression, combined with features of clinical course made the diagnosis of primary RCM the most probable. The whole exome sequencing was performed. A mutation in the sarcomeric gene desmin (DES) in the heterozygous state was found. Missense variant chr2:g.220290456C>T (ENST00000373960.3:c.1360C>T, ENSP00000363071.3:p.Arg454Trp) in the DES gene affects the tail region of desmin protein in a direct neighborhood of CRYAB-interacting domain (aminoacids 438–453) [6]. This variant was shown to disturb severely filament-formation competence and filament-filament interactions, and to increase interaction with CRYAB protein (PS3 strong criterion) [7], not found in gnomAD genomes (PM2_Supporting); its pathogenic computational verdict was based on 12 pathogenic predictions vs. no benign predictions (PP3_Supporting criterion), and ClinVar classifies this variant as Pathogenic with two stars (multiple consistent, 10 submissions) (PP5_Supporting). Summarizing this evidence, we classify this variant as Likely Pathogenic (Class IV). DNA samples from parents were unavailable and the origin of the mutation (de novo vs. inherited) was not tested.\n",
      "\n",
      "At the same time, the prominent RCM phenotype required ruling out its secondary forms. Amyloidosis was highly unlikely, due to the age of the patient and early onset of symptoms. Cardiac sarcoidosis was more likely among the secondary forms (a typical pattern of LGE in MRI, RBBB combined with severe AV block), but chest CT demonstrated no signs of sarcoidosis. There is an accumulation of contrast with thickened endocardium by MRI but the absence of eosinophilia in the blood and intraventricular thrombosis made Loeffler endocarditis unlikely. Blood tests showed a marked increase in serum iron level and transferrin saturation and a moderate increase of liver function tests, together with liver enlargement and site of skin hyperpigmentation it made hemochromatosis plausible. In the HFE1 gene, a recessive mutation, typically associated with hemochromatosis was found, but in heterozygous state: missense variant chr6:g.26093141G>A (ENST00000357618.5:c.845G>A, ENSP00000417404.1:p. Cys282Tyr). This variant is a well-known common mutation (prevalence is 0.03825 in gnomAD genomes) [8]. It affects the Alfa-3 region of Hereditary hemochromatosis protein (aminoacids 206–297) and posttranslational modification of the protein disturbing disulfide bond between 225Cys and Cys282 aminoacids [9] (Criterium PS3_Strong and PM1_Strong); pathogenic computational verdict based on 7sevenpathogenic predictions vs. 3 benign predictions (PP3_Supporting); it was classified as pathogenic in more than 10 articles and many ClinVar submitters (PP5_Strong). Taking all the evidence, we classify this variant as Pathogenic (Class V). As it is in a heterozygous state, it does not fully confirm but also does not deny the presence of hemochromatosis.\n",
      "\n",
      "The patient had absolute indications for implantation of a pacemaker. However, because of unpredictable progression of CHF and as a consequence of highly possible ventricular rhythm abnormalities, a cardioverter defibrillator (ICD) was implanted. CHF treatment was initiated (bisoprolol up to 5 mg/day with subsequent withdrawal, torasemid 5 mg/day and spironolactone 25 mg/day). A diet with a strict restriction of iron was recommended.\n",
      "\n",
      "The patient was admitted again in December 2019 to correct the treatment. He was doing well except for episodes of irregular heartbeat. The physical examination revealed hepatomegaly (+3 from the costal margin), the consistency of the liver was firm, palpation was painless. The ECHO did not show any significant dynamics. Holter monitoring revealed 7700 PSBs. Lappaconitine hydrobromide (class IC) 75 mg/day was administered. The number of PSBs reduced to 1500/day. Blood tests showed an increase in hemoglobin to 17.5 g/dL, erythrocytes 5.8 × 106/L, hematocrit 51%, a moderate increase in total and direct bilirubin, normalization of serum iron level and transferrin saturation percentage. The last, however, did not allow us to rule out hemochromatosis. In addition, a significantly enlarged and firm liver in the absence of other signs of right-sided heart failure could be considered to be a sign of hemochromatosis.\n",
      "\n",
      "A liver biopsy was obtained to verify the diagnosis of hemochromatosis, assess its possible contribution to the RCM progression and determine indications for treatment. The biopsy revealed three groups of morphological changes: (1) The nuclei of several hepatocytes were large with optically empty vacuoles. Fragments of the cytoplasm of some hepatocytes resembled ground glass (hyperplasia of the granular endoplasmic reticulum). Moderate focal hydropic and balloon dystrophy of hepatocytes of zones 2 and 3 of the acinus and moderate diffuse fine fatty dystrophy of hepatocytes (up to 40%) without zonal predominance (++) were observed. In the cytoplasm of hepatocytes of acinus zones 2 and 3, there were moderate amounts of small and large greenish-brown Pearl’s-negative granules: bilirubin. Diffuse steatosis (++), bilirubinostasis and cholangiopathy, and signs of hepatocytes hyperfunction are consistent with drug exposure to the organ; (2) dilation of centrilobular sinusoids, central vein sclerosis and capillarization of adjacent sinusoids may be the consequence of prolonged CHF; (3) mild hemosiderin accumulation is a sign of hemosiderosis (+).\n",
      "\n",
      "Two years later, the patient remains relatively stable. He is now on the waiting list for heart transplantation in the case of deterioration or heart failure.\n",
      "==================================================\n",
      "**Discharge Summary**\n",
      "\n",
      "**Patient Information:**\n",
      "- **Name:** [Patient Name]\n",
      "- **Age:** 28 years\n",
      "- **Gender:** Male\n",
      "- **Date of Admission:** February 2019\n",
      "- **Date of Discharge:** [Discharge Date]\n",
      "\n",
      "**Chief Complaint:**\n",
      "The patient presented with episodes of greyout in vision, bradycardia (heart rate of 40 BPM), and reduced tolerance for physical exertion.\n",
      "\n",
      "**Clinical History:**\n",
      "The patient has a significant family history of cardiovascular events, including a fatal stroke in an uncle at age 50 and the grandfather's death at age 53. He does not smoke, consume alcohol, or follow a special diet but engages in regular moderate exercise.\n",
      "\n",
      "**Medical History:**\n",
      "- Notable for complete right bundle branch block (RBBB) and frequent premature supraventricular beats (PSBs) since age 23.\n",
      "- Episodes of transient second-degree AV block since 2017, leading to the initiation of paroxetine for depressive disorder.\n",
      "- Hospitalization in November 2018 for congestive heart failure (CHF) decompensation with ascites and hydrothorax.\n",
      "\n",
      "**Investigations:**\n",
      "- **ECG:** Bifascicular block, RBBB, and episodes of AV block.\n",
      "- **Echocardiography:** Moderate left ventricular hypertrophy, left atrial dilation, and diastolic dysfunction.\n",
      "- **Cardiac MRI:** Left ventricular ejection fraction (EF) of 53%, thickened endocardium, and late gadolinium enhancement.\n",
      "- **Liver Imaging:** MRI confirmed hepatomegaly.\n",
      "- **Blood Tests:** Elevated serum iron and transferrin saturation; slightly elevated liver function tests.\n",
      "\n",
      "**Genetic Testing:**\n",
      "Whole exome sequencing identified a heterozygous mutation in the desmin (DES) gene, classified as likely pathogenic. A recessive mutation in the HFE1 gene associated with hemochromatosis was also found in a heterozygous state.\n",
      "\n",
      "**Diagnosis:**\n",
      "- Primary restrictive cardiomyopathy (RCM).\n",
      "- Heterozygous hemochromatosis.\n",
      "\n",
      "**Treatment:**\n",
      "- Implantation of a cardioverter defibrillator (ICD) due to the risk of ventricular rhythm abnormalities.\n",
      "- CHF management with bisoprolol, torasemide, and spironolactone.\n",
      "- Dietary recommendations to restrict iron intake.\n",
      "\n",
      "**Follow-Up:**\n",
      "The patient was readmitted in December 2019 for treatment adjustment. He exhibited episodes of irregular heartbeat and hepatomegaly. Holter monitoring revealed a reduction in PSBs following the introduction of lappaconitine hydrobromide. Blood tests indicated an increase in hemoglobin and normalization of serum iron levels, although hemochromatosis could not be ruled out.\n",
      "\n",
      "**Liver Biopsy Findings:**\n",
      "The biopsy revealed morphological changes consistent with drug exposure, signs of CHF, and mild hemosiderin accumulation.\n",
      "\n",
      "**Current Status:**\n",
      "As of [Current Date], the patient remains relatively stable and is on the waiting list for heart transplantation should his condition deteriorate.\n",
      "\n",
      "**Recommendations:**\n",
      "- Continue monitoring cardiac function and liver status.\n",
      "- Adhere to dietary restrictions and medication regimen.\n",
      "- Regular follow-up appointments to assess heart function and manage symptoms.\n",
      "\n",
      "**Physician's Signature:**\n",
      "[Physician Name]  \n",
      "[Title]  \n",
      "[Date]\n",
      "==================================================\n",
      "==================================================\n",
      "\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "import numpy as np\n",
    "for idx, row in outliers_low.iterrows():\n",
    "    print(row[[\"filenameid\", \"n_words_cc\", \"n_words_ds\", \"gen_orig_ratio\", \"n_words_cc\", \"n_words_ds\"]].to_dict())\n",
    "    \n",
    "    print(\"=\" * 50)\n",
    "    \n",
    "    print(df_auto_merge[df_auto_merge[\"filenameid\"] == row[\"filenameid\"]].fillna(value=\"None\").drop(columns=[\"filenameid\"]).to_markdown())\n",
    "    # print(np.array(extract_text_without_sections(row[\"clinical_case\"]).split(\".\")))\n",
    "    print(\"=\" * 50)\n",
    "\n",
    "    print(row[\"clinical_case\"])\n",
    "    \n",
    "    print(\"=\" * 50)\n",
    "    \n",
    "    print(row[\"discharge_summary\"])\n",
    "\n",
    "    print(\"=\" * 50)\n",
    "    print(\"=\" * 50)\n",
    "\n",
    "    print(\"\\n\\n\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 89,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'filenameid': '30503742_1', 'n_words_cc': 124, 'n_words_ds': 217, 'gen_orig_ratio': 1.75}\n",
      "==================================================\n",
      "|      | mention_class   | term                     | span_orig                  | span_gen                   |\n",
      "|-----:|:----------------|:-------------------------|:---------------------------|:---------------------------|\n",
      "| 7054 | DISEASE         | Cardiomyopathies         | None                       | cardiomyopathy             |\n",
      "| 7055 | DISEASE         | Heart failure            | heart failure              | Heart failure              |\n",
      "| 7056 | DISEASE         | Heart failure            | heart failure              | heart failure symptoms     |\n",
      "| 7057 | DISEASE         | Heart failure            | heart failure              | heart failure              |\n",
      "| 7058 | DISEASE         | Left-Sided Heart Failure | bi-ventricular failure     | bi-ventricular failure     |\n",
      "| 7059 | DISEASE         | Left-Sided Heart Failure | bi-ventricular failure     | bi-ventricular failure     |\n",
      "| 7060 | DISEASE         | Shock                    | None                       | shock                      |\n",
      "| 7061 | DISEASE         | Shock, Cardiogenic       | cardiogenic shock          | Cardiogenic shock          |\n",
      "| 7062 | DISEASE         | Thrombus                 | thrombotic                 | thrombotic                 |\n",
      "| 7063 | DISEASE         | Torsades de Pointes      | Torsades de pointes        | Torsades de pointes        |\n",
      "| 7064 | DISEASE         | Torsades de Pointes      | Torsades de pointes        | Torsades de pointes        |\n",
      "| 7065 | CHEMICAL        | None                     | HeartMate II               | HeartMate II               |\n",
      "| 7066 | DISEASE         | None                     | nonischemic cardiomyopathy | Nonischemic cardiomyopathy |\n",
      "| 7067 | DISEASE         | None                     | nonischemic cardiomyopathy | nonischemic cardiomyopathy |\n",
      "==================================================\n",
      "A third patient, a 29-year-old man with history of nonischemic cardiomyopathy on LVAD support for 3.5 years (HeartMate II) presented with several months of progressive heart failure symptoms requiring repeat hospitalization for intravenous diuretics and temporary inotropic support. Several weeks after hospital discharge, he was readmitted with Torsades de pointes requiring cardioversion, severe bi-ventricular failure, and cardiogenic shock requiring inotropic support and intravenous diuretics. He did not have any low-flow alarms preceding these events. CCTA demonstrated significant thrombotic material throughout the outflow graft, with marked narrowing of contrast flow in the more proximal aspect. The patient was taken to the operating room to unroof and relieve this obstruction. He recovered postoperatively with improvement in symptoms and decreased pharmacologic support.\n",
      "\n",
      "\n",
      "==================================================\n",
      "**Discharge Summary**\n",
      "\n",
      "**Patient Information:**\n",
      "- Name: [Patient Name]\n",
      "- Age: 29 years\n",
      "- Gender: Male\n",
      "- Medical Record Number: [MRN]\n",
      "\n",
      "**Admission Date:** [Admission Date]  \n",
      "**Discharge Date:** [Discharge Date]  \n",
      "\n",
      "**Diagnosis:**\n",
      "1. Nonischemic cardiomyopathy\n",
      "2. Heart failure exacerbation\n",
      "3. Torsades de pointes\n",
      "4. Severe bi-ventricular failure\n",
      "5. Cardiogenic shock\n",
      "\n",
      "**History of Present Illness:**\n",
      "The patient is a 29-year-old man with a history of nonischemic cardiomyopathy who has been on left ventricular assist device (LVAD) support (HeartMate II) for 3.5 years. He presented with several months of progressive heart failure symptoms, necessitating repeat hospitalization for intravenous diuretics and temporary inotropic support. \n",
      "\n",
      "**Hospital Course:**\n",
      "Several weeks post-discharge, the patient was readmitted due to Torsades de pointes, which required cardioversion. He exhibited severe bi-ventricular failure and cardiogenic shock, necessitating inotropic support and intravenous diuretics. Notably, there were no low-flow alarms prior to these events. \n",
      "\n",
      "A coronary computed tomography angiography (CCTA) was performed, revealing significant thrombotic material throughout the outflow graft, with marked narrowing of contrast flow in the proximal segment. The patient was subsequently taken to the operating room for surgical intervention to unroof and relieve the obstruction.\n",
      "\n",
      "**Postoperative Course:**\n",
      "The patient recovered well postoperatively, demonstrating improvement in symptoms and a reduction in the need for pharmacologic support.\n",
      "\n",
      "**Discharge Medications:**\n",
      "- [List of medications]\n",
      "\n",
      "**Follow-Up:**\n",
      "The patient is advised to follow up with the cardiology clinic in [time frame] for ongoing management of his cardiomyopathy and LVAD support.\n",
      "\n",
      "**Instructions:**\n",
      "- Monitor for any signs of heart failure exacerbation.\n",
      "- Adhere to medication regimen.\n",
      "- Seek immediate medical attention for any concerning symptoms.\n",
      "\n",
      "**Physician's Signature:**  \n",
      "[Physician Name]  \n",
      "[Title]  \n",
      "[Date]\n",
      "==================================================\n",
      "==================================================\n",
      "\n",
      "\n",
      "\n",
      "{'filenameid': '30503742_2', 'n_words_cc': 131, 'n_words_ds': 215, 'gen_orig_ratio': 1.6412213740458015}\n",
      "==================================================\n",
      "|      | mention_class   | term                              | span_orig                                                           | span_gen                         |\n",
      "|-----:|:----------------|:----------------------------------|:--------------------------------------------------------------------|:---------------------------------|\n",
      "| 7068 | DISEASE         | Heart failure                     | heart failure                                                       | heart failure symptoms           |\n",
      "| 7069 | DISEASE         | Heart failure                     | heart failure                                                       | heart failure                    |\n",
      "| 7070 | DISEASE         | Heart failure                     | heart failure                                                       | heart failure                    |\n",
      "| 7071 | CHEMICAL        | Low sodium diet                   | None                                                                | low-sodium                       |\n",
      "| 7072 | DISEASE         | Obstruction within Medical Device | None                                                                | obstruction of the outflow graft |\n",
      "| 7073 | DISEASE         | None                              | nonischemic cardiomyopathy                                          | Nonischemic cardiomyopathy       |\n",
      "| 7074 | DISEASE         | None                              | obstruction of the outflow graft suggestive of external compression | Nonischemic cardiomyopathy       |\n",
      "==================================================\n",
      "A second patient, a 46-year-old man with nonischemic cardiomyopathy on 4.5 years of support (HeartWare Assist Device; Medtronic, Minneapolis, Minn) presented with progressive heart failure symptoms and accompanied low-flow alarms and increased power irregularities on device interrogation. Transthoracic echocardiogram demonstrated severely dilated left ventricle (left ventricular internal diastolic diameter, 9.2 cm) at speed of 3200 RPM, with preserved aortic valve excursion. CCTA revealed severe narrowing and obstruction of the outflow graft suggestive of external compression. The patient underwent surgical intervention with removal of the anterior portion of the Gore-Tex wrap and evacuation of exudate from around the outflow graft, resulting in immediate resolution of low flow. The patient had reduced diuretic requirements with adequate pump support and improvement in functional status over the following weeks.\n",
      "\n",
      "\n",
      "==================================================\n",
      "**Discharge Summary**\n",
      "\n",
      "**Patient Information:**\n",
      "- **Name:** [Patient Name]\n",
      "- **Age:** 46 years\n",
      "- **Gender:** Male\n",
      "\n",
      "**Admission Date:** [Admission Date]  \n",
      "**Discharge Date:** [Discharge Date]  \n",
      "**Diagnosis:** Nonischemic cardiomyopathy with progressive heart failure symptoms\n",
      "\n",
      "**Clinical Summary:**\n",
      "The patient was admitted with worsening heart failure symptoms, characterized by low-flow alarms and increased power irregularities detected during device interrogation of the HeartWare Assist Device (Medtronic, Minneapolis, Minn), which he has been using for 4.5 years. \n",
      "\n",
      "**Investigations:**\n",
      "- **Transthoracic Echocardiogram:** Showed a severely dilated left ventricle with a left ventricular internal diastolic diameter of 9.2 cm at a pump speed of 3200 RPM. Aortic valve excursion was preserved.\n",
      "- **Cardiac CT Angiography (CCTA):** Indicated severe narrowing and obstruction of the outflow graft, likely due to external compression.\n",
      "\n",
      "**Surgical Intervention:**\n",
      "The patient underwent surgical intervention, which involved the removal of the anterior portion of the Gore-Tex wrap and evacuation of exudate surrounding the outflow graft. This procedure resulted in an immediate resolution of low-flow alarms.\n",
      "\n",
      "**Postoperative Course:**\n",
      "Following the surgery, the patient experienced a reduction in diuretic requirements and maintained adequate pump support. Over the subsequent weeks, there was a notable improvement in his functional status.\n",
      "\n",
      "**Discharge Condition:**\n",
      "The patient is stable and has shown significant improvement. He is advised to follow up with his cardiologist and continue monitoring his heart function.\n",
      "\n",
      "**Follow-Up Instructions:**\n",
      "- Schedule a follow-up appointment with cardiology within 1-2 weeks.\n",
      "- Continue prescribed medications and monitor for any signs of heart failure.\n",
      "- Maintain a low-sodium diet and engage in light physical activity as tolerated.\n",
      "\n",
      "**Physician's Signature:**  \n",
      "[Physician Name]  \n",
      "[Date]\n",
      "==================================================\n",
      "==================================================\n",
      "\n",
      "\n",
      "\n",
      "{'filenameid': '29437819', 'n_words_cc': 89, 'n_words_ds': 146, 'gen_orig_ratio': 1.6404494382022472}\n",
      "==================================================\n",
      "|      | mention_class   | term                                    | span_orig                    | span_gen                     |\n",
      "|-----:|:----------------|:----------------------------------------|:-----------------------------|:-----------------------------|\n",
      "| 2373 | DISEASE         | Cardiomyopathies                        | non-ischaemic cardiomyopathy | Non-ischaemic cardiomyopathy |\n",
      "| 2374 | DISEASE         | Heart failure                           | heart failure                | heart failure                |\n",
      "| 2375 | DISEASE         | Heart failure                           | heart failure                | heart failure                |\n",
      "| 2376 | DISEASE         | Replacement of aortic valve (procedure) | None                         | aortic valve replacement     |\n",
      "| 2377 | DISEASE         | None                                    | HeartMate II LVAD            | HeartMate II LVAD            |\n",
      "==================================================\n",
      "A 67-year-old man with a history of non-ischaemic cardiomyopathy (ejection fraction 15%–20%) and previous mechanical aortic valve replacement presented for HeartMate II left ventricular assist device (LVAD) implantation due to worsening heart failure symptoms (New York Heart Association III–IV). After redo sternotomy, the aortic valve was closed with a prefashioned occluder device. After occluder placement, the aortic cross-clamp was removed and the valve assessed with transoesophageal echocardiography (TOE) to ensure proper closure. Once satisfactory closure was confirmed, a HeartMate II LVAD was inserted.\n",
      "\n",
      "\n",
      "==================================================\n",
      "**Discharge Summary**\n",
      "\n",
      "**Patient Information:**\n",
      "- Name: [Patient Name]\n",
      "- Age: 67 years\n",
      "- Gender: Male\n",
      "\n",
      "**Medical History:**\n",
      "- Non-ischaemic cardiomyopathy (ejection fraction 15%–20%)\n",
      "- Previous mechanical aortic valve replacement\n",
      "\n",
      "**Admission Date:** [Admission Date]  \n",
      "**Discharge Date:** [Discharge Date]  \n",
      "\n",
      "**Reason for Admission:**\n",
      "The patient was admitted for HeartMate II left ventricular assist device (LVAD) implantation due to worsening heart failure symptoms classified as New York Heart Association (NYHA) functional class III–IV.\n",
      "\n",
      "**Procedure Summary:**\n",
      "The patient underwent a redo sternotomy. During the procedure, the aortic valve was closed using a prefashioned occluder device. Following the placement of the occluder, the aortic cross-clamp was removed, and transoesophageal echocardiography (TOE) was performed to assess the closure of the valve. Upon confirmation of satisfactory closure, a HeartMate II LVAD was successfully inserted.\n",
      "\n",
      "**Postoperative Course:**\n",
      "The patient tolerated the procedure well and was monitored for any complications. \n",
      "\n",
      "**Discharge Instructions:**\n",
      "- Follow-up appointments should be scheduled with the cardiology team.\n",
      "- Monitor for any signs of heart failure or complications related to the LVAD.\n",
      "- Adhere to prescribed medications and lifestyle modifications.\n",
      "\n",
      "**Physician's Signature:**  \n",
      "[Physician Name]  \n",
      "[Date]\n",
      "==================================================\n",
      "==================================================\n",
      "\n",
      "\n",
      "\n",
      "{'filenameid': '30971480_1', 'n_words_cc': 147, 'n_words_ds': 240, 'gen_orig_ratio': 1.6326530612244898}\n",
      "==================================================\n",
      "|      | mention_class   | term                  | span_orig                  | span_gen                   |\n",
      "|-----:|:----------------|:----------------------|:---------------------------|:---------------------------|\n",
      "| 9499 | DISEASE         | Dyspnea               | shortness of breath        | shortness of breath        |\n",
      "| 9500 | DISEASE         | Dyspnea               | shortness of breath        | dyspnea                    |\n",
      "| 9501 | DISEASE         | Dyspnea               | dyspnea                    | shortness of breath        |\n",
      "| 9502 | DISEASE         | Dyspnea               | dyspnea                    | dyspnea                    |\n",
      "| 9503 | DISEASE         | Fibrosis              | fibrosis                   | fibrosis                   |\n",
      "| 9504 | DISEASE         | Heart failure         | None                       | Heart failure              |\n",
      "| 9505 | DISEASE         | Heart failure         | None                       | heart failure              |\n",
      "| 9506 | DISEASE         | Heart failure         | None                       | heart failure              |\n",
      "| 9507 | DISEASE         | Heart failure         | None                       | heart failure              |\n",
      "| 9508 | DISEASE         | Hydrops Fetalis       | HF                         | HF                         |\n",
      "| 9509 | DISEASE         | Infarction            | infarction                 | infarction                 |\n",
      "| 9510 | DISEASE         | Ischemia              | ischemia                   | ischemia                   |\n",
      "| 9511 | DISEASE         | Neoplasms             | Tumor                      | None                       |\n",
      "| 9512 | DISEASE         | Scheuermann's Disease | valve disease              | valve disease              |\n",
      "| 9513 | CHEMICAL        | doxorubicin           | doxorubicin                | doxorubicin                |\n",
      "| 9514 | CHEMICAL        | ifosfamide            | ifosfamide                 | ifosfamide                 |\n",
      "| 9515 | DISEASE         | leiomyosarcoma        | leiomyosarcoma             | leiomyosarcoma             |\n",
      "| 9516 | CHEMICAL        | pazopanib             | pazopanib                  | pazopanib                  |\n",
      "| 9517 | CHEMICAL        | trabectedin           | trabectedin                | trabectedin                |\n",
      "| 9518 | DISEASE         | None                  | nonischemic cardiomyopathy | Nonischemic cardiomyopathy |\n",
      "| 9519 | DISEASE         | None                  | nonischemic cardiomyopathy | nonischemic cardiomyopathy |\n",
      "==================================================\n",
      "A 67‐year‐old woman with a recurrent leiomyosarcoma had an echocardiogram (ECHO) showing a LVEF of 60% with normal cardiac function. She began doxorubicin and olaratumab but progressed 6 months later. Tumor progressed on trabectedin and pazopanib was begun; she was admitted 5 days later for shortness of breath and found to have nonischemic cardiomyopathy and HF with a traced LVEF of 12.9%. Pazopanib was stopped and she was treated medically. Five days later, she felt better, and a magnetic resonance imaging (MRI) stress test showed a LVEF of 21% but no valve disease, infarction, fibrosis, or ischemia. Eight days after stopping pazopanib, she had no dyspnea on exertion; 4 days later she began treatment with ifosfamide with no recurrence of cardiac symptoms; five months later, LVEF was 47% by ECHO, and a month later LVEF was 51% with normal systolic function on cardiac MRI.\n",
      "\n",
      "\n",
      "==================================================\n",
      "**Discharge Summary**\n",
      "\n",
      "**Patient Information:**\n",
      "- **Name:** [Patient Name]\n",
      "- **Age:** 67 years\n",
      "- **Gender:** Female\n",
      "\n",
      "**Diagnosis:**\n",
      "- Recurrent leiomyosarcoma\n",
      "- Nonischemic cardiomyopathy\n",
      "- Heart failure (HF)\n",
      "\n",
      "**Clinical Summary:**\n",
      "The patient was initially evaluated with an echocardiogram (ECHO) revealing a left ventricular ejection fraction (LVEF) of 60%, indicating normal cardiac function. She commenced treatment with doxorubicin and olaratumab; however, disease progression was noted after 6 months. Following this, she was treated with trabectedin, but upon progression, pazopanib was initiated.\n",
      "\n",
      "**Hospital Admission:**\n",
      "The patient was admitted 5 days after starting pazopanib due to shortness of breath. During this admission, she was diagnosed with nonischemic cardiomyopathy and heart failure, with a significantly reduced LVEF of 12.9%.\n",
      "\n",
      "**Treatment During Admission:**\n",
      "- Pazopanib was discontinued.\n",
      "- The patient received medical management for heart failure.\n",
      "- After 5 days of treatment, the patient reported improvement in symptoms.\n",
      "- A magnetic resonance imaging (MRI) stress test performed showed an LVEF of 21%, with no evidence of valve disease, infarction, fibrosis, or ischemia.\n",
      "\n",
      "**Follow-Up:**\n",
      "Eight days post-discontinuation of pazopanib, the patient experienced no dyspnea on exertion. Four days later, she began treatment with ifosfamide, which was well-tolerated without recurrence of cardiac symptoms.\n",
      "\n",
      "**Outcome:**\n",
      "Five months post-treatment, a follow-up ECHO demonstrated an LVEF of 47%. One month later, a subsequent cardiac MRI indicated an LVEF of 51% with normal systolic function.\n",
      "\n",
      "**Discharge Condition:**\n",
      "The patient is stable and has shown significant improvement in cardiac function and overall well-being. \n",
      "\n",
      "**Plan:**\n",
      "- Continue monitoring cardiac function.\n",
      "- Follow-up appointments for oncology and cardiology as scheduled.\n",
      "- Education on signs and symptoms of heart failure and when to seek medical attention.\n",
      "\n",
      "**Discharge Date:** [Insert Date]  \n",
      "**Physician:** [Physician Name]  \n",
      "**Signature:** [Signature]\n",
      "==================================================\n",
      "==================================================\n",
      "\n",
      "\n",
      "\n",
      "{'filenameid': '26512038', 'n_words_cc': 80, 'n_words_ds': 130, 'gen_orig_ratio': 1.625}\n",
      "==================================================\n",
      "|     | mention_class   | term                       | span_orig           | span_gen                     |\n",
      "|----:|:----------------|:---------------------------|:--------------------|:-----------------------------|\n",
      "| 607 | DISEASE         | Acute heart failure        | acute heart failure | None                         |\n",
      "| 608 | DISEASE         | Aneurysm                   | None                | aneurysm                     |\n",
      "| 609 | DISEASE         | Dental Occlusion           | PDA occlusion       | PDA occlusion                |\n",
      "| 610 | DISEASE         | Rupture                    | None                | a ruptured sinus             |\n",
      "| 611 | DISEASE         | Sinus of Valsalva aneurysm | Valsalva aneurysm   | Valsalva aneurysm            |\n",
      "| 612 | DISEASE         | None                       | None                | acute heart failure symptoms |\n",
      "==================================================\n",
      "We present a case of a 34-year-old man with acute heart failure symptoms of 1 week duration. Transthoracic echocardiogram revealed a ruptured sinus of Valsalva aneurysm entering into the right ventricle. Angiogram revealed a classical windsock deformity. Successful device closure was achieved using a 10/12 mm LIFETECH CERA PDA occlusion device. Subsequent angiogram and echocardiogram revealed no residual shunt. The patient was on regular follow-up for 6 months and did not have any recurrence of symptoms.\n",
      "\n",
      "\n",
      "==================================================\n",
      "**Discharge Summary**\n",
      "\n",
      "**Patient Information:**\n",
      "- Name: [Patient Name]\n",
      "- Age: 34 years\n",
      "- Gender: Male\n",
      "\n",
      "**Admission Date:** [Admission Date]  \n",
      "**Discharge Date:** [Discharge Date]  \n",
      "\n",
      "**Chief Complaint:**  \n",
      "The patient presented with acute heart failure symptoms lasting for one week.\n",
      "\n",
      "**Clinical Findings:**  \n",
      "Upon evaluation, a transthoracic echocardiogram was performed, which revealed a ruptured sinus of Valsalva aneurysm extending into the right ventricle. An angiogram demonstrated a classical windsock deformity associated with the aneurysm.\n",
      "\n",
      "**Intervention:**  \n",
      "The patient underwent a successful device closure using a 10/12 mm LIFETECH CERA PDA occlusion device. \n",
      "\n",
      "**Post-Procedure Assessment:**  \n",
      "Follow-up angiogram and echocardiogram post-procedure indicated no residual shunt.\n",
      "\n",
      "**Follow-Up:**  \n",
      "The patient has been on regular follow-up for six months following the procedure and has not experienced any recurrence of symptoms.\n",
      "\n",
      "**Discharge Condition:**  \n",
      "The patient is stable and has been discharged in good condition with instructions for continued follow-up care.\n",
      "\n",
      "**Recommendations:**  \n",
      "- Continue regular follow-up appointments.\n",
      "- Monitor for any new symptoms and report immediately.\n",
      "\n",
      "**Physician's Signature:**  \n",
      "[Physician Name]  \n",
      "[Date]\n",
      "==================================================\n",
      "==================================================\n",
      "\n",
      "\n",
      "\n",
      "{'filenameid': '31452187', 'n_words_cc': 131, 'n_words_ds': 212, 'gen_orig_ratio': 1.618320610687023}\n",
      "==================================================\n",
      "|       | mention_class   | term                   | span_orig                         | span_gen                          |\n",
      "|------:|:----------------|:-----------------------|:----------------------------------|:----------------------------------|\n",
      "| 13692 | DISEASE         | Atrial Fibrillation    | atrial fibrillation               | atrial fibrillation               |\n",
      "| 13693 | DISEASE         | Atrial Fibrillation    | atrial fibrillation               | atrial fibrillation               |\n",
      "| 13694 | DISEASE         | Atrial Fibrillation    | atrial fibrillation               | atrial fibrillation               |\n",
      "| 13695 | DISEASE         | Heart failure          | None                              | heart failure                     |\n",
      "| 13696 | CHEMICAL        | Thin (qualifier value) | thin                              | thin                              |\n",
      "| 13697 | DISEASE         | Thrombus               | thrombus                          | thrombus                          |\n",
      "| 13698 | DISEASE         | Thrombus               | thrombus                          | thrombus                          |\n",
      "| 13699 | DISEASE         | Thrombus               | thrombus                          | thrombus                          |\n",
      "| 13700 | DISEASE         | Thrombus               | thrombus                          | thrombus                          |\n",
      "| 13701 | DISEASE         | None                   | acute decompensated heart failure | Acute decompensated heart failure |\n",
      "| 13702 | DISEASE         | None                   | acute decompensated heart failure | acute decompensated heart failure |\n",
      "==================================================\n",
      "A 77-year-old woman was hospitalized for acute decompensated heart failure due to paroxysmal atrial fibrillation (AF) with rapid ventricular response. Transesophageal echocardiography (TEE) was performed prior to electrical cardioversion because a left atrial appendage (LAA) thrombus had been described 3 years earlier. Right next to the left atrium, an echogenic, multilobulated, partially mobile mass, similar to the one previously reported, was visualized. However, on closer examination, the cavity surrounding the mass was not continuous with the left atrium. By slightly rotating the TEE probe the true LAA lumen was found, thrombus-free, but collapsed by an echogenic mass. Computed tomography (CT) showed a thin tubular thrombus-free LAA lumen surrounded by isodense fluid in the left pulmonary artery recess of the transverse pericardial sinus and by hypodense epicardial fat.\n",
      "\n",
      "\n",
      "==================================================\n",
      "**Discharge Summary**\n",
      "\n",
      "**Patient Information:**  \n",
      "- **Name:** [Patient Name]  \n",
      "- **Age:** 77 years  \n",
      "- **Gender:** Female  \n",
      "\n",
      "**Admission Date:** [Admission Date]  \n",
      "**Discharge Date:** [Discharge Date]  \n",
      "**Diagnosis:** Acute decompensated heart failure due to paroxysmal atrial fibrillation (AF) with rapid ventricular response.\n",
      "\n",
      "**Clinical Summary:**  \n",
      "The patient was admitted for management of acute decompensated heart failure secondary to paroxysmal atrial fibrillation with rapid ventricular response. Given the history of a left atrial appendage (LAA) thrombus identified three years prior, a transesophageal echocardiography (TEE) was performed prior to proceeding with electrical cardioversion.\n",
      "\n",
      "**Findings:**  \n",
      "During the TEE, an echogenic, multilobulated, partially mobile mass was observed adjacent to the left atrium, resembling the previously reported thrombus. However, further evaluation revealed that the cavity surrounding this mass was not continuous with the left atrium. Upon slight rotation of the TEE probe, the true LAA lumen was identified, which was free of thrombus but collapsed by the echogenic mass.\n",
      "\n",
      "Additionally, a computed tomography (CT) scan demonstrated a thin tubular thrombus-free LAA lumen, surrounded by isodense fluid located in the left pulmonary artery recess of the transverse pericardial sinus, along with hypodense epicardial fat.\n",
      "\n",
      "**Plan:**  \n",
      "The patient will be discharged with appropriate follow-up for management of her atrial fibrillation and heart failure. Recommendations include monitoring for any signs of recurrence of thrombus and regular cardiac evaluations.\n",
      "\n",
      "**Follow-Up:**  \n",
      "The patient is advised to follow up with her cardiologist within one week of discharge for further assessment and management.\n",
      "\n",
      "**Physician's Signature:**  \n",
      "[Physician Name]  \n",
      "[Date]\n",
      "==================================================\n",
      "==================================================\n",
      "\n",
      "\n",
      "\n",
      "{'filenameid': '37983114', 'n_words_cc': 152, 'n_words_ds': 245, 'gen_orig_ratio': 1.611842105263158}\n",
      "==================================================\n",
      "|       | mention_class   | term                       | span_orig               | span_gen                          |\n",
      "|------:|:----------------|:---------------------------|:------------------------|:----------------------------------|\n",
      "| 49722 | DISEASE         | Heart failure              | heart failure           | heart failure                     |\n",
      "| 49723 | DISEASE         | Heart failure              | heart failure           | heart failure                     |\n",
      "| 49724 | DISEASE         | Heart failure              | heart failure           | heart failure                     |\n",
      "| 49725 | DISEASE         | Magnetic Resonance Imaging | MR                      | MR                                |\n",
      "| 49726 | DISEASE         | Magnetic Resonance Imaging | MR                      | MR                                |\n",
      "| 49727 | DISEASE         | Magnetic Resonance Imaging | MR                      | MR                                |\n",
      "| 49728 | DISEASE         | Magnetic Resonance Imaging | MR                      | MR                                |\n",
      "| 49729 | DISEASE         | Magnetic Resonance Imaging | MR                      | MR                                |\n",
      "| 49730 | DISEASE         | Magnetic Resonance Imaging | MR                      | MR                                |\n",
      "| 49731 | DISEASE         | Magnetic Resonance Imaging | MR                      | MR                                |\n",
      "| 49732 | DISEASE         | Magnetic Resonance Imaging | MR                      | MR                                |\n",
      "| 49733 | DISEASE         | Magnetic Resonance Imaging | MR                      | MR                                |\n",
      "| 49734 | DISEASE         | Mitral Valve Insufficiency | mitral regurgitation    | mitral regurgitation              |\n",
      "| 49735 | DISEASE         | Mitral Valve Insufficiency | mitral regurgitation    | degenerative mitral regurgitation |\n",
      "| 49736 | DISEASE         | None                       | fibroelastic deficiency | fibroelastic deficiency           |\n",
      "==================================================\n",
      "An 80-year-old man was referred to our center for heart failure and severe degenerative mitral regurgitation (MR). Transesophageal echocardiography revealed severe MR due to anterior leaflet prolapse, mainly in its central portion (A2) in the context of fibroelastic deficiency. Percutaneous edge-to-edge repair was chosen by the Heart Team due to high surgical risk. Using a wide MitraClip G4 XTW (Abbott Vascular), a good grasp with appropriate leaflet insertion and MR reduction to mild was obtained. Shortly afterwards, just before clip release, echocardiography revealed the appearance of a massive regurgitant jet due to a posterior leaflet perforation/laceration just posteriorly to the clip. The patient developed hemodynamic instability with an urgent treatment required. The wide MitraClip was then reopened and a new leaflet grasp included the laceration inside the grasping zone with mild-to-moderate residual MR. Considering the previous laceration, mild-to-moderate residual MR was considered acceptable.\n",
      "\n",
      "\n",
      "==================================================\n",
      "**Discharge Summary**\n",
      "\n",
      "**Patient Information:**\n",
      "- **Age:** 80 years\n",
      "- **Gender:** Male\n",
      "\n",
      "**Referring Diagnosis:**\n",
      "- Heart failure\n",
      "- Severe degenerative mitral regurgitation (MR)\n",
      "\n",
      "**Clinical Findings:**\n",
      "The patient was referred to our center for evaluation and management of heart failure secondary to severe degenerative mitral regurgitation. Transesophageal echocardiography indicated severe MR attributed to anterior leaflet prolapse, primarily affecting the central portion (A2) in the context of fibroelastic deficiency.\n",
      "\n",
      "**Procedure:**\n",
      "After thorough evaluation by the Heart Team, percutaneous edge-to-edge repair was deemed appropriate due to the patient's high surgical risk. The procedure was performed using a wide MitraClip G4 XTW (Abbott Vascular). Initial placement resulted in a successful grasp and a reduction of MR to mild levels.\n",
      "\n",
      "**Complications:**\n",
      "However, shortly before the clip release, echocardiography revealed the emergence of a massive regurgitant jet caused by a perforation/laceration of the posterior leaflet, located just posterior to the clip. This complication led to the development of hemodynamic instability, necessitating urgent intervention.\n",
      "\n",
      "**Intervention:**\n",
      "The MitraClip was reopened, and a new grasp was performed that included the laceration within the grasping zone. This maneuver resulted in mild-to-moderate residual MR, which was considered acceptable given the prior laceration.\n",
      "\n",
      "**Conclusion:**\n",
      "The patient was stabilized with mild-to-moderate residual MR post-procedure. He will require follow-up for ongoing management of his heart failure and monitoring of mitral valve function. \n",
      "\n",
      "**Recommendations:**\n",
      "- Schedule follow-up echocardiogram to assess mitral valve function.\n",
      "- Monitor for signs of heart failure exacerbation.\n",
      "- Consider cardiology follow-up for ongoing management.\n",
      "\n",
      "**Discharge Status:**\n",
      "The patient is stable for discharge with appropriate follow-up arrangements in place.\n",
      "==================================================\n",
      "==================================================\n",
      "\n",
      "\n",
      "\n",
      "{'filenameid': '36742441_1', 'n_words_cc': 105, 'n_words_ds': 168, 'gen_orig_ratio': 1.6}\n",
      "==================================================\n",
      "|       | mention_class   | term                              | span_orig                             | span_gen                              |\n",
      "|------:|:----------------|:----------------------------------|:--------------------------------------|:--------------------------------------|\n",
      "| 44643 | DISEASE         | Adenocarcinoma of lung (disorder) | None                                  | lung adenocarcinoma                   |\n",
      "| 44644 | DISEASE         | Fatigue                           | fatigue                               | fatigue                               |\n",
      "| 44645 | DISEASE         | Heart Failure, Systolic           | systolic heart failure                | None                                  |\n",
      "| 44646 | DISEASE         | Heart failure                     | None                                  | heart failure                         |\n",
      "| 44647 | DISEASE         | Heart failure                     | None                                  | heart failure                         |\n",
      "| 44648 | DISEASE         | Malignant neoplasm of lung        | None                                  | lung cancer                           |\n",
      "| 44649 | DISEASE         | Metastatic Lung Adenocarcinoma    | oligometastatic lung adenocarcinoma   | None                                  |\n",
      "| 44650 | DISEASE         | Non-Small Cell Lung Carcinoma     | None                                  | upper-lobe non-small cell lung cancer |\n",
      "| 44651 | DISEASE         | None                              | incidental left-sided chest wall mass | incidental left-sided chest wall mass |\n",
      "==================================================\n",
      "A 71-year-old woman had a history of advanced systolic heart failure status post HM 3 LVAD and left upper-lobe non-small cell lung cancer status post lobectomy. She was found to have an incidental left-sided chest wall mass on computed tomography (CT) imaging, with subsequent biopsy demonstrating oligometastatic lung adenocarcinoma. She consequently underwent 5 fractions of 600 centigray (cGy) SBRT to her left lateral chest wall over a period of 10 days. Mild fatigue was reported following radiation; however, LVAD log files sent after each fraction were unremarkable. During the first year of follow-up, device malfunction has not been witnessed.\n",
      "\n",
      "\n",
      "==================================================\n",
      "**Discharge Summary**\n",
      "\n",
      "**Patient Information:**\n",
      "- Name: [Patient Name]\n",
      "- Age: 71 years\n",
      "- Gender: Female\n",
      "\n",
      "**Medical History:**\n",
      "- Advanced systolic heart failure, status post HeartMate 3 left ventricular assist device (HM 3 LVAD) implantation.\n",
      "- Left upper-lobe non-small cell lung cancer, status post lobectomy.\n",
      "\n",
      "**Reason for Admission:**\n",
      "The patient was admitted for evaluation and treatment of an incidental left-sided chest wall mass identified on computed tomography (CT) imaging.\n",
      "\n",
      "**Diagnosis:**\n",
      "Oligometastatic lung adenocarcinoma, confirmed by biopsy.\n",
      "\n",
      "**Treatment Provided:**\n",
      "The patient received stereotactic body radiation therapy (SBRT) consisting of 5 fractions of 600 centigray (cGy) to the left lateral chest wall over a duration of 10 days.\n",
      "\n",
      "**Post-Treatment Course:**\n",
      "- The patient reported mild fatigue following the radiation therapy.\n",
      "- LVAD log files were reviewed after each treatment fraction and showed no abnormalities.\n",
      "- During the first year of follow-up, there have been no instances of device malfunction.\n",
      "\n",
      "**Plan:**\n",
      "- Continue regular follow-up for monitoring of heart failure and lung cancer status.\n",
      "- Assess for any potential late effects of radiation therapy in subsequent visits.\n",
      "\n",
      "**Discharge Condition:**\n",
      "The patient is stable and has been discharged with instructions for follow-up care. \n",
      "\n",
      "**Follow-Up Appointment:**\n",
      "Scheduled for [insert date] at [insert location]. \n",
      "\n",
      "**Physician's Signature:**\n",
      "[Physician Name]\n",
      "[Date]\n",
      "==================================================\n",
      "==================================================\n",
      "\n",
      "\n",
      "\n",
      "{'filenameid': '36742441_2', 'n_words_cc': 119, 'n_words_ds': 188, 'gen_orig_ratio': 1.5798319327731092}\n",
      "==================================================\n",
      "|       | mention_class   | term                            | span_orig                 | span_gen                  |\n",
      "|------:|:----------------|:--------------------------------|:--------------------------|:--------------------------|\n",
      "| 44652 | DISEASE         | Complication                    | LVAD complications        | None                      |\n",
      "| 44653 | DISEASE         | Dyspnea                         | dyspnea                   | dyspnea                   |\n",
      "| 44654 | DISEASE         | Dyspnea                         | dyspnea                   | dyspnea                   |\n",
      "| 44655 | DISEASE         | Heart Failure, Systolic         | systolic heart failure    | systolic heart failure    |\n",
      "| 44656 | DISEASE         | Heart failure                   | None                      | heart failure             |\n",
      "| 44657 | CHEMICAL        | Hydrops Fetalis                 | HF                        | None                      |\n",
      "| 44658 | DISEASE         | Hydrops Fetalis                 | HF                        | HF                        |\n",
      "| 44659 | DISEASE         | Lymphadenopathy                 | lymphadenopathy           | lymphadenopathy           |\n",
      "| 44660 | DISEASE         | Malignant neoplasm of lung      | None                      | lung cancer               |\n",
      "| 44661 | DISEASE         | Squamous cell carcinoma of lung | squamous cell lung cancer | squamous cell lung cancer |\n",
      "==================================================\n",
      "A 70-year-old man with a history of advanced systolic heart failure (HF) and HM3 LVAD implantation presented with worsening dyspnea. He was found to have a right upper-lobe nodule with mediastinal lymphadenopathy on CT imaging. Ensuing biopsy diagnosed squamous cell lung cancer without metastatic disease. SBRT was initiated, and five treatments of 1,000 cGy were delivered to the right upper-lobe lesion within 10 days. No LVAD complications or symptoms of HF were witnessed during treatment or in subsequent follow-up. On outpatient follow-up, the patient denied any symptoms and normal LVAD function was observed with flow 4.3 L/min, speed 5,200 rpm, pulse index 4.8, and power 3.8 watts.\n",
      "\n",
      "\n",
      "==================================================\n",
      "**Discharge Summary**\n",
      "\n",
      "**Patient Information:**\n",
      "- **Name:** [Patient Name]\n",
      "- **Age:** 70 years\n",
      "- **Gender:** Male\n",
      "\n",
      "**Admission Date:** [Admission Date]  \n",
      "**Discharge Date:** [Discharge Date]  \n",
      "**Attending Physician:** [Physician Name]  \n",
      "\n",
      "**Chief Complaint:**  \n",
      "Worsening dyspnea.\n",
      "\n",
      "**History of Present Illness:**  \n",
      "The patient is a 70-year-old male with a known history of advanced systolic heart failure (HF) and a HeartMate 3 (HM3) left ventricular assist device (LVAD) implantation. He presented with worsening dyspnea, prompting further investigation.\n",
      "\n",
      "**Diagnostic Imaging:**  \n",
      "A CT scan revealed a right upper-lobe nodule accompanied by mediastinal lymphadenopathy.\n",
      "\n",
      "**Biopsy Results:**  \n",
      "A biopsy of the nodule confirmed the diagnosis of squamous cell lung cancer, with no evidence of metastatic disease.\n",
      "\n",
      "**Treatment:**  \n",
      "The patient was initiated on stereotactic body radiation therapy (SBRT), receiving five treatments of 1,000 cGy to the right upper-lobe lesion over a span of 10 days.\n",
      "\n",
      "**Clinical Course:**  \n",
      "Throughout the treatment period, the patient experienced no complications related to the LVAD, nor did he exhibit any symptoms of heart failure. \n",
      "\n",
      "**Follow-Up:**  \n",
      "During outpatient follow-up, the patient reported no symptoms. The LVAD function was assessed, revealing:\n",
      "- Flow: 4.3 L/min\n",
      "- Speed: 5,200 rpm\n",
      "- Pulse Index: 4.8\n",
      "- Power: 3.8 watts\n",
      "\n",
      "**Discharge Condition:**  \n",
      "The patient is stable and has been discharged in good condition with normal LVAD function.\n",
      "\n",
      "**Follow-Up Recommendations:**  \n",
      "The patient is advised to continue regular follow-up appointments for monitoring of his lung cancer and LVAD function.\n",
      "\n",
      "**Signature:**  \n",
      "[Physician Name]  \n",
      "[Date]\n",
      "==================================================\n",
      "==================================================\n",
      "\n",
      "\n",
      "\n",
      "{'filenameid': '35038791_3', 'n_words_cc': 152, 'n_words_ds': 235, 'gen_orig_ratio': 1.5460526315789473}\n",
      "==================================================\n",
      "|       | mention_class   | term                         | span_orig              | span_gen                       |\n",
      "|------:|:----------------|:-----------------------------|:-----------------------|:-------------------------------|\n",
      "| 35981 | DISEASE         | Atrial Fibrillation          | atrial fibrillation    | Atrial fibrillation            |\n",
      "| 35982 | DISEASE         | Atrial Fibrillation          | atrial fibrillation    | atrial fibrillation            |\n",
      "| 35983 | DISEASE         | Bradycardia                  | bradycardia            | Bradycardia                    |\n",
      "| 35984 | DISEASE         | Bradycardia                  | bradycardia            | bradycardia                    |\n",
      "| 35985 | DISEASE         | Cardiomyopathy, Dilated      | dilated cardiomyopathy | Dilated cardiomyopathy         |\n",
      "| 35986 | DISEASE         | Cardiomyopathy, Dilated      | dilated cardiomyopathy | dilated cardiomyopathy         |\n",
      "| 35987 | DISEASE         | Fibrosis                     | fibrosis               | fibrosis                       |\n",
      "| 35988 | DISEASE         | Fibrosis                     | fibrosis               | fibrosis                       |\n",
      "| 35989 | DISEASE         | Fibrosis                     | fibrosis               | fibrosis                       |\n",
      "| 35990 | DISEASE         | Fibrosis                     | fibrosis               | fibrosis                       |\n",
      "| 35991 | DISEASE         | Heart failure                | heart failure          | heart failure                  |\n",
      "| 35992 | DISEASE         | Left bundle branch structure | None                   | Left Bundle Branch Area Pacing |\n",
      "| 35993 | CHEMICAL        | None                         | LBBAP                  | LBBAP                          |\n",
      "| 35994 | DISEASE         | None                         | CRTD                   | CRTD                           |\n",
      "==================================================\n",
      "A 52‐year‐old female, was diagnosed with dilated cardiomyopathy and had a single‐chamber pacemaker implanted 10 years ago due to atrial fibrillation and bradycardia. Ventricular pacing percentage was 100%. Due to the progression of heart failure with reduced LVEF (31.3%), the patient's pacemaker was upgraded to CRTD with LBBAP implantation. Approximately 1 year later, she got a heart transplant. The dissection of the diseased heart showed the location of the lead in relation to the ventricular septum. The lead was located in the superior with a depth of 7 mm, which was consistent with the intraoperative DSA image and the findings of immediately postoperative cardiac ultrasound. Fibrotic tissue was seen around the tip of the lead. Histopathologic examination showed obvious myocardial fibrosis in the ventricular septum where the pacing lead was deployed while there was no obvious tissue fibrosis in the septal myocardium far away from the lead.\n",
      "\n",
      "\n",
      "==================================================\n",
      "**Discharge Summary**\n",
      "\n",
      "**Patient Information:**\n",
      "- Name: [Patient Name]\n",
      "- Age: 52 years\n",
      "- Gender: Female\n",
      "\n",
      "**Diagnosis:**\n",
      "- Dilated cardiomyopathy\n",
      "- Atrial fibrillation\n",
      "- Bradycardia\n",
      "\n",
      "**Medical History:**\n",
      "The patient was diagnosed with dilated cardiomyopathy and underwent implantation of a single-chamber pacemaker 10 years ago due to atrial fibrillation and bradycardia. The pacemaker was functioning with a ventricular pacing percentage of 100%.\n",
      "\n",
      "**Recent Interventions:**\n",
      "Due to the progression of heart failure, characterized by a reduced left ventricular ejection fraction (LVEF) of 31.3%, the patient’s pacemaker was upgraded to a Cardiac Resynchronization Therapy Defibrillator (CRTD) with Left Bundle Branch Area Pacing (LBBAP) implantation. Approximately one year post-upgrade, the patient received a heart transplant.\n",
      "\n",
      "**Intraoperative Findings:**\n",
      "During the dissection of the diseased heart, the location of the pacing lead in relation to the ventricular septum was assessed. The lead was positioned in the superior aspect of the septum, with a depth of 7 mm, which correlated with intraoperative Digital Subtraction Angiography (DSA) imaging and immediate postoperative cardiac ultrasound findings.\n",
      "\n",
      "**Histopathological Examination:**\n",
      "Histopathological analysis revealed significant myocardial fibrosis in the ventricular septum at the site of the pacing lead. In contrast, there was no notable tissue fibrosis observed in the septal myocardium located further away from the lead.\n",
      "\n",
      "**Conclusion:**\n",
      "The patient has been successfully discharged following heart transplantation, with careful monitoring of cardiac function and follow-up appointments recommended to assess recovery and management of her cardiac health. \n",
      "\n",
      "**Follow-Up:**\n",
      "- Schedule follow-up appointments with cardiology and transplant team.\n",
      "- Monitor for signs of rejection and manage immunosuppressive therapy as per protocol.\n",
      "\n",
      "**Prepared by:**\n",
      "[Your Name]\n",
      "[Your Title]\n",
      "[Date]\n",
      "==================================================\n",
      "==================================================\n",
      "\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "import numpy as np\n",
    "for idx, row in outliers.iterrows():\n",
    "    print(row[[\"filenameid\", \"n_words_cc\", \"n_words_ds\", \"gen_orig_ratio\"]].to_dict())\n",
    "    \n",
    "    print(\"=\" * 50)\n",
    "    \n",
    "    print(df_auto_merge[df_auto_merge[\"filenameid\"] == row[\"filenameid\"]].fillna(value=\"None\").drop(columns=[\"filenameid\"]).to_markdown())\n",
    "    # print(np.array(extract_text_without_sections(row[\"clinical_case\"]).split(\".\")))\n",
    "    print(\"=\" * 50)\n",
    "\n",
    "    print(row[\"clinical_case\"])\n",
    "    \n",
    "    print(\"=\" * 50)\n",
    "    \n",
    "    print(row[\"discharge_summary\"])\n",
    "\n",
    "    print(\"=\" * 50)\n",
    "    print(\"=\" * 50)\n",
    "\n",
    "    print(\"\\n\\n\")\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.16"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
